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ABSTRACT 	
In prokaryotes, protein glycosylation can be a determinant of pathogenicity 
as it plays a role in host adherence, invasion, and colonization. Impairment of 
glycosylation in some organisms, for example N-linked glycosylation in 
Campylobacter jejuni, leads to decreased pathogenicity; thus, opening new avenues 
for the development of antivirulence agents. A member of the protein 
glycosylation (pgl) gene locus in C. jejuni, PglC, is predicted single-pass 
transmembrane (TM) protein, that catalyzes the phosphoglycosyl transferase 
(PGT) reaction in the first membrane-committed step of the N-linked glycosylation 
pathway. The small size of PglC (201 aa) compared to homologous PGTs suggests 
it may represent the minimal catalytic unit for the monotopic PGT superfamily. 
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Herein, the structure of C. concisus PglC including its putative TM domain 
has been solved to 2.74 Å resolution to reveal a novel protein fold with a unique 
alpha-helix-associated beta-hairpin (AHABh) motif and largely solvent-exposed 
structure. There is noted a parsimony of fold in the form of short-range motifs 
underpinning the structural basis for critical functions of PglC: membrane 
association and active-site geometry. Biochemical and bioinformatics studies 
support structural evidence suggesting the crystallographically-observed, kinked 
TM helix is re-entrant on the cytoplasmic face of the membrane rather than 
membrane spanning. Thus, PglC represents a first-in-class structure of a novel 
membrane interaction mode for monotopic membrane proteins. Additionally, the 
AHABh-motif and active-site helical geometry establishes co-facial positioning of 
the catalytic-dyad. Molecular docking of PglC substrates, undecaprenyl 
phosphate (UndP) and UDP-N,N-diacetylbacillosamine (UDP-diNAcBac), within 
the active-site reveals co-incident binding sites, consistent with the proposed ping-
pong enzymatic mechanism.  
Loading of PglC into membrane-bilayer nanodiscs (ND) allows for the 
investigation of PglC structure and function within a native-like membrane 
environment by small-angle x-ray scattering (SAXS). Observation of PglC in ND via 
SAXS confirms the application of the method for studying small, integral, monotopic 
  xii 
membrane proteins in a membrane environment. Moreover, development of a 
mathematical approach by which resident-protein: ND stoichiometry can be deduced 
from measured scattering intensity enables independent confirmation of loading 
stoichiometry.  
Overall, the membrane-interaction modality observed for PglC is the first 
structurally characterized example of a new membrane association mode for 
monotopic proteins with the membrane. These studies provide insight into the 
structural determinants of the chemical mechanism and substrate-binding for C. 
concisus PglC and for the extensive homologous monotopic PGT superfamily, thus 
allow homology modeling and enabling future inhibitor design. 
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1.1   Glycoconjugates impart structure and function in bacteria 
 
Glycosylation of proteins is a commonly occurring post-translational 
modification. In general, glycosylation pathways involve monosaccharides that 
are linked by glycosidic bonds to create glycan chains (1). These glycan chains are 
attached to serine (Ser), threonine (Thr), or asparagine (Asn) residues of a target 
protein. The residue that is modified determines the identity of the glycosylation 
as either nitrogen-linked (N-linked), if on Asn, or oxygen-linked (O-linked), if on 
Ser or Thr. Notably, 30 - 40% of the eukaryotic proteome is glycosylated to produce 
glycoproteins or other downstream glycoconjuates, which play roles in critical 
cellular processes including protein folding, protein trafficking, cell-cell 
interactions, and the host-immune response (2, 3). Whereas the prevalence of 
glycosylation is significantly higher in eukaryotes, glycosylation plays a no-less 
critical role for members of the prokaryotic kingdom. The resulting glycoproteins 
and glycoconjugates in bacteria are involved in pathways promoting improved 
survival and pathogenicity where they play structural and modulatory roles 
through the formation of cell wall peptidoglycan and mediation of host-cell 







The prevalence of glycoconjugates within critical cellular processes 
necessitates the extensive characterization of bacterial glycosylation pathways. In 
bacteria, glycosylation occur via two main biosynthetic mechanisms, sequential 
transfer or en bloc transfer (4).  Sequential glycosylation mechanisms involve 
transfer of sugar moieties directly to the substrate (lipid, protein, etc.) of interest 
by glycosyltransferases (GT) enzymes to build up simple glycans.  In contrast, en 
bloc bacterial glycosylation pathways involve commencement of glycosylation 
through a phopshoglycosyl transferase (PGT) followed series of GT enzymes 
which function at the cytoplasmic membrane interface to create and grow an 
oligosaccharide chain linked to a membrane-embedded polyprenol-phosphate 
(Pren-P). Upon translocation of the glycan chain to the periplasmic space the fully-
assembled glycan chains can then be transferred en bloc to a protein target or 
further processed into glycoconjugates.  En bloc glycosylation enables biosynthesis 
of complex glycoconjugates, such as peptidoglycan, capsular polysaccharides 










Figure 1.1.  Exemplar downstream glycoconjugates arising from en bloc 
glycoconjugate biosynthetic pathways in bacteria. Phosphoglycosyl transferase 
(PGT) and glycosyltransferase (GT) enzymes comprising the en bloc biosynthetic 
pathways depicted in red text. CPS is capsular polysaccharide. LPS is 
lipopolysaccharide. PrenP is polyprenol-phosphate. NDP is nucleotide 
diphosphate. Green block represents lipid A anchor. Hexagons represent sugar 
moieties. 
 
These downstream glycoconjugates produced by en bloc glycosylation 
pathways are associated with bacterial survival and pathogenicity. For example, 







protection.  Cell-wall structural integrity, as well as host-pathogen interactions, 
are further mediated by the cell-wall polysachharide CPS. Together with CPS, O-
antigen and LPS comprise the majority of the antigens on the surface of the Gram-
negative bacterium Eschericia coli (8). Similarly, N- and O-linked glycoproteins 
resultant from en bloc glycosylation pathways have been implicated in host-cell 
adhesion, colonization, and invasion (9, 10). The roles played by bacterial 
glycoconjugates as determinants of bacterial pathogenicity necessitate a detailed 
understanding of both the functions glycoconjugates and the glycosylation 
pathways.  
 
1.2   N-linked glycosylation in pathogenic bacteria 
 
The N-linked glycosylation pathway from Campylobacter jejuni is the most 
widely characterized N-linked glycosylation pathway and often serves as the 
prototype for the study of bacterial en bloc glycosylation pathways (6, 9). Genetic 
impairment of the N-linked glycosylation pathway in Campylobacter jejuni via 
glycosylation-null mutants results in decreased pathogenicity via a decrease in the 
ability of a bacterium to adhere to, invade, and/or colonize its host (6, 9). From 
these studies, it is only clear that bacterial virulence requires N-linked 







glycoproteins within the bacteria; therefore, making it uncertain if this effect is the 
result of a singular or cumulative loss of glycoproteins within the cells.  
The N-linked glycosylation pathway in C. jejuni shares similarity to pathways in 
Nesseria gonhorreae and Heliobacter pullorum, all three of which are major causative 
agents of human disease. Enzymes which make up the C. jejuni N-linked 
glycosylation pathway, summarized in figure 1.2, are encoded by a single protein 
glycosylation (pgl) gene locus (11). The pathway starts with soluble UDP-GlcNAc 
(uridine diphosphate N-acetylglucosamine) which is then transformed into the 
unique sugar containing UDP-N,N′-diacetyl-bacillosamine (UDP-diNAcBac) by 
PglD, PglE, and PglF. PglC, an integral membrane PGT, then links this unique 
sugar-phosphate to a membrane-resident undecaprenol phosphate (UndP) and 
releases UMP. At this point the nascent glycan chain is committed to the 
membrane with the membrane-bound PrenP-PP-diNAcBac allowing for the 
commencement of glycoconjugate biosynthesis. Through the action of subsequent 
glycosyltransferases PglA, PglJ, PglH, and PglI, the heptasaccharide glycan chain 
is fully assembled. The PglK flippase translocates the completed glycan (GalNAc-
α-1,4-GalNAc-α-1,4-(Glc-β-1,3)-GalNAc-α-1,4-GalNAc-α-1,4-GalNAc-α-1,3-
diNAcBac) from the cytoplasmic space into the periplasmic space, where PglB can 







proteins (12, 13).  Notably, the crystal structures of  the Campylobacter 
oligiosaccharyl transferase PglB (PDB ID: 3RCE, C. lari; 3AAG, C. jejuni) and the 
flippase PglK (PDB ID: 5C76, C. jejuni) have been previously determined.  
 
 
Figure 1.2. N-linked glycosylation pathway in C. jejuni. 
 
 
Within en bloc glycosylation pathways, typified by the C. jejuni N-linked 
pathway, catalysis of the the first membrane-committed step by a membrane-
bound phosphoglycosyl transferase (PGT) is a shared feature. The PGT isalso 







phosphosugar from a soluble nucleoside-diphosphate sugar to a polyprenol 
phosphate (PrenP) resident in the cytoplasmic face of the membrane (Figure 1.3) 
(14, 15).  PGTs effectively act as gatekeepers of glycan biosynthesis within these 
pathways; as such, they are well-poised for inhibition. It should be noted that 
PGTs are not unique to bacteria; they are also found in similar eukaryotic 
glycosylation pathways, where they initate N-linked glycosylation through the 




Figure 1.3. General PGT reaction scheme in C. jejuni PglC as an exemplar for 
bacterial PGT reactions. 
 
 
1.3   Bacterial PGT enzyme superfamiles 
The PGT reaction is carried out by two isofunctional superfamilies of PGT 
enzymes: the polytopic PGT superfamily and the monotopic PGT superfamily (14, 
17). While the superfamilies catalyze the same general reaction, they are 
structurally and mechanistically divergent. The polytopic PGT superfamily, 
typified by the MraY and WecA subfamilies, is characterized by 10-11 













































is responsible for the transfer of 1-phospho-MurNAc-pentapeptide (L-Ala-γ-D-
Glu-diaminopimelic acid/ L-Lys-D-Ala-D-Ala) to UndP in the membrane to 
initiate the biosynthesis of peptidoglycan. Similarly, the 11-TM helix enzyme 
WecA catalyzes the transfer of GlcNAc-1-phosphate to PrenP (18) within the O-
antigen biosynthesis pathway. Of the polytopic PGTs, MraY remains the only 
structurally characterized member of the superfamily (19). In contrast, the 
isofunctional monotopic PGT superfamily is predicted to assume single-pass 
transmembrane topology with a hydrophobic membrane-associated domain and 
a soluble globular domain. The monotopic PGT superfamily is subdivided into the 
PglC-monofunctional, PglB-bifunctional, and WbaP subfamilies (Figure 1.4b) (20). 
The monofunctional-PglC and bifunctional-PglB subfamilies catalyze the transfer 
of the unique sugar (diNAcBac) with the C1’-phosphate to UndP (20, 21) in the 
biosynthesis of N-linked and O-linked glycoproteins, respectively. The WbaP 
subfamily catalyzes the transfer of galactose-phosphate (Gal-P) to UndP (22) to 
initiate the O-antigen biosynthetic pathway. Prior to the work elucidating the 
molecular structure of C. concisus PglC presented in this dissertation, this entire 









Figure 1.4. Schematic of topology differences between members of the polytopic 
and monotopic PGT superfamilies.  
 
 
In addition to the stark differences in molecular architecture, the polytopic 
and monotopic PGT superfamiles are mechanistically divergent. Mechanistic 
studies of MraY and WecA have demonstrated that the PGT reaction proceeds 
through a ternary complex reaction mechanism; both substrates, the UDP-sugar 
and the polyprenol phosphate, occupy the active site simultaneously for catalysis 
(Figure 1.4) (23, 24). In contrast, recent biochemical studies of C. concisus PglC 
provide evidence that the monotopic PGTs proceeds through a covalent-phospho-
sugar intermediate which undergoes two-step, ping-pong kinetics (Figure 1.5). In 
the first step, the UDP-sugar enters the active site where the enzyme nucleophile, 
the carboxylate of Asp, attacks at the β-phosphate of the UDP to create the 
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second step, the membrane-resident UndP enters the active site where it attacks 
the phospho-sugar intermediate to release the enzyme aspartate and produce the 
membrane-bound Und-PP-diNAcBac product (25). As structure and function are 
intimately married in biomolecules, it is unsurprising that the marked difference 
in molecular architecture is mirrored by a stark difference in enzymatic 





Figure 1.5.  Schematic representation of polytopic and monotopic PGT 
enzymatic mechanisms. Enzyme active site represented by blue circle. PGT 








1.4   PGTs as targets for anti-virulence and antibacterial agent development 
PGTs, in general, carry out the first membrane-committed step of many 
glycoconjugate pathways. It has been noted that PGT enzymes are inhibited by 
nucleoside antibiotics (26). Many of such antibiotics appear to be a bi-substrate 
analog inhibitors based on their chemical structures as they possess chemical 
moieties similar to the substrates (UDP-Sugar and PrenP) of the PGT enzymes. 
Tunicamycin, a member of this class of antibacterial compounds, possesses a 
nucleoside analog, sugar analog, Pren-P analog, and a pseudo-GalNAc (N-
acetylglucosamine) moiety to serve as a diphosphate mimic (Figure 1.5) (27). 
 
 
Figure 1.6. Chemical structure of the nucleoside antibiotic Tunicamycin. 








 As a result, tunicamycin is a potent inhibitor of both eukaryotic and 
prokaryotic glycosylation. Activity assays show that WecA from the polytopic 
PGT superfamily, has reduced activity upon inhibition by tunicamycin. 
Conversely, in the same assay C. jejuni PglC, from the monotopic PGT 
superfamily, activity was not inhibited (20). Given what is currently known about 
the differing mechanisms for the polytopic PGT family in comparison to the 
monotopic PGT family, it follows that the architecture of the enzyme active sites 
must be largely different. From this view it is unsurprising that the polytopic PGT 
WecA was inhibited by tunicamycin as the antibiotic chemical structure could 
functionally mimic the bi-substrate complex in the active site. Conversely, for the 
monotopic PglC substrate binding cannot be coincident as the covalent phospho-
sugar intermediate mechanism suggests; therefore, the tunicamycin scaffold is no-
longer a functional mimic for the catalytically-active enzyme-substrate complex. 
Overall, this differential sensitivity to tunicamycin suggests a detailed molecular 
understanding of the fundamental structural and mechanistic divergence of the 
monotopic and polytopic PGTs is necessary to provide an avenue for development 








1.5   C. jejuni PglC represents the minimal catalytic unit for monotopic PGTs 
Development of specific and potent inhibitors of N-linked glycosylation in 
bacteria necessitates a molecular understanding of the monotopic PGT 
superfamily. Thus, it is critical to have an experimentally determined three-
dimensional structure of one of the superfamily members. As discussed earlier, 
the monotopic PGT superfamily is characterized by three subfamilies: the PglC-
monofunctional, PglB-bifunctional, and WbaP subfamilies (17, 20). Differences in 
sugar specificity and molecular architecture between each subfamily account for 
their differentiation (Figure 1.6) (15). The PglC-monofunctional subfamily is 
structurally characterized by a single predicted TM helix domain and a small 
globular domain. The PglB-bifunctional subfamily contains a C-terminal-domain 
homologous to the PglC-monofunctional subfamily fused to a soluble N-terminal 
acetyltransferase domain homologous to the trimeric β-helix of PglD in C. jejuni 
(13). Seemingly misfit for the monotopic classification, the WbaP subfamily is 
characterized by a multipass transmembrane topology; however, truncation 
mutagenesis in a WbaP homolog, WcaJ, suggests that the C-terminal domain, 
comprised of one TM helix homologous to the PglC-monofunctional subfamily, is 
sufficient for full PGT activity making the family functionally monotopic (Figure 







monofunctional subfamily, with its relatively small size (~200 aa) and small 
cytosolic and membrane-associated domains, represents the minimal catalytic unit 
for the monotopic PGT reaction. 
 In the absence of an experimentally-determined structure, Lukose et al. 
leveraged biochemical structure-function analyses and bioinformatics to construct 
structural model of the cytosolic globular domain of C. jejuni PglC (17). Ultimately, 
the model was calculated by employing three-dimensional distance constraints 
suggested by residue evolutionary-covariance across a monotopic PGT 
superfamily alignment of 15,000 sequences. The PglB-bifunctional and WbaP 
subfamilies share significant sequence identity with the PglC-monofunctional 
subfamily (53% and 34%, respectively); thus, any structural insight gained for the 
minimal PglC scaffold can be readily translated to the entire monotopic PGT 









Figure 1.7. PglC represents the minimal catalytic unit for the monotopic PGT 
reaction. EV-fold model of globular domain of C. jejuni PglC (17) shown in color 
ramp from blue N-terminus to red C-terminus. Homologous soluble domain of 
the PglB-bifunctional and WbaP families represented by light blue PglC domain 
model (17). Experimentally determined acetyltransferase domain of PglB (4M98) 
from Neisseria gonorrhoeae shown in gray ribbon (28).  
  
As a target for structure elucidation, the smallest (23 kDa, 200 aa) of the 
PglC-monofunctional subfamily members is from the well-characterized N-linked 
glycosylation pathway in C. jejuni. Overall, the enzyme PglC from C. jejuni 
presents as an optimal candidate for structure elucidation and inhibitor 
development as it represents the minimal catalytic unit for the superfamily and 
catalyzes the first membrane-committed step of the N-linked glycosylation 







Not only is the structure of PglC of significant biological interest, the 
structure of PglC is poised to expand general knowledge in structural biology. 
Notably, single-pass trans-membrane proteins, the topological classification of 
which PglC is predicted to belong to, are vastly under-represented in the PDB 
(Protein Data Bank) with only 0.5% (387 structures) of the non-redundant PDB 
having the same classification. Additionally, computational modeling of PglC 
structure using co-evolution and covariance constraints coupled with low 
sequence identity to proteins of known structure suggests the fold of the globular 
domain to be a novel protein fold (17). 
 
1.6   Dissertation research specific aims 
PglC, a putative single-pass transmembrane protein, represents the 
minimal catalytic unit for a structurally uncharacterized superfamily of PGT 
enzymes. The objective of my thesis research is to elucidate the unique structural 
characteristics of PglC that underpin membrane association and function of the 
minimal scaffold for the phosphoglycosyl transferase reaction in PGTs through 
work on the following specific aims:  
 
Aim 1: Elucidate the structural determinants of membrane association.  







binding and specificity for PglC.  
Aim3: Assess nanodiscs as a tool to study PglC in a native-like lipid 
environment by small angle x-ray scattering. 
 
1.7   Summary of chapters in dissertation 
The work presented in this dissertation explores the structural 
determinants of membrane association and enzymatic mechanism for PglC, an 
exemplar of the monotopic PGT superfamily. In the following chapter, the 
circuitous path required to determine the novel molecular structure of PglC from 
C. concisus, a related strain to C. jejuni, is discussed. Subsequently, chapters three 
and four, analyze the membrane interaction interface and structural determinants 
of the covalent-intermediate mechanism for PglC through structural, 
bioinformatics, and biochemical frameworks. Chapter Five lays the groundwork 
for understanding PglC, and therefore other small integral monotopic membrane 
proteins, in a native-like lipid in environment through the use of lipid-bilayer 
nanodiscs. Lastly, the major conclusions arising from the work presented in this 






































The work presented in this chapter is included in the following accepted article: 
Ray, L.C., Das, D., Entova, S., Lukose, V., Lynch, A.J., Imperiali, B., and Allen, 
K.N. Membrane association of monotopic phosphoglycosyl transferase 








PglC, a monotopic PGT, is responsible for the first membrane-committed 
step of N-linked glycosylation in the pathogenic Gram-negative bacterium C. 
jejuni. To this end, PglC catalyzes the transfer of the unique sugar-phosphate 
bacillosamine from the UDP-activated form (UDP-diNAcBac) to a membrane-
resident undecaprenol phosphate (UndP) (20). As the downstream 
glycoconjugates assembled through similar glycosylation pathways play roles in 
promoting pathogenicity and survival, targeting of PGTs through antibiotic 
intervention is well documented (6, 9, 29). However, due to the significant 
structural and mechanistic divergence of the two bacterial PGT superfamilies, the 
potent nucleoside antibiotics active against polytopic PGTs WecA and MraY, do 
not show inhibitory activity towards members of the monotopic PGT superfamily 
(20). Overall, development of novel antivirulence agents is of considerable interest 
and necessitates structural characterization of the monotopic PGT superfamily. 
As discussed in the previous chapter, the small size (23 kDa, 200 aa) and its 
homology to the soluble domain conserved among the monotopic PGT 
subfamilies, makes C. jejuni PglC representative of the minimal catalytic unit for 
the monotopic PGT reaction, and therefore an optimal target for structure 







single-pass hydrophobic TM domain, brings inherent challenges to structure 
determination. Although prevalent (30), single-pass TM proteins are immensely 
underrepresented in the PDB comprising only 0.5% of the non-redundant PDB, 
suggesting intrinsic, and often insurmountable, challenges in determination of 
their three-dimensional structures.  
  
2.1.1 X-ray crystallography as a tool to elucidate structures of integral membrane 
proteins 
 
Macromolecular x-ray crystallography is a remarkably powerful method 
for determining the three-dimensional structure of proteins to atomic resolution. 
In this method, a three-dimensional, highly-ordered array of proteins, in the form 
of a crystal, is required to produce diffraction patterns of sufficient quality and 
high resolution in order to resolve the atomic structure.  
As production of high quality protein crystals is at the core of this structural 
biology method, use of crystallography to solve the structure of an integral 
membrane protein is fraught with challenges. First, membrane proteins are highly 
hydrophobic in nature and therefore poorly soluble in aqueous purification and 
crystallization buffers. Additionally, heterologous expression of these proteins is 
often challenging as a result of their frequent expression into inclusion bodies, or 







cell membranes (31). Lastly, to surmount the first two challenges, purification and 
crystallization of membrane proteins often requires the use of high concentrations 
of detergents to mimic the hydrophobic membrane environment, however the 
heterogeneous compositions of detergents can inhibit crystal growth (32). Even 
with considerable advances in membrane protein crystallography, many of the 
challenges inherent to studies with integral membrane proteins remain (33). A 
common strategy to surmount the challenges brought by the TM domains of 
integral membrane proteins is the “divide-and-conquer” approach to 
crystallography. This approach, utilizing natural domain boundaries within the 
protein to create truncation constructs with more amenable properties for 
purification and crystallization, often creates constructs omitting TM domains 
entirely. Frequently this leads to structure determination of the soluble domains 
of the protein, however the benefit must be weighed against the cost that any 
opportunity for structural insight into membrane association through the TM 
domain is therefore lost.  
 
2.1.2 Prior optimization of crystallization constructs and conditions for PglC 
Previous work towards the 3D-structure determination of PglC in the Allen 







soluble domain, including the active site, of C. jejuni PglC is homologous to the 
soluble domains of the other monotopic PGT subfamilies (Figure 2.1). Contrary to 
expectation, the N-terminal hydrophobic helix was found to be required for robust 
expression, purification, and crystallization (34, 35). Additionally, this work 
identified PglC from an orthologous organism, Campylobacter concisus, with 72% 
sequence identity that lacks a C-terminal hydrophobic patch hypothesized to 
cause insolubility observed for C. jejuni PglC, to be more soluble and amenable to 
crystallography. A serine (S) – glycine (G) repeat linker (SGSG) was added 
between the N-terminus of PglC and the SUMO-purification tag to allow for 
efficient removal of SUMO (34). Initial crystallization conditions for wild-type 
(WT) C. concisus SGSG-PglC were determined through high-throughput screening 
(HTS) at the Hauptmann-Woodward Institute (HWI) crystallization facility. 
Optimization of the crystallization conditions to 300-600 mM MgCl2, 100 mM Bis-
Tris pH 6.0, and 25-30% polyethylene glycol 3350 in hanging-drop format 
produced crystals which produced high-quality diffraction patterns to a resolution 
of 3.00-3.38 Å (35). Although considered to be moderate, such diffraction limits 











Figure 2.1. Sequence alignment of C. jejuni PglC-like minimal catalytic domain 
across all three monotopic-PGT superfamilies.  Representative sequences from 
the PglC subfamily (BLUE): C. concisus PglC (A0A0M4SI81)/ C. jejuni PglC 
(O86156)/ H. pullorum PglC (E1B268)/ L. geestiana PglC (A0A0W0UA41). 
Representative sequences from the PglB-bifunctional subfamily (RED): N. 







transferase (A0A0P7CW64). Representative sequences from the WbaP subfamily 
(BLACK): E. coli WcaJ (P71241)/ S. enterica WbaP (S4IKQ0)/ M. smegmatis WcaJ 
(A0A0D6J209). The hydrophobic membrane associated domain is identified by a 
blue box. The active-site catalytic dyad characterized by Das, Kuzmic, and 
Imperiali (25) identified by the red box.   
 
 
2.1.3 Overcoming the phase problem in x-ray crystallography 
Although x-rays behave as waves with both amplitude and phase 
properties, in practice experimental detection is only able to record the intensity 
and angle of the diffracted ray while all accompanying phase information is lost. 
This is the “phase problem” inherent to macromolecular crystallography (36). As 
a result, the atomic model of the protein structure can only be built when patterns 
of recorded diffraction intensities are recombined via Fourier transformations 
with calculated phases obtained by a phasing method into an interpretable 
electron density map. The phases required for structure elucidation are primarily 
obtained via molecular replacement (MR) or an experimental phasing method, or 
a combination thereof. 
Obtaining phase information for the unknown structure via MR is 
increasingly common as new macromolecular structures are added to the PDB 
routinely. MR is an algorithmic method, which relies and rotation and translation 







as a MR search model, in the unknown unit cell (37). This ultimately requires a 
high degree of similarity between the known and unknown structures. In general, 
for MR to be successful in providing phases for an unknown structure, the search 
model and unknown structures must share approximately 40% sequence identity 
and cover approximately 50% of the structure (38). As PglC has low sequence 
similarity and homology to proteins of known structure in the PDB, previous 
attempts to phase datasets of WT SGSG-PglC used computationally derived 
models as for MR search (17, 35). Even though the computational models created 
by EV-fold and I-TASSER are produced through employment of evolutionary 
sequence constraints to inform possible tertiary structure conformations, they 
were ineffective as MR search models for the native datasets of WT-PglC. 
For proteins like PglC which lack MR search models with sufficient 
structural homology to produce viable phases, experimental phasing methods are 
required. One of the many methods developed to determine phases 
experimentally, exploits the anomalous dispersion from atoms heavier than the H, 
C, N, and O atoms that typically comprise most proteins (36, 39). This dispersion 
arises from the capacity of heavy atoms to absorb a fraction of the incident x-rays 
at unique wavelengths. Consequently, Friedel’s law is effectively broken as the 







found within proteins is negligible at the wavelengths used for crystallographic 
experiments. Therefore, any differences in intensity observed in the diffraction 
patterns collected correspond to absorption by the heavy atoms within the 
structure.  
In theory, single-wavelength anomalous dispersion (SAD) phasing is the 
simplest case of phasing via the exploitation of anomalous dispersion. SAD is 
accomplished through the collection of diffraction data at a single wavelength 
corresponding to the elemental absorption edge which elicits the most anomalous 
scattering from the heavy atom, and therefore a peak in the f″ spectra (36). The 
anomalous scattering coefficient, f″, provides a measure of the peak anomalous 
scattering power for the element. The heavy atoms central to SAD experiments can 
be endogenous to the protein or incorporated through a variety of methods (40). 
Anomalous scattering from endogenous, native sulfur atoms present in cysteines 
and methionines within the protein sequence can be measured at longer 
wavelengths (>1.54 Å or 8 keV) where f″ is approximately equal to 0.57 scattering 
electrons per S atom (Figure 2.2). Although it is theoretically possible to measure 
anomalous scattering, and therefore phases using sulfur-SAD (S-SAD), the low 
anomalous signal from S is often insurmountable (41). As a result, it significantly 







to the protein sample. Of these, the most common method of incorporation of 
heavy atoms is through the substitution of selenomethionine (SeMet) for 
methionine in the primary sequence of the protein during protein expression (42). 
Thereby, replacing the low anomalous signal S atoms with selenium. Substitution 
of SeMet for methionine residues allows for significant anomalous scattering 
power upon data collection at ~1 Å (12.6 keV) with f″ = 3.77 e- (Figure 2.2). 
 
Figure 2.2. Theoretical f′ and f″ plots for sulfur and selenium.  S-SAD datasets 
collected 8000 eV result in the theoretical absorption of 0.57 e- per S atom. Se-SAD 
datasets collected at the peak energy (12669 eV) result in the theoretical absorption 
of 3.77 e- per Se atom. Plot range encompasses energies accessible by synchrotron 
x-ray source beamline 24-ID-C (NE-CAT) at Advanced Photon Source (APS) in 



































2.1.4 Towards the structure of PglC 
The work presented in this chapter summaries the path from crystal to the 
structure of C. concisus PglC, the first example of the monotopic PGT superfamily. 
First, this chapter discusses the optimization of crystallization conditions for the 
three variants of C. concisus PglC ultimately required to solve the structure. Next, 
the attempts and eventual success of determining experimental phases for PglC 
are explored through the use of SAD phasing to calculate initial interpretable 
electron-density maps, which were further enhanced through exploitation of non-
crystallographic symmetry (NCS) within the  assymetric unit (ASU), and iterative 
model building. The subsequent use of MR to phase higher-resolution data-sets of 
PglC leading to the final model is discussed. Ultimately, the final refined structure 
of full-lengthPglC encompassing both soluble and membrane-associated domains 
determined via SAD phasing and subsequent MR using wild-type SeMet-
substituted protein and I57M/I87M and I57M/Q175M variants is revealed. 
Comparison to extant folds confirmed that PglC comprises a novel protein fold. 
Lastly, the overall agreement of the final model for PglC with computationally-
derived models is discussed.  The novel structure of PglC presented in this chapter 







superfamily, but also adds an example of a monotopic protein complete with its 
membrane-associated domain to the PDB. Thus, the molecular knowledge gleaned 
from PglC in the subsequent chapters can be translated across the ~15,000 
members of the monotopic PGT superfamily, and monotopic proteins overall.  
 
2.2 Materials and Methods 
 
2.2.1 Crystallization of PglC constructs for experimental phasing 
Preparation of the three variants (WT-SeMet, I57M/I87M, and 
I57M/Q175M) of C. concisus used for crystallography was performed by Dr. 
Debasis Das (Imperiali Lab, MIT) and provided at a concentration of 260-276 µM 
in 50 mM HEPES pH 7.5, 100 mM NaCl, and 0.03% DDM. Notably, the constructs 
of PglC co-purified with approximately 3 phosphatidyl ethanolamine : 1 
phosphatidtyl glycerol endogenous lipid observed by thin layer chromatography.  
Final crystallization conditions of 0.1 M Bis-Tris pH 6.0, 0.4 M MgCl2, and 23-27% 
PEG 3350 were optimized for a protein concentration of 260-276 µM for the three 
constructs of PglC. Additional detergent was not added during crystallization. 
Hanging-drop crystallization experiments were set up at 17 °C with solutions 







up of crystallization experiments. I57M/I87M PglC at a concentration 260 µM was 
co-crystallized with 260 µM UndP (using a 10 mM stock solution of UndP in 
DMSO) following a 30-minute incubation step on ice. I57M/I87M PglC crystals 
used for data collection appeared within 7 days. I57M/Q175M PglC crystals were 
grown under similar conditions (0.1 M Bis-Tris pH 6.0, 0.4 M MgCl2, 23% PEG 
3350) at 17 °C with temperature equilibrated solutions. Co-crystallization 
experiments with 5-iodo-UDP were carried out following incubation of 1 mM 5-
iodo-UDP in 260 µM protein on ice for 30 minutes. I57M/Q175M PglC crystals 
used for data collection appeared within 7 days. WT Se-Met PglC crystals were 
grown at 17 °C with temperature equilibrated crystallization conditions of 0.1 M 
Bis-Tris pH 6.0, 0.3 M MgCl2, 27% PEG 3350, and 1 mM TCEP. Se-Met PglC at a 
concentration of 276 µM was co-crystallized with 1 mM UDP after incubation on 
ice for 30 minutes. WT Se-Met PglC crystals used for data collection appeared 
within 3 days and reached their final size after 14 days. Addition of 
cryoprotectants resulted in decrease in diffraction limits for all crystals tested, thus 
crystals used for data collection were not subjected to cryoprotection. All crystals 
used for data collection were flash-cooled by plunging into liquid nitrogen for 







Table 2.1. Amino acid sequences of constructs used in structure solution of PglC. 
Underline denotes N-terminal methionine residue. Yellow represents SeMet. Red 
illustrates position of the point mutations.  
Construct Amino acid sequence 
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2.2.2 Data collection and processing 
A WT Se-Met PglC dataset collected from a crystal diffracting to 3.11 Å at 
beamline 24-ID-C at the Advanced Photon Source (Chicago, IL) at the Se X-ray 
absorption energy peak (12665 eV) allowed initial partial phases to be solved by 
SAD using the Phenix suite (43). Matthews coefficient analyses for the data set 
with increased unit-cell dimensions (a = b = 143. 375 Å, c = 194.004 Å; P 31 2 1) 
suggested 8 copies in the ASU. WT Se-Met data were scaled and integrated using 
XDS (44). SHELXD (45) was run for 5000 trials with a resolution cut-off of 4.5 Å to 







and calculate subsequent Se substructure phases for 22 out of the expected 32 Se 
atoms in the ASU. Phenix.RESOLVE (47)  was used to perform initial solvent 
flattening and phase-extension.  
 
2.2.3 Model building 
Alpha-helical density apparent in the solvent-flattened map allowed for 
initial building of poly-Ala helical fragments manually. Using these α-helical 
fragments as a starting model, Phenix.AutoBuild (48) was able to locate and assign 
sequence to two copies of the RMH in the ASU. Phenix.Find_NCS was used to find 
the two-fold NCS operators relating the two helices, and the two-fold used for 
NCS map-averaging in Phenix.NCS_average. Phenix.Find_NCS was used to find 
all 8 NCS related positions from the electron density in the two-fold averaged map. 
The two-fold averaged map was further averaged over all eight NCS operators by 
Phenix.NCS_average. Additional residues were built manually into the density 
with sequence assigned, using as a guide computationally-derived models of PglC 
from EV-fold (Campylobacter jejuni)  and RaptorX (49), as well as the model of E. 
coli WcaJ (Pfam accession P71241) computed by covariance using Rosetta (50). This 
manually-extended model containing a dimer of 94 residues (AAs 3-60, 74-98, 165-







Phenix.PhaserMR (51) into a native I57M/I87M 2.59 Å dataset collected at beamline 
24-ID-C at the Advanced Photon Source (Chicago, IL) containing 2 copies in the 
ASU with smaller unit cell dimensions (a = b = 70.802 Å, c = 188.442 Å; P 32 2 1). 
Phenix.AutoBuild (48) was used to complete building of 86% of the model and an 
additional 14 residues were built manually into the electron density using COOT 
(52). This model containing two subunits with 185 residues in each chain was used 
to phase a more complete, higher I/σ(I) dataset of I57M/Q175M PglC at 2.74 Å 
resolution. The overall fold of the WT and variant structures are identical despite 
crystallizing in enantiomeric space groups of P 31 2 1 for the native datasets and P 
32 2 1 for the SeMet-derivatized dataset. The space-group change is a result of 
subtle rearrangements as the crystal contacts within the lattice are unchanged 
between space groups. .  
 
2.2.4 Model Refinement 
Refinement against the electron density map was performed with 
Phenix.Refine(53) to refine XYZ coordinates, real-space, rigid body, and group B-
factors. Subsequent rounds of refinement included refinement of translation-
libration-screw (TLS) parameters, manually placed waters, and simulated 







subunits in the asymmetric unit was refined to Rwork/Rfree of 0.2587/0.2815 with 
no significant outliers using Phenix.Refine (53). Both chains of the model contain 
185 out of 205 amino acids. Chain A contains amino acids (-)3 to 182 and chain B 
contains amino acids (-)2 to 183 (the minus signs indicate non-native residues 
resulting from addition of expression tags). Chains A and B are highly similar with 
an RMSD of 0.31 Å. The extended loop structure encompassing residues 62-81 is 
well ordered in chain B owing to its participation in crystal contacts, however only 
weak density for this loop was observed in chain A. Residues 148- 153 were not 
well resolved in either chain and were placed into 2Fo-Fc density contoured at 1 
RMSD in COOT(52). The final model of PglC was refined with two protein chains, 
four molecules of phosphatidylethanolamine (PE), two Mg2+ ions, one inorganic 
phosphate ion, and one PEG (tetraethylene glycol). The chemical structures of 
endogenous, natural abundance PE were built into the model using electron 
density maps calculated with the coefficients 2Fo-Fc and Fo-Fc resulting in 4 
molecules with differing acyl chain lengths (two PE per monomer of PglC). 
Molecules 303 (Chain A) and 302 (Chain B) lie within the predicted membrane 
interaction surface for each monomer of PglC, while molecules 304 (Chain A) and 
303 (Chain B) are not believed to be in physiologically relevant positions. 







Rwork and Rfree statistics during refinement. Additionally, diffuse scattering 
from disordered detergent and additional unobserved lipid molecules could have 
contributed to slightly elevated Rwork/Rfree values, as extensive analysis of 
Matthews coefficients and examination of special projections excluded twinning 
as a factor. An inorganic phosphate (PO4-3) ion and a Mg2+ ion were modeled in 
Chain A, and a Mg2+ ion and ordered water molecule were modelled in Chain B 
into positive Fo-Fc density contoured to 4 RMSD in COOT  (52). The PEG molecule 
was modeled into positive Fo- Fc density in Chain A contoured to 2.5 RMSD in 
COOT (52). 
 
2.3 Results and Discussion 
2.3.1 Crystallization of PglC Constructs for Experimental Phasing 
We were unable to obtain sufficient phase information using the published 
covariation model (17) for structure solution via MR from datasets collected by 
Andrew Lynch from WT crystals. Thus, three variants of SGSG-PglC were 
prepared by Debasis Das (Imperiali Lab, MIT) to pursue structure solution via 
experimental phasing techniques: I57M/I87M, I57M/Q175M and 







I57M/Q175M variants were engineered with additional methionines to allow for 
increased signal for phasing via native sulfur-SAD. Crystallization of both variants 
was obtained through optimization of the final crystallization conditions for WT 
C. concisus SGSG-PglC identified by Andrew Lynch. Final crystallization 
conditions for I57M/I87M PglC co-crystallized with UndP (0.1 M Bis-Tris pH 6.0, 
0.4 M MgCl2, 23% PEG 3350; 2 µL PglC: 1.5 µL well solution) produced crystals 
which diffracted to 2.59 - 3.0 Å (Figure 2.3). Crystals of I57M/Q175M PglC were 
optimized in similar conditions (0.1 M Bis-Tris pH 6.0, 0.5 M MgCl2, 25% PEG 3350; 
2 uL PglC: 2 uL well solution) to produce crystals which diffracted to 2.74 - 3.5 Å 
(Figure 2.3). Indexing of the datasets collected for both methionine variants found 
unit-cell dimensions of a = b = 70.802 Å, c = 188.442 Å for I57M/Q175M, and a = b 
= 71.61 Å, c = 189.442 Å for I57M/I87M. Matthews coefficient analyses for these 
data sets suggests 2 copies in the asymmetric unit (ASU). In addition, WT SeMet 
derivatized PglC was crystallized by optimization of the initial crystallization 
condition to a final crystallization condition of 0.1 M Bis-Tris pH 6.0, 0.3 M MgCl2, 
27% PEG 3350, 1 mM TCEP, and 1 mM UDP. Optimized WT Se-Met crystals 
diffracted to between 3.0 – 3.5 Å resolution (Figure 2.3). Notably, derivatization 
with Se-Met resulted in doubling of unit cell axes a and b to give a larger unit cell 







a and b unit cell axes, Matthews coefficient analysis suggests ASU composition 
increased from 2 subunits to 8 subunits of PglC.  
 
 
Figure 2.3. Representative crystals of C. concisus PglC constructs used for 
experimental phasing. A, WT-SeMet. B, I57M/Q175M. C, I57M/I87M PglC.  
 
2.3.2 Experimental phasing of PglC datasets 
Pursuing experimental phase information from native S-SAD is challenging 
and requires high data quality and exceedingly high redundancy to enrich the 
native sulfur anomalous signal (f″ = 0.57 e- at collection wavelength of 1.5498 Å) 
(41). Despite using the engineered PglC constructs with additional methionines to 
increase the sulfur signal (I57M/I87M and I57M/Q175M), initial datasets of PglC 
did not contain sufficient anomalous signal for phasing via SAD. For the data sets 
collected, the anomalous measurability, a measure of the fraction of Bijvoet related 







below the threshold for sufficient signal (> 0.05) at useful resolution ranges. A 
second measure of anomalous signal strength (CCanom) also remained below the 
usable threshold for all datasets indicating insufficient signal to obtain phases by 
S-SAD (54). Ultimately, the moderate diffraction (≥ 2.74 Å) of the two methionine 
variant construct crystals, did not provide sufficient data quantity and quality for 
successful native S-SAD phasing. 
To circumvent the low signal-to-noise inherent in native S-SAD data for 
PglC, the Se-Met derivatized WT-PglC construct was utilized to increase the 
anomalous phasing power. Selenium atoms have approximately 7.5-times more 
anomalous scattering power with f″= 3.77 e- at a data-collection wavelength of 
0.9792 Å compared to 0.56 e- scattered by sulfur. From the Se-Met PglC crystals, a 
dataset from Se-Met WT PglC was collected to a resolution of 3.11 Å in the large 
unit cell. Initial phasing of this dataset was accomplished with the assistance of 
Dr. Raj Rajankrishnar (APS, NE-CAT). The selenium substructure was partially 
solved by SHELXD (45) which found 16 of 32 Se-sites expected for the large unit 
cell (8 Copies * 4 Se/ PglC). Notably, a suitable solution was only found using an 
exhaustive search of 5,000 trials at a low-resolution threshold of 4.5 Å; fewer trials 
and higher-resolution cut-offs did not yield viable heavy-atom substructure 







(45) the correlation coefficient (CC) between the observed structure factors and 
calculated structure factors between all of the reflections (CCall) and reflections not 
used in calculation (CCweak) are compared. A good indication of correct heavy atom 
substructure solutions calculated by SHELXD is separation of some solutions over 
the bulk of the solutions and a high CCall versus CCweak ≥ 30% (45). The low-
resolution of the measurable anomalous signal for this dataset which dropped 
below 0.05 at 4.0 Å contributes to the necessity of a low-resolution cut-off and large 
number of trials for substructure search. Using the initial sites found by SHELXD 
(45), the selenium substructure was extended to 22 sites with Phaser (51) and 
subsequent determination of phases allowed for the calculation of a weakly 
interpretable electron density map allowing the placement of polyAla helices into 









Figure 2.4. Correlation coefficient plots indicating quality of substructure 
solutions as output from SHELXD during Se-atom substructure search 
visualized through HKL2MAP (55).  A, CCall vs. CCweak for 5,000 SHELXD 
solutions calculated at 4.5 Å resolution. Plausible solutions with CCal ≥ 30% and 
separation over the bulk solutions circled in red. B, CCall vs. CCweak for 100 
SHELXD solutions calculated at 4.5 Å resolution. C, CCall vs. CCweak for 5000 
SHELXD solutions calculated at 3.5 Å resolution, the resolution maximum for 
anomalous signal calculated by SHELXC (56). 
 
 
2.3.3 Building the final model of C. concisus PglC 
Initial phases and maps were improved through a combination of 
AutoBuild, NCS averaging, manual iterative model building guided by 
computational models to yield a model with sequence placed for 46% (residues 3-







resolution in the small unit cell (a = b = 71.61 Å, c = 189.442Å) was collected and 
the model from the WT SeMet dataset was used as a molecular replacement search 
model for the higher resolution (I57M/Q175M) dataset (2.59 Å). Molecular 
replacement successfully placed two protomers in the ASU allowing for 
AutoBuild to extend the model with an additional 32 residues. Notably, molecular 
replacement was only successful in the enantiomeric space group of P 32 2 1. An 
origin shift of approximately 0.5 between the small cell (Met Mutants) and the 
large cell (SeMet) datasets explains the change of space group from P 31 2 1 for the 
small cell to P 32 2 1 for the large cell. Notably, attempts to use the SeMet-dataset-
derived model as a molecular replacement search model for the 2.74 Å dataset did 
not produce a viable solution. From this result, it is clear that the increase in 
resolution in 2.59 Å dataset, though minimal, provided critical data for molecule 
placement resulting in an acceptable solution. From the MR solution in the 2.59 Å 
dataset, the remaining 20 residues were built manually into the density to 
complete the model of PglC. Due to low data quality, in particular low signal-to-
noise, in the highest resolution shells for the 2.59 Å dataset, isomorphous 
replacement was used with the model encompassing residues 3-60, 74-140, and 
165-180 to phase the 2.74 Å dataset. Ultimately, the final model of PglC was 







selenomethionine-substituted protein and I57M/I87M and I57M/Q175M variants. 
The model of full-length I57M/Q175M PglC from C. concisus, encompassing both 
soluble and membrane-associated domains was fully refined with excellent 
geometry to an Rwork/Rfree = 0.2587/0.2815 (Figure 2.6; Table 2.2). 
 
Figure 2.5. Progress of iteratively built model of PglC. A, Computational-model 
guided placement of main-chain and subsequent placement of side-chains (pink) 
allowed extension from the initial polyAla helix (blue). B, 2-fold NCS averaging of 
the electron-density map enabled extension of the initial model (pink) to the 
extended model (salmon). C, 8-fold NCS averaging of the electron-density map 
enabled extension (from salmon to purple) of the model with 46% coverage of the 










Figure 2.6. The final refined model of C. concisus I57M/Q175M SGSG-PglC.  A, 
Cartoon representation of structure colored from N-terminus (blue) to C-terminus 










Table 2.2. Data collection and refinement statistics. 





   
 Data Collection    
 Beamline APS 24-ID-C APS 24-ID-C APS 24-ID-C 
 Wavelength (Å) 1.5498 0.9792 0.9791 
 Resolution range (Å) 62. 81 - 2.74  
(2.84-2.74) 
94.93 - 2.59  
(2.71 - 2.59) 
124.17- 3.11  
(3.22-3.11) 
 Space group P 32 2 1 P 32 2 1 P 31 2 1 
 Unit Cell (Å) a = b = 70.802                           
c = 188.442  
a = b = 71.61                            
c = 189.442 
a = b = 143.375                     
c = 194.004  
 Total Reflections 272497 (22932) 70621 (8076) 204661(77521) 
 Unique reflections 27735 (1941) 18030 (2131) 41202 (1010) 
 Multiplicity 18.0 (11.8) 3.8 (3.8) 5.0 (3.4) 
 Completeness  0.99 (1.0) 0.98 (0.97) 0.97 (0.97) 
 Mean I/sigma(I) 21.4 (2.5) 11.6 (0.7) 10.5 (0.9) 
 Wilson B-factor 68.21 70.69 75.42 
 Rmerge 0.0987 (1.1) 0.084 (1.708) 0.118 (1.414) 
 Rmeas 0.1016 (1.159) 0.098 (1.981) 0.148 (1.839) 
 CC1/2 1.0 (0.71) 0.99 (0.321) 0.99 (0.36) 
 CC* 1.0 (0.893)   
 Refinement    
 Ref. used in refinement 27735 (1941)   
 Reflections used for Rfree 1403 (127)   
 Rwork 0.2587 (0.3334)   
 Rfree 0.2815 (0.3663)   
 CCwork 0.801(0.673)   
 CCfree 0.879 (0.603)   
 Number of non-H atoms 3145   
    macromolecules 3043   
    ligands 82   
    solvent 20   
 Protein residues 370   
 RMS(bonds) 0.003   
 RMS(angles) 0.66   
 Ramachandran favored 97.54 %   
 Ramachandran allowed 2.19 %   
 Ramachandran outliers 0.27%   
 Rotamer outliers (%) 0   
 Clashscore 6.52   
 Average B-factor 79.75   
    macromolecules 79.49   
    ligands 93.44   







2.3.4 Molecular Structure of PglC adopts a novel fold 
The final model of the catalytically-active I57M/Q175M variant will be 
designated as PglC throughout this dissertation. As discussed previously, PglC 
crystallizes with two protomers in the asymmetric unit. However, previous 
characterization of PglC in lipid bilayer nanodiscs via gel densitometry supports 
a functional monomeric biological assembly (57).  The structure of PglC, 
comprising residues 1-183 (of the total 201, with observation of a GSG linker at the 









Figure 2.7. Representative electron density observed for PglC. Final 2Fo-Fc 
electron density (gray mesh) contoured to 2σ in the region of the hydrophobic N-
terminal helix (blue). Crystallographic symmetry mates (blue-gray) illustrating 
interdigitating Pro residues from the hydrophobic helices.  
 
Overall, the structure of PglC reveals a new protein fold (Figure 2.6), where 
the extramembrane surface comprises a unique α-helix-associated β-hairpin motif, 







the structure is α-helical with the exceptions of the long β-hairpin of the AHABh-
motif, an extended loop joining the β-hairpin to the first two amphipathic helices 
(helices C and D; Figure 2.6B), and a double twisted loop (residues 105-140) 
contributing to the only globular domain of PglC. From the N-terminus, α-helices 
A and B form a helix-break-helix motif which extends into a long β-hairpin 
structure (strands 1 and 2). An extended loop structure links the β-hairpin motif 
to planar helices C and D to create the AHABh-motif. The C-terminal end of helix 
D supports the base of the globular double twisted loop domain formed by the 
loops connecting helices E, F, G, and H. Lastly, helix I, co-planar with helices C 
and D, encompasses the C-terminal end of the resolved structure (Figure 2.6B). 
It is important to note that crystal contacts resulting in the formation of the 
crystallographic dimer place the extended loop of one protomer impinging upon 
the space between the AHABh-motif β-hairpin and extended loop of the other 
protomer (Figure 2.8A). Although these crystal contacts are near the active site, the 
steric volume of the impinging loop does not occlude the active-site, and thus does 
not preclude further analysis of the structure of the active site. Each protomer of 
the crystallographic dimer contributes to a tetramer of symmetry mates to build 
the crystal lattice (Figure 2.8B). In each tetramer, the PglC protomer is arranged 







(Pro24) residue forming the kink interdigitating with corresponding proline 
(Pro24) on the proximal protomer. The packing of PglC within the crystal lattices 
explains the necessity for inclusion of the hydrophobic helix for crystallization of 
PglC to occur as previously observed (35). Furthermore, as described below, the 
hydrophobic helix is integral to the protein fold, and does not comprise a separate 









Figure 2.8.  Crystal packing observed for C. concisus I57M/Q175M SGSG-PglC. 
A, Crystal contacts near the active site do not preclude analysis of the PglC active 
site. Crystallographic dimer of PglC shown in cartoon representation. Molecular 
surface of Chain B displayed to illustrate solvent excluded volume of the 
monomer. Catalytic Asp-Glu dyad shown in red sticks. B, Crystal contacts are 
mediated through the RMH neighboring symmetry mates. Crystallographic ASU 










2.3.5 Confirmation of novel protein fold 
As described previously, the structure of PglC adopts a novel fold 
characterized by the AHABh-motif and kinked, hydrophobic helix. This was 
expected due to the low sequence identity to proteins of known structures in the 
PDB, as well as the failure of computationally derived models from EV-fold and I-
TASSER for phasing via molecular replacement (17, 35). To confirm that the fold 
of PglC is novel, Chain A of the PglC model was used as the query structure for 
three-dimensional protein fold comparison to known structures in the PDB by the 
DALI protein structure comparison server (58). As expected, no significant tertiary 
structure matches to PglC were reported by DALI. Furthermore, the only 
secondary structure elements showing structural similarity were matches to 
sections of PglC helices C and D by long alpha-helices from a large variety of 
proteins from designed proteins, viral envelope proteins, and components of 








Table 2.3. Top 10 matches from DALI (58) search with final PglC model as query  
 
 
2.3.6 Agreement of final model of PglC with computationally-derived models 
 In determining the structure of PglC, three computational models were 
utilized to guide iterative model building in weak electron density maps. In order 
to debias placement of PglC main chain within the density, their placement was 
guided by an overlay of the three models computed from independent sources. 
Two of the models, the EV-fold (17) and Rosetta (50) derived models utilize co-
evolution and sequence alignment constraints and free-energy minimization to 
predict probable tertiary folds. The EV-fold model as reported in Lukose et al., 
2015, was computed for C. jejuni PglC omitting the N-terminal helix. The Rosetta 

















1 5j0i-A 4.3 3.7 61 73 8 Designed protein 2l6hc3_12 
2 3csx-B 4.0 3.3 61 71 7 Putative uncharacterized prot. 
3 5j2l-A 3.9 4.4 60 76 2 Protein design 2l4hc2_11 
4 4knh-B 3.8 8.8 90 857 11 Nup192p 
5 4knh-A 3.8 8.8 90 914 11 Nup192p 
6 3hr0-B 3.8 8.2 74 249 7 Cog4 
7 4i0x-E 3.8 5.1 61 67 3 Esat-6-like protein mab_3112 
8 1jq0-A 3.7 4.4 57 71 2 Gp41 envelope protein 
9 2vs0-B 3.7 6.5 68 84 9 Virulence factor esxa 







calculated for a homolog from the WbaP subfamily, WcaJ. A third model, that of 
C. concisus PglC was calculated by the deep-learning protein-structure prediction 
algorithm RaptorX (49) by Lingqui Luo in our laboratory. This algorithm does not 
employ any co-evolutionary or sequence constraints to predict the fold, but rather 
performs de novo structure prediction through trained prediction of residue pair 
contacts without a template, or homologous, sequence. When superimposed, it is 
clear the three computational models possess the same overall tertiary structure 
with some slight differences in the positioning of the loops and helices (Figure 
2.9A). This is reflected in the root mean square deviation (RMSD) values for 
alignment of the RaptorX and Rosetta models with the published EVfold model of 
5.6 Å and 5.2 Å, respectively. Superposition of the final model of I57M/Q175M 
PglC with the three computational models provides validation of the overall 
tertiary fold observed experimentally (Figure 2.9B). Notably, the greatest 
divergence between the final experimental model and computationally-derived 
models of PglC is an ~32 ° rotation opening of the extended loop structure between 
β-strand 2 and helix D. This divergence could point to a functionally important 








Figure 2.9. Experimentally determined tertiary fold of PglC agrees reasonably 
well with the computationally derived models. A, Superposition of the three 
computationally derived models calculated for PglC. EV-fold model of C. jejuni 
soluble domain shown in red. Model of WcaJ from E. coli computed by Rosetta 
shown in green. Model of WT C. concisus PglC computed by RaptorX shown in 
blue. B, Superposition of the computational models of PglC with the 
experimentally determined structure (black). Arrow indicates the relative 
movement of the extended loop joining strand 2 to helix C observed 
experimentally vs. calculated. RMSDs between the experimental PglC and 
RaptorX, Rosetta, and EV-fold models were 5.9 Å, 3.1 Å, and 6.1 Å, respectively.  
 
2.4 Conclusions 
Determination of the structure of PglC was circuitous and involved the 
iterative application of various crystallographic methodologies. The final structure 
required three distinct data sets each providing critical information: the 3.11 Å WT 
Se-Met dataset allowed initial phasing by SAD, the 2.59 Å I57M/I87M dataset 
allowed for the molecular replacement and automatic and manual model- 







structure refinement. Overall, the structure of PglC described in this chapter 
represents the first example of a novel protein fold and the structure of a 
monotopic PGT with its membrane-interaction domain. Monotopic proteins are 
vastly underrepresented in the PDB, representing only 0.05% of known structures. 
The molecular knowledge gained from the structure of PglC is thus not only 
applicable to the 15,000 members of the monotopic PGT superfamily, but also to 



























The work presented in this chapter is included in the following accepted article: 
Ray, L.C., Das, D., Entova, S., Lukose, V., Lynch, A.J., Imperiali, B., and Allen, 
K.N. Membrane association of monotopic phosphoglycosyl transferase 








Although membrane proteins make up approximately 30% of the proteome 
(59), they are vastly underrepresented in the PDB with only 5% of protein 
structures in the non-redundant PDB representing membrane proteins. These 
proteins can be categorized by their associations with the membrane both 
functionally by their association with the membrane and topologically by the 
physical arrangement of their structure with respect to the membrane (Figure 3.1). 
Functionally, membrane proteins are classified as either peripheral or integral. 
Peripheral membrane proteins are water soluble and often associate with lipid 
bilayers reversibly. Conversely, integral membrane proteins are permanently 
resident in the membrane, and generally cannot be extracted from the membrane 










Figure 3.1. Classifications and structural representation of membrane proteins. 
A, Peripheral proteins associate reversibly with the lipid bilayer. B, Integral 
membrane proteins are classified as monotopic, biotopic, or polytopic dependent 
upon their membrane-associated topology and domain distribution across the 
membrane. C, Distribution of membrane protein structures within the PDB. 
Numbers for each class compiled from non-redundant (70% sequence ID) PDB, 
OPM, and MPStruct databases: soluble proteins- 34,987; peripheral proteins – 
1,350; integral proteins – 1,679; monotopic – 24; biotopic – 256; polytopic – 1,399.  
 
Integral membrane proteins are further classified as described by Blobel 
into three topologically distinct categories: monotopic proteins, which associate 
with only one leaflet of the lipid bilayer, bitopic proteins, which span the entirety 
of the bilayer once with soluble domains on either side, and polytopic proteins 
which span the membrane many times with soluble domains on one or both sides 
of the membrane (62). Not only are the membrane-embedded domains 
topologically different, the soluble domains and overall structures are largely 







bitopic proteins are largely unknown, primary structure homology indicates that 
the soluble domains sample vast areas of known protein fold space. Recent 
analysis of the metazoan proteome has established that may of the bitopic proteins 
arose from recruitment of soluble domains to the membrane during evolution (63, 
64). Unlike the diversity of folds present for soluble domains, analyses of the 
integral membrane proteins with known structure reveals membrane embedded 
domains are largely α-helical in character (65, 66).  
 
3.1.1 Structural and sequence motifs for monotopic-membrane protein interaction 
 Overall, the nature of the interaction interface for monotopic membrane 
proteins is markedly less well understood than protein-membrane interactions for 
peripheral and polytopic proteins; however, a few main themes are prevalent 
within these interactions. Unsurprisingly, a survey of the role of hydrophobic 
interactions in membrane association of peripheral and integral monotopic 
proteins identified amphipathic helices as a highly prevalent structural motif 
driving membrane association (65). Additionally, bioinformatic analyses suggest 
basic residues (K, and R) and hydrophobic (L, W, Y, F, L, I, and V) play a key role 
in anchoring the monotopics (67, 68). Basic residues are thought to satisfy 







membrane phospholipids. As expected, based on molecular dynamics (MD) 
simulations and structural bioinformatics, hydrophobic interactions anchor these 
monotopic proteins to the hydrophobic core of the membrane. Overall, it is 
apparent that there are two subclasses of monotopic proteins, those with shallow 
insertions that interact primarily with the bilayer surface, and those that penetrate 
deeper into the hydrophobic core of the membrane. MD simulations have noted 
that the membrane association of the monotopics which extend deeper into the 
membrane result in local perturbations in the lipid bilayer (67), which could be of 
functional importance to allow access to hydrophobic, membrane-embedded 
substrates. 
 
3.1.2 Monotopic membrane protein membrane-interaction modes 
 It is universally acknowledged that integral monotopic membrane 
proteins associate with the membrane permanently, with their soluble domains 
not traversing the bilayer as seen in bitopic and polytopic proteins; however, there 
is considerable ambiguity and dispute within the literature as to what constitutes 
integral monotopic proteins. Despite the ambiguity, five main classes of 
membrane-interaction modes are evident (61, 66, 67, 69). These modalities of 







helices parallel to the membrane plane, single-pass TM containing proteins with a 
soluble domain on only one face of the membrane, hydrophobic loops extending 
into one leaflet, hydrophobic patches coupled with electrostatic interactions, and 
covalently-bound lipid anchors. The membrane-interaction modality of the 
monotopic proteins of known structure can all be classified into one of these five 
modes (Figure 3.2). 
 
Figure 3.2. Schematic representation of interactions between monotopic 
membrane proteins and the membrane. A, Interaction via an amphipathic α-helix 
parallel to the plane of the membrane.  B, Interaction via hydrophobic loops. C, 
Electrostatic or ionic interactions with lipid head groups. D, membrane association 
via a covalent fatty acyl, prenyl or glycosylphosphatidylinositol post-translational 
modification. 
 
PglC was predicted to adopt the canonical “lollipop”-like topology of a 
single-pass TM helix containing monotopic protein from secondary structure and 
hidden Markov model TM helix prediction (20); however, the molecular structure 







topology. Instead, the N-terminal hydrophobic helix is kinked resulting in both N- 
and C- termini residing within the same plane. Comparison of the structure of 
PglC with the canonical membrane interaction motifs reveals that PglC does not 
appear to fit. Thus structural, biochemical, and bioinformatics approaches were 
used to understand the mode of membrane-interaction in PglC. The idiosyncratic 
kinked reentrant membrane helix of PglC represents a novel architecture for 
membrane interaction. However, due to the packing of PglC within the crystal 
lattice mediated through interdigitation of the kink-forming proline residues, 
further evidence is required to convincingly assign this unique structure as 
functionally and physiologically relevant. 
 
3.2 Materials and Methods 
3.2.1 Covariance mapping 
The webserver GREMLIN (http://gremlin.bakerlab.org/) was used to create a 
statistical model of the conservation and covariance in the PglC family alignment 
by Lingqi Luo (Allen Lab, BU) as previously reported (17). Contact pairs with 
greater than or equal to 99% probability of co-evolution were plotted as pseudo-








3.2.2 Hydrophobicity analysis 
Hydrophobicity of residues of PglC was analyzed in PyMol according to 
the Eisenberg normalized consensus hydrophobicity scale (70). Amphipathic α-
helices identified from hydrophobic coloring in PyMol were analyzed via helical 
wheel projections created using the Helixator (71) webserver 
(http://www.tcdb.org/progs/helical_wheel.php). The following helix sequences 
were used in construction of the projections: helix C – KFGKLMRSL (Residues 86-
94), helix D – LDELPQLFNVLK (Residues 96-107), helix I – 
FMLDVKIALQTIEKVLK (Residues 170-186).  
 
3.2.3 Calculation of ΔGtransfer and PglC placement within the membrane 
The free energy of transfer of PglC into the membrane was calculated as 
∆Gtransfer = -42.9 kcal/mol with the PPM (Positioning of Proteins in Membrane) 
server (http://opm.phar.umich.edu/server.php) (72). The core of this calculation is 
a summation of two terms – a solvent accessible surface-area dependent term and 
an electrostatic term. The solvent accessible surface-area term accounts for van der 
Waals interactions, hydrogen-bonding, solvent-solute interactions, and the 
entropy of the solvent in the hydration shell around the protein. In addition, the 







coupled to penalties for placement of ionizable groups in hydrophobic 
environments. 
 
3.2.4 Electrostatic surface analysis 
Electrostatic surface analyses for PglC were performed using the Adaptive 
Poisson-Boltzmann Solver (APBS) (73) plug-in for PyMol (Fig. 3c and 3d). APBS 
was run in Linearized Poisson-Boltzmann Equation mode with surface calculation 
by cubic B-splines with harmonic average smoothing. Electrostatic surface was 
visualized with contours at ± 5 kT/e.  
 
3.2.5 Helix D geometry analysis 
The change of the N-terminal end of helix D from alpha-helical to 310- helical 
geometry was confirmed using the webserver HELANAL-plus (74). Helix D 
geometry was analyzed in the following partitions: full-length (residues 92-104), 
N-terminus (residues 92-96), C-terminus (aa 96-104). 
 
3.2.6 Structure packing analyses 
UCSF Chimera (75) was used to calculate the solvent-accessible surface area 
(SAS) and the volume contained within, or solvent-excluded volume (SEV), for 







extra-membrane portions of PglC and using the membrane plane defined by 
hydropathy analyses. Solvent accessible surfaces used in SAS and SEV volume 
calculations. The surface-to-volume ratio (SVR) was defined by the following 
equation: SVR = SAS/SEV. Surface-to-volume ratios (SVRs) calculated for full-
length PglC, intra-membranous, and extra-membranous domains of PglC. A test-
set of ten proteins of similar molecular weight to PglC and determined at 
resolutions between 4 Å - 1.5 Å was chosen from the PDB to compare PglC to other 
proteins of known structure. Test-set PDB IDs: 5LDO, 5KBC, 4L1N, 4HVR, 3USY, 
3CGN, 3ZNB, 2IQI, 1GZE, 3DO9.  
 
3.3 Results and Discussion 
3.3.1 PglC N-terminal hydrophobic helix adopts distinct re-entrant topology 
The molecular structure of PglC, as presented in chapter 2, is the first 
experimentally determined structure of monotopic PGT. PglC adopts a novel 
protein fold where the N-terminal hydrophobic helix, predicted to transverse the 
membrane, is instead kinked into a helix-break-helix motif. This helix mediates the 
formation of a tetrameric crystal-lattice contact through interdigitation of proline 
residues at the kink from neighboring symmetry mates (Figure 2.8B). As the 







for a predicted single-pass transmembrane protein, detailed structural analyses 
were undertaken to gain insight into the potential membrane interaction interface 
of PglC. As such, the analyses aimed at determining the functional relevance of 
the observed helix-break-helix structure of the N-terminal hydrophobic helix.  
The amphiphilic nature of the phospholipids which compose lipid bilayers 
in biological systems imparts a defined topology to the membrane as a whole. The 
phospholipids are arranged such that the hydrocarbon tails form the hydrophobic 
core, and hydrophilic head-groups form the membrane surface. As a result, 
membrane-proteins often have asymmetrical distribution of hydrophilic and 
hydrophobic residues to create unique intra-membranous and extra-membranous 
surfaces. Mapping the normalized consensus hydrophobicity(70) of each residue 
of PglC illustrates a clear plane of hydrophobicity bounded by helices C, D, and I 
that includes the kinked, hydrophobic helix (A, B) (Figure 3.3A). While it was 
evident that the N-terminal helix would display a high frequency of hydrophobic 
residues based on primary structure, the amphipathic nature of helices C, D, and 
I became apparent upon mapping of hydrophobicity to the structure. Helical 
wheel projections of helices C, D, and I confirm clear amphipathic character with 
one face of the helix surface marked by hydrophobic residues opposite a more 







residue hydropathy analyses suggest the membrane-interaction interface for PglC 
would bury the hydrophobic helix-break-helix within the membrane forming a 
reentrant membrane helix (RMH) resulting in both N and C-termini of the helix 
resident on the same side of the membrane. The resulting membrane-interaction 
interface for PglC would be bounded by the three co-planar amphipathic helices 
embedded in the surface of the membrane.  
 
 
Figure 3.3.  Hydrophobicity and electrostatics corroborate membrane placement. 
A, The hydrophobic surfaces (ramped from white to red for polar to hydrophobic) 
of amphipathic helices labeled C, D, and I establish a planar hydrophobic surface 
(left); also shown rotated by 90° with RMH removed (right). B, Helical wheel 
representations for helices C, D, and I illustrate the clear amphipathic nature of the 
co-planar helices. Hydrophilic residues represented in white, hydrophobic 








 Independent confirmation of the positioning of PglC within the 
membrane was accomplished through the use of the Positioning of Proteins in 
Membrane (PPM) server (72). Assignment of the membrane-embedded position 
via this server is irrespective of the qualitative assignment of the hydrophobic 
plane from residue hydrophobicity mapping. The PPM server calculates the 
optimal rotational and translational orientation of proteins within membrane 
through minimization of the free energy, ΔGtransfer, of the transfer of the protein 
from water to a simulated, homogeneous DOPC (1,2-Dioleoyl-sn-glycero-3-
phosphocholine) membrane slab. Minimization of ΔGtransfer for the coordinate set 
of PglC resulted in the placement of PglC in an orientation in which the kinked 
RMH extends 14 Å deep into the membrane and the three amphipathic helices 
(AH) identified through hydrophobicity analysis (C, D, and I) sit at the membrane 
interface (Figure 3.4). It should be noted that the discrepancy between positioning 
of the membrane planes calculated by the PPM server and estimated by 
hydrophobicity analyses of the RMH and AHs suggests that PglC may be 
positioned approximately 5 Å deeper in the membrane than calculated by the PPM 
server (Figure 3.5). The inconsistency arises from the modelling of the bilayer by 
the PPM server, where the membrane is treated as a rigid hydrophobic slab which 







the membrane (67). The membrane-bound orientation of PglC calculated by the 
PPM server represents the minima of ΔGtransfer = -42.9 kcal mol-1, which places 27% 




Figure 3.4. PglC reveals a distinct architecture and topology for monotopic 
membrane proteins. Predicted position of PglC with respect to the membrane 










Figure 3.5. Comparison of PglC membrane plane location calculated by PPM 
server (gray spheres) and manually-positioned plane (blue spheres) using 
hydropathy analyses of the RMH and coplanar α-helices. Model of PglC 
rendered with hydrophobic coloring. 
 
The extensive membrane interaction interface observed for PglC is unusual 
compared to other previously-reported monotopic membrane protein structures. 
In contrast, the known structures of monotopic membrane proteins are principally 
comprised of extensive soluble domains and comparatively minimal membrane-
associated domains as exemplified by the well characterized, classical examples of 
monotopic proteins: prostaglandin H2 synthase (PGHS, PDB: 1CQE) (76), fatty 
acid acyl hydrolase (FAAH, PDB:1MT5) (77), and squalene synthase (PDB: 2SQC) 








Figure 3.6. Membrane interaction surfaces of exemplar monotopic proteins. 
Protein surface colored by normalized consensus hydrophobicity from 
hydrophobic (red) to hydrophilic (white). Membrane represented by gray box. 
Location of membrane plane calculated with PPM server 
(http://opm.phar.umich.edu/server.php) for 1CQE (PGHS), 1MT5 (FAAH), 2SQC 
(S-synthase), and PglC.  
 
The extensive soluble domains of these monotopic examples comprise 
known soluble folds (e.g. Rossmann-like, α-β-α sandwich-like) which have been 
recruited to the membrane interface. In addition, computation of the membrane-
embedded interface and the free energy of transfer into the membrane for all 
monotopic proteins of known structure provides a quantification of the divergence 
in membrane association mode for known monotopic structures and PglC. On 
average, monotopic proteins currently in the non-redundant PDB have 
comparatively minimal interaction interfaces with only 3.9% of their residues 







membrane illustrated by an average ΔGtransfer = -17.4 kcal mol-1 (Table 3.1). It is 
worth noting that there are some examples of monotopics with interaction 
interfaces which appear more like that of PglC quantitatively (Alternative oxidase- 
PDB: 3VV9, 16% embedded, ΔGtransfer = -61.4 kcal mol-1; Monofunctional 
glycosyltransferase- PDB:3VMT, 11% embedded, ΔGtransfer = -35.4 kcal mol-1, Figure 









 Table 3.1. Quantitative comparision of membrane interaction interfaces for all monotopics of known structure, 
including PglC (red).  
Macromolecule PDB ID 
!Gtransfer 
(kcal mol) 




% embedded % exposed 
Cyanide-insensitive alternative oxidase 3VV9 -61.4 329 54 16.4 83.6 
Prostaglandin H2 Synthase 1CQE -43.4 580 44 7.6 92.4 
PglC 5W7L -39.5 200 47 23.5 76.5 
Cyclooxygenase-2 1CX2 -37.4 587 56 9.5 90.5 
Lanosterol 14-alpha demethylase 4LXJ -36.1 536 43 8.0 92.0 
Monofunctional glycosyltransferase 3VMT -35.4 263 29 11.0 89.0 
Fatty acid alpha-dehydrogenase 4HHS -33.7 652 38 5.8 94.2 
Lysophosphatidic acid  acyltransferase 5KYM -32.4 247 40 16.2 83.8 
Squalene-hopene cyclase 2SQC -27.8 631 10 1.6 98.4 
Monoamine oxidase A (human) 1O5W -23.1 534 37 6.9 93.1 
Penicillin-binding protein 1B 3VMA -21.7 758 20 2.6 97.4 
Monoamine oxidase A (rat) 2BXR -21.4 527 35 6.6 93.4 
WaaA 2XCI -20.3 374 2 0.5 99.5 
Sulfide:quinone oxidoreductase 3HYW -19.4 430 24 5.6 94.4 
Flavoprotein-ubiquinone oxidoreductase 2GMH -18.5 584 7 1.2 98.8 
15-lipoxygenase 1LOX -14.3 662 6 0.9 99.1 
LpxK 4EHW -13.9 317 7 2.2 97.8 
Retinoid isomerohydrolase P65 4F3D -13.9 533 2 0.4 99.6 
Type II NADH dehydrogenase 4NWZ -13.7 405 2 0.5 99.5 
NAPE-PLD 4QN9 -11.3 549 18 3.3 96.7 
Peptidoglycan glycosylatransferase 2OQO -11 200 12 6.0 94.0 
Wall teichoic acid polymerase (TagF) 3L7I -10.8 729 18 2.5 97.5 
NADH-ubiquinone 4G6G -10.6 502 11 2.2 97.8 
15-lipoxygenase-2 4NRE -10.6 696 9 1.3 98.7 








Figure 3.7.  Membrane interaction surfaces of other highly-embedded 
monotopic proteins. Protein surface colored by normalized consensus 
hydrophobicity from hydrophobic (red) to hydrophilic (white). Membrane 
represented by gray box. Location of membrane plane calculated with PPM server 
(http://opm.phar.umich.edu/server.php) for 3VMT (16% embedded) , 3VV9 (11% 
embedded), and PglC (27% embedded).  
 
 
3.3.2 Biochemical and bioinformatic validation of PglC membrane-interaction mode 
The reentrant-helix topology of the hydrophobic helix at the core of the 
membrane-interaction mode in PglC appears unique across other monotopic 
membrane proteins of known structure. This suggests the RMH motif in PglC is 
the first-in-class example of a novel modality of membrane interaction. 
Bioinformatic and biochemical analyses of PglC corroborate the observed 
membrane interaction modality as the physiologically-relevant conformation for 
PglC. Notably, the crystallographically observed topology is consistent with 







which propose this re-entrant topology for the hydrophobic domain homologous 
to PglC (34% sequence identity) (79).  
Bioinformatic analysis supports the reentrant topology through calculation 
of covariance and co-evolution of residue pairs within the monotopic PGT-
superfamily sequence alignment. Covariance and co-evolution analyses infer that 
two residues in physical contact will co-vary throughout evolutionary space, and 
therefore throughout the primary sequences, to retain the physical interaction (80). 
Thus, a high probability of covariance between pairs of residues correlates with a 
high-probability of physical contact. In PglC, ten pairs of residues with 99% 
probability of covariance map to contacts between the RMH and the planar 
amphipathic helices (Figure 3.8). These pairs include π-π stacking, van der Waals, 








Figure 3.8. PglC crystallizes in a native conformation. Co-evolution and 
covariance analyses across the monotopic PGT superfamily predict 10 interactions 
with ≥99% probability of contact (black lines). For example, Phe32/Phe83 exhibit 
π-π-stacking, Leu19/Phe99; Leu16/Leu102; Thr29/Leu92; Tyr34/Val41; Ala30/Val41 
make hydrophobic interactions between the RMH and the coplanar helices and 
Asp11/Ser107 form a hydrogen bond. 
 
In concert, the reentrant topology was validated for PglC via substituted 
cysteine accessibility method (SCAM) (81, 82) analyses performed by Sonya 







engineered at the N- and C-termini of PglC both display cytoplasmic localization 
(Figure 3.9). As a result, the kinked helix must also adopt reentrant rather than 
membrane spanning topology in whole cells. Additionally, highly-conserved basic 
residues at the N-terminus of PglC, and therefore the reentrant helix, are consistent 
with the “positive-inside” rule for a topology that faces the cytoplasm (83).  
 
Figure 3.9. PglC crystallizes in a native conformation. In vivo SCAM analysis 
indicates that the N-and C-termini of the RMH are localized at the cytoplasmic 
face (* = native PglC; ** = PglC labeled with PEG-mal, C = control, no PEG-mal 
labeling). PEG-maleimide (PEG-mal); N-Ethylmaleimide (NEM); 2-sulfonatoethyl 
methanethiosulfonate (MTSES). Data and figure courtesy of Sonya Entova 
(Imperiali Lab, MIT).  
 
In addition to the bioinformatics and SCAM confirmations of PglC 
membrane topology, observation of an endogenous PE lipid head group in the 











provides further evidence for placement of the membrane plane (Figure 3.10A). 
As PE was not added during at any point during purification or crystallization, 
the presence of PE within the crystal could only have resulted from retention of 
tight-binding, endogenous PE throughout purification and crystallization of PglC. 
To confirm the presence of PE in protein samples used for crystallization, thin 
layer chromatography (TLC) analyses were performed by Dr. Debasis Das 
(Imperiali Lab, MIT). TLC demonstrates the presence of endogenous POPE (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine) and POPG (1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglycerol) in approximately a > 3:1 stoichiometry 
(Figure 3.10B). The retention of endogenous lipids through purification is common 
across membrane protein structures with resolved lipids (84). The composition of 
the binding-site with a hydrogen bond between a positively-charged, arginine side 
chain (Arg8) and the PE phosphoryl moiety, is consistent with the types of 
interactions observed for PE-protein binding sites across other membrane proteins 
(84) (Figure 3.10A). The localization and binding-mode of the PE moiety supports 
the positioning of the membrane with respect to PglC in our model (Figure 3.10C). 
It should be noted that the observed PE head-group is not in a physiological 
orientation with the ammonium group facing towards the predicted hydrophobic 







non-physiological orientation is enforced through a π-cation interaction (85) 
between the -NH3+ and the aromatic ring of a phenylalanine (Phe35) residue from 
a symmetry-related molecule in the crystal lattice (Figure 3.10C). Although TLC 
analysis suggests a 3:1 mixture of PE:PG present in the crystallization sample, the 
shape and fit of the electron density and clear cation-π interaction with the 
symmetry mate Phe35 corroborate assignment of the density as a PE molecule 










Figure 3.10. Crystallographically-observed PE head group corroborates position 
of the membrane-interaction interface. A, Fo-Fc simulated annealing omit map 
contoured to 3σ shown as gray wire mesh. PE molecule 303 (chain A) shown in 
green sticks. RMH of PglC chain A shown in blue. Phe35 from a symmetry mate 
shown in gray. Interactions between the PE phosphoryl moiety and Arg8 
(hydrogen bond) and Phe35 (cation-π) shown with distances given in . B, TLC 
analysis performed by Dr. Debasis Das (Imperiali Lab, MIT) demonstrates the 
presence of both phosphatidylethanolamine (POPE) and phosphatidylglycerol 
(POPG) phospholipids in the purified PglC at a ~3:1 stoichiometry. C, PE head 
group binding site at Arg8 locates this position to the membrane interface. PglC 
colored by electrostatic potential from +5 kT/e (blue) to -5 kT/e (red). D, Chemical 









3.3.3 Small tertiary fold motifs underpin the structure and function of PglC 
Overall, PglC is largely divergent from other monotopic proteins of known 
structure in membrane-association interface, free energy of transfer to the 
membrane, and in general domain structure. The novel architecture of PglC 
encompassing the unique RMH containing membrane-embedded domain and 
minimal cytosolic domain, appears largely open with only the double-twisted loop 
motif forming a typical globular-like domain. Though the structure of PglC 
appears poorly packed, analysis of surface-to-volume ratio (86, 87) for full-length 
monomeric PglC reveals an (SVR) of 0.44 Å-1 which is similar to that of other 
globular proteins of comparable size in a test-set of structures from the PDB, where 
the average SVR = 0.47 Å-1 (Figure 3.11). Therefore, the novel architecture as a 
whole can be considered globular. In addition, computational analysis with 
Voidoo (88) to determine the presence of solvent-excluded cavities within PglC 
revealed only small cavities with volumes of 0.554 ± 0.232 Å3 and 0.754 ± 0.344 Å3, 
respectively (Figure 3.12). The insignificant cavities, with volumes considerably 
smaller than a water molecule, coupled with the SVR analysis demonstrate that 
the fold of full-length monomeric PglC is a well-packed globular-like fold despite 







establishment of its fold in order to perform the PGT reaction with a minimal 
scaffold.  
 
Figure 3.11.  Molecular packing of PglC compared to structures of similar size. 
A, UCSF Chimera (75) was used to calculate the solvent accessible surface area 
(SAS) and the volume contained within, or solvent excluded volume (SEV), for 
full-length PglC and a test-set of similar proteins from the PDB. The surface-to-
volume ratio (SVR) was defined as follows, SVR = SAS/SEV Test set of similar 
structures from the PDB shown in surface representation. B, SVR of PglC (arrow) 









Figure 3.12.  Solvent-excluded cavities detected in the double-twisted loop 
domain of PglC. Cavities detected by Voidoo shown in dark blue with volumes 
of 0.554 ± 0.232 Å3 and 0.754 ± 0.344 Å3, respectively. Solvent-accessible surface of 
PglC displayed as rendered by PyMol in transparent gray. 
 
Overall, the structure of PglC is parsimonious in that its tertiary structure 
features are established not through large domain-domain interactions, but rather 
through short-range non-covalent fold motifs in the form of proline-kinks and 
elaborate hydrogen-bonding networks. A proline-kink established by Pro24 in 
tandem with a short intra-molecular hydrogen bond between the Ser23 hydroxyl 







necessary for the reentrant topology of the RMH (Figure 3.13B). Additionally, β-
sheet-like network of short intra-molecular hydrogen bonds between the 
backbone amide and carbonyl groups of proximal segments stabilize the base of 
the globular double-twisted loop motif (Figure 3.13C). The RMH N-terminus is 
pinned into the base of the double-twisted loop-motif through short hydrogen-
bonding interactions between a triad of polar residues (Tyr2, Asp169, and, 
Tyr160). This critical structural feature supporting the reentrant topology is 
consistent with proposed structural role of absolutely conserved Asp169 
determined by mutagenesis studies by Lukose, et al. (17) (Figure 3.13D). 
Furthermore, the strictly conserved Pro-Arg-Pro (111-113) motif in the double 
twisted loop creates a rigid turn which pins Arg112 towards the active-site 
catalytic dyad (figure 3.13E). This forced orientation allows the guanidinium side 










Figure 3.13.  Proline-kinks and short hydrogen bonds establish critical 
interactions that impart unique structure-function relationships in PglC (A). B, 
A proline-kink from Pro24 in tandem with a short intra-molecular hydrogen bond 
between Ser23 and the backbone carbonyl of Ile20 establishes the helix-break-helix 
motif of the RMH. C, An extensive hydrogen-bonding network of short intra-
molecular hydrogen bonds between backbone amide and carbonyl groups 
stabilize the double-twisted loop motif. D, A triad of polar residues 
(Tyr2/Asp169/Tyr160) form a hydrogen-bonding network that establishes critical 
intra-molecular interactions between helices A (blue), H (orange) and I (red). E, A 
strictly-conserved Pro-Arg-Pro (residues 111-113) motif orients Arg112 towards 








3.3.4 The AHABh-motif is structurally and functionally significant 
The AHABh-motif (strands 1-2, helices C-D) encompasses both of the 
structurally efficient fold-motifs seen in PglC: a hydrogen bonding network, and 
structurally and functionally critical proline kinks. The tertiary fold of the AHABh-
motif is established through a network of hydrogen bonds stabilizing the close 
interaction between β-strand 2 with the full length of helix D (Figure 3.14). The C-
terminal end of helix D is held in close proximity to the β-hairpin through 
interactions between both the backbone amide and tyrosyl hydroxyl of Tyr58 to 
the side chain carbonyl of Asn100 and Lys103 ammonium group, respectively. 
Similarly, N-terminus of helix D is stabilized within the AHABh-motif through a 









Figure 3.14. The AHABh(alpha-helix-associated beta-hairpin)-motif that defines 
the superfamily fold is formed by a β-hairpin comprising β-strands 1 and 2 
packing against helix D.  
 
Quantitative analysis of helical geometry confirms a kink formed by Pro96 
in concert with residues with low helix propensity (89) (Ser91, Asp93, Glu94) 
distorts the !-helical geometry of the N-terminal end (residues 92-96) of helix D 
into 310-helix geometry (figure 3.15; Table 3.2). The 310-helix geometry is defined by 
the amide N-H  group of each amino acid forming a hydrogen bond with the 







(90, 91). Thus, each turn of the helix formed by the hydrogen bond is comprised of 
ten atoms, making it a more tightly wound helix than a canonical α-helix. As a 
result, the 310 geometry is considered relatively unstable in comparison; however, 
it has been postulated that inherent instability imparts a unique dynamic character 
to these helices (92). Unsurprisingly, 310-helices are often found in functionally-
dynamic regions of protein structure such as the active-site, voltage switches in 
ion channels, and heme-iron coordination sites (92, 93). Despite lacking the some 
of the stabilizing hydrogen bonds canonical to !-helix geometry, the 310-helix 
extension of helix D in PglC is stabilized through the presence of the Asp93 at the 
helical N-cap position (94) to satisfy the positive electrostatic environment of the 
helix dipole. Additionally, the hydrophobic packing of the two leucine residues 
(L92 and L95) at the N′ and C0 positions of the helix add further stability to the 










Figure 3.15. Active-site helix D 310-geometry allows for co-facial positioning of 
Asp-Glu catalytic dyad. A, Helix D (residues 92- 104) shown in color ramp 
representation from N-terminus (blue) to C-terminus (red). B, Looking down 
helical axis from N-terminus. N-terminus of helix D adopts 310–helix geometry. C, 
Looking down helical axis from C-terminus. C-terminus of helix D adopts 













Twist (°) Residues/ Turn Unit Height (Å) 
Full-length 13 107.2 ± 6.35 3.36 ± 0.20 1.75 ± 0.28 
N-terminal 5 112.8 ± 8.08 3.19 ± 0.23 2.06 ± 0.40 
C-terminal 9 104.3 ± 5.14 3.45 ± 0.17 1.58 ± 0.14 
310 (ideal*) -- 120 3.0 2.0 
α (ideal*) -- 105 3.6 1.5 
* Ideal helix geometries defined as reported by Barlow and Thornton, 1988 (91). 
 
In PglC, this stablized 310-helical geometry is both structurally and 
functionally relevant as it architects proximal positioning of the catalytic-dyad by 
favoring the observed Asp93 rotomer via interactions with the 310-helix dipole 
(Figure 3.14, dashed gray bonds). Participation of one of the Asp93 sidechain 
oxygen atoms in these helix-capping hydrogen bonds in addition to coordination 
of the catalytically required Mg2+ ion contributes to the nucleophilic reactivity of 
the non-coordinating Asp oxygen via a disruption of resonance stabilization. This 
increased nucleophilic reactivity for one oxygen of the Asp sidechain is distinctive 
of covalent-intermediate enzymatic mechanisms (95). As such, the AHABh-motif 









3.4 Conclusions  
Independent validations of the topology of PglC with respect to the 
membrane establish the unique membrane interaction modality inclusive of the 
reentrant membrane helix (helices A, B) and three co-planar amphipathic helices 
(C, D, and I). This modality acts to stabilize the minimal functional unit of PglC in 
the membrane. As previously described, the overall structure and membrane-
association mode of PglC is largely divergent from other monotopic proteins of 
known structure in both domain structure, membrane-association interface, and 
free energy of transfer to the membrane. Additionally, as there are no known 
structural homologs, either soluble or membrane-associated, it is plausible that the 
evolution of this the novel PglC fold was intimately associated with the 
membrane.  
As a result, the extensive membrane-resident volume of PglC together with 
the membrane in which it is positioned effectively forms a folding core and 
membrane interaction modality distinct from other structurally characterized 
monotopic proteins. These monotopic membrane proteins of known structure can 
be classified by the canonical modes of monotopic protein membrane interaction 
(Figure 3.2): (A) interactions mediated through an amphipathic helix, (B) 







between ions and lipid headgroups, and (D) covalent lipid anchors. From the 
comparison of membrane interaction interface of PglC versus the other 
monotopics of known structure, it is clear that the structure of PglC represents a 
first-in-class example of a new modality in which the membrane interaction 
interface of PglC is comprised of an extensive hydrophobic membrane-embedded 
domain formed by the reentrant membrane helix and three amphipathic helices 
(Figure 3.16).  
 
Figure 3.16. Schematic representation of interactions between monotopic 
membrane proteins and the membrane. A, Interaction via an amphipathic α-helix 
parallel to the plane of the membrane (prostaglandin H2 synthase – 1CQE); B, 
Interaction via hydrophobic loops (carboxylesterase – 3CN9); C, Electrostatic or 
ionic interactions with lipid head groups (arachidonate 15-lipoxygenase – 2P0M); 
D, membrane association via a covalent fatty acyl, prenyl or 
glycosylphosphatidyl-inositol post-translational modification 
(acetylcholinesterase – 1N5M) ; E, Reentrant membrane helix (RMH) with C- and 
N-termini on the same face of the membrane and amphipathic α-helices parallel 
to the membrane plane (PglC – 5W7L). 
 
Though it is minimal by comparison to other monotopics of known 







is both structurally and functionally significant. Small parsimonious structural 
motifs not only underpin the critical structural feature of membrane-association, 
the RMH, they also directly influence active-site geometry through specific 
positioning of catalytically-important residues (Arg 112 and Asp93). Overall, the 
unique structure of C. concisus PglC represents a novel architecture for membrane 


























The interpretation of PEG and PO42- electron density and phosphate release 
kinetics presented in this chapter are included in the following accepted article: 
Ray, L.C., Das, D., Entova, S., Lukose, V., Lynch, A.J., Imperiali, B., and Allen, K.N. 
Membrane association of monotopic phosphoglycosyl transferase underpins 








Although the monotopic and polytopic PGT superfamilies perform the 
same general PGT reaction, a transfer of a C1-phosphosugar from a UDP-sugar to 
a polyprenol phosphate embedded in the membrane, they rely on vastly different 
scaffolds and molecular logic. The structure of PglC, an exemplar of the monotopic 
PGT superfamily reveals a novel architecture for membrane association and 
function that is largely divergent from that of the polytopic PGT class. As these 
two families are so structurally and mechanistically divergent, it follows that the 
active-site and binding-site geometry should be dissimilar as well.  
 
4.1.1 Catalytic sequence motifs in the PGT superfamily 
Previous biochemical and bioinformatics studies of polytopic family 
members MraY and WecA identified a conserved DDxxD motif across the 
superfamily essential for catalysis (96). In MraY, the only structurally 
characterized member of the superfamily, conserved adjacent aspartic acid 
residues originally proposed to responsible for the coordination of the catalytically 
required Mg2+ ion have been shown to be required for substrate orientation and 
participation in catalysis (19). This sequence motif is reminiscent of the highly 







physical geometry of these residues do not follow the same architecture; the co-
facial positioning of the adjacent acidic residues enforced by the 310—helix 
geometry of helix D in PglC (Figure 3.14) is not mirrored in MraY. The adjacent 
aspartic acid residues in MraY are part of an α-helix and are thus splayed apart 
according to canonical α-helix geometry (19). The difference in architecture is 
subtle (figure 4.1), however the shortest distance between oxygen atoms on the 
adjacent residues for PglC illustrates the enforced rotomer for PglC Asp93 places 
the residues 0.5 – 1 Å closer together. As a result, the functional role of the similar 
motif is likely different in both families. For the monotopic PGTs, the Asp-Glu 
dyad has been confirmed as the catalytic motif with Asp93 acting as the catalytic 
nucleophile (25). It should be noted, that trapping of the UDP-sugar intermediate 
on Glu94 in PglC has been observed, but to a much lesser extent than for Asp93 









Figure 4.1. Difference in catalytic-dyad architecture for MraY and PglC. A, MraY 
(blue) residues Asp117 and Asp118 shown as sticks. B, PglC (cyan) residues Asp93 
and Glu94 shown as sticks. Shortest distances between oxygen atoms on proximal 
residues (gray dashed lines) given in Å.  
 
In addition to the differences in molecular architecture of the catalytic-
dyads and the active-sites as a whole, the polytopic and monotopic PGT 
superfamiles are mechanistically divergent. MraY and WecA act through a ternary 
complex reaction mechanism where both substrates, the UDP-sugar and the 
polyprenyl phosphate, enter the active site at the same time for catalysis (Figure 
4.2A) (23, 24). In contrast, that the monotopic PGTs proceed through a covalent-
phospho-sugar intermediate enzymatic mechanism which undergoes two-step, 







enzyme nucleophile, Asp93, attacks the UDP-sugar to create the phospho-sugar-
enzyme intermediate and liberate the mechanistic by-product, UMP. In the second 
step, the membrane-embedded polyprenol phosphate (pren-P) can enter the active 
site for catalysis to release the membrane-bound Pren-PP-sugar product (figure 
4.2B) (25). As structure begets function, it is expected that the marked difference 
in enzymatic mechanism should be mirrored by a difference in the molecular 
architecture of the active site and substrate binding sites between the polytopic 
and monotopic PGT superfamilies.  
 
Figure 4.2. Schematic representation of polytopic and monotopic PGT 
enzymatic mechanisms. Enzyme active site represented by blue circle. A, 
Polytopic PGTs proceed through one-step ternary complex mechanisms. B, 








4.1.2 Substrate binding sites in PGTs 
Biochemical and bioinformatics analyses can predict likely binding sites for 
the UDP-sugar and Pren-P substrates of PGTs, however these analyses are often 
met with challenges owing to the complex nature of the substrate and non-
conserved binding motifs (97). Sequence conservation analysis for the polytopic 
superfamily reveals sequence motifs with several conserved histidine residues 
that are thought to be involved in sugar binding. Nucleoside-inhibitor bound 
structures of MraY have corroborated the implication of these conserved histidine 
residues in the positioning of the sugar moiety from localization of the competitive 
inhibitors in the active site (98). As a consequence of the bi-substrate analog nature 
of the nucleoside-inhibitor class, binding of the uridine moiety suggests the 
binding site for the UDP of the native UDP-sugar substrate to be anchored by 
hydrogen-bonding interactions to the pyrimidine ring and further stabilized 
through ring-stacking of the uracil moiety.  
  As no canonical nucleotide-sugar binding site its apparent from 
bioinformatics or biochemical studies for PglC, one can only postulate as to its 
architecture. The lack of a conserved canonical-like binding site suggests that 
UDP-sugar binding in PglC could be driven by electrostatic and steric effects 







site has been seen in the glycosyltransferase GT-A and GT-B folds.  While the GT-
B fold possesses a strictly-conserved polar loop biochemically observed to 
influence sugar specificity adjacent to the  putative nucleotide sugar-diphosphate 
binding-site, exemplified in OleD (99), the GT-fold shows conservation of loops 
surrounding the DXD-coordinated cation-mediated sugar-nucleotide binding site  
(100). As a result of the dearth of specific molecular interactions, this type of steric-
occlusion-driven binding site is often indiscriminant towards substrates (101). 
However, it should be noted that promiscuous substrate binding directly counters 
the observed high-sugar specificity for some PGTs (figure 4.3). In addition to the 
lack of conserved sugar binding signatures in the superfamilies, the complex 
nature of the sugar-nucleotides employed in these reactions has made 
understanding of sugar specificity across PGTs a difficult undertaking with most 








Figure 4.3. UDP-sugar substrates of the Polytopic and Monotopic PGT 
superfamilies. Polytopic PGT family denoted by a blue box and text, monotopic 
PGT family denoted by a gray box text. Species names abbreviated as follows: H.p. 
= H. pullorum, C.j. = C. jejuni, N.g. = N. gonorroheae, S.a. = S. aureus, S.p. = S. 
pneumoniae, and X.c. = X. campestris. 
 
 
The polyprenol phosphate specificity for PGTs is similarly difficult to 
determine biochemically due to lack of commercially available substrates and 
difficulty in purification of the native substrates from bacteria. Despite this 
challenge, it has been shown that members of the polytopic PGT superfamily tend 
to be less specific for polyprenol chain-length and saturation. Specifically, WecA 
will accept polyprenols carbon chains made up of 10 to 35 carbons, albeit with 
lower activity than the native C55 substrate (23, 102). MraY also displays a wide 






















































PglC (C.j.), PglB (N.g.) WbaP, WacJ, CpsE (S.p.)










and dolichols of widely varying chain-length and saturation (102). Structural 
analysis of MraY affords prediction of the polyprenol phosphate binding site. The 
structure of MraY reveals a U-shaped hydrophobic cleft extending towards the 
membrane from the active-site Mg2+ cofactor and catalytic aspartic acid (Asp117) 
(19). Recent crystal structures of MraY in complex with the nucleoside inhibitors 
tunicamycin and muramycin D2 corroborates the involvement of this 
hydrophobic cleft in polyprenol phosphate binding. Despite a lack of density for 
the flexible acyl chain of the inhibitor, the sidechain of Asn172 located within this 
cleft near the active site was observed to directly interact with the fatty acid amide 
moieties (98, 103).  
In contrast to the broad polyprenol phosphate specificity evident in the 
polytopic superfamily, monotopic PGTs are characteristically more specific for 
polyprenol chain length. Both WbaP and PglC only show significant activity with 
undecaprenol phosphate (104, 105), and are wholly unable to perform the PGT 
reaction with polyprenol substrates that have fewer than 35 carbons. As there is 
no lipid binding motif evident biochemically or through bioinformatics, the 
structure of presented in this dissertation PglC should afford a platform from 








4.1.3 Implications of active-site and binding site geometry on inhibitor design  
Although the inhibitor-bound structures of MraY have provided critical 
confirmation of the predicted architecture and composition of the active site and 
natural substrate binding sites in the polytopic superfamily, this knowledge is not 
easily transferred to the monotopic PGT superfamily. As discussed in Chapter 1, 
inhibition by the nucleoside inhibitor tunicamycin of the monotopic PGT 
superfamily, exemplified by PglC, is not seen (20). Clearly, the overall divergence 
observed between these two families extends to active site geometry and binding 
sites, as well. The divergent enzymatic mechanisms and molecular structures of 
the polytopic and monotopic PGT superfamilies provides a basis for 
understanding the differential sensitivities of these two classes of PGTs to 
inhibition. Structural understanding of the active site and substrate interactions is 
needed for the monotopic PGT superfamily to be able to inform targeting of this 








4.2 Materials and Methods 
4.2.1 Interpretation of PEG and phosphate electron density in the I57M/Q175M           
C. concisus PglC electron density map 
 
The inorganic phosphate (PO43-) and the PEG were observed in only one of 
the two chains in the asymmetric unit. A PO43- ion and a Mg2+ ion were modeled 
in Chain A, and a Mg2+ ion and ordered water molecule were modeled in Chain B 
into positive Fo-Fc density contoured to 4 RMSD in COOT. The PEG molecule was 
modeled into positive Fo-Fc density in Chain A contoured to 2.5 RMSD in COOT. 
Refinement with the DDM detergent alkyl group (dodecane- Ligand ID:D12) is 
approximately equivalent to refinement with PEG. However, the absence of any 
observed density for the maltose disaccharide of the DDM detergent led us to 
continue the final refinement with the PEG moiety. Notably, the observed density 
cannot be the undecaprenol moiety of undecaprenol phosphate  as the density was 
observed in all datasets including those collected from crystals which were not co-
crystallized with added Und-P.  
 
4.2.2 Phosphate Release Kinetics Assays  
Phosphate release from UDP by PglC was measured using the Biomol 
Green reagent (Enzo Life Sciences) for phosphate detection. Purified C. concisus 







"M in assay buffer (50 mM HEPES pH 7.5, 100 mM NaCl, 5% glycerol, 0.03% 
DDM) to a final volume of 40 "L. UDP was added at a final concentration of 200 "M in the presence and absence of 5 mM MgCl2. Enzyme and substrate were 
incubated at room temperature at time points up to 180 minutes in a sealed 96-
well microtiter plate. Reactions were quenched by addition of 100 "L Biomol 
Green reagent to each reaction well. The denatured sample of I57M/I87M PglC 
was heat-inactivated by incubation at 98 °C for 10 minutes. The plate was 
incubated for 30 minutes at room temperature for color to develop. Absorbance at # = 620 nm was measured on a Molecular Devices SpectraMax M5 plate reader. All 
reactions were performed in triplicate. Inorganic phosphate release was quantified 
by comparison to a standard curve of KH2PO4 in deionized H2O. Controls with 
UMP (200 µM), UDP-GlcNAc (80 µM), and catalytically-inactive variants, 
I57M/I87M/D93N and I57M/I87M/E94Q, (20 µM) were performed to address the 
mechanism of phosphate release. Separate control phosphate analysis experiments 
using PglC, UDP, buffer, water, DDM (0.03%) and MgCl2 (5 mM) individually 










4.2.3 Computational identification of potential substrate binding sites in PglC 
To prepare structures for computational docking experiments ligands were 
removed from Chain B of the model of I57M/Q175M PglC. The 3-D coordinates of 




The 3D coordinates of UndP (ligand ID: 5TR) were downloaded from the 
PDB in .cif format.  Coordinate files for the structure of PglC and substrates were 
prepared to for computational docking experiments with AutoDockTools (107) 
and DockPrep in UCSF Chimera (75) to include polar hydrogen atoms, partial 
charges, and atom types. PglC-substrate docking was performed using AutoDock 
Vina (108) implemented through UCSF Chimera with default parameters 
accepted. The PglC model was used as the receptor for docking of the substrates 
(UndP and UDP-Bac). Nine binding modes were generated for each PglC-
substrate combination. Binding modes with the lowest predicted binding-energy 







4.2.4 Crystallographic efforts towards substrate liganded structures  
High-throughput crystallization screening at Hauptman-Woodward Institute. 
Preparation of C. concisus PglC constructs (Table 4.1) for high-throughput 
crystallization screening was performed by Dr. Debasis Das (Imperiali Lab, MIT). 
All protein samples were provided at a concentration of 6.1 - 6.5 mg/ mL in 50 mM 
HEPES 7.5, 100 mM NaCl, 5% glycerol, and 0.12% DDM to the HWI HT 
Crystallization Screening Center (http://hwi.buffalo.edu/high-throughput-
crystallization-center/). E93Q PglC containing 1 mM MgCl2 and 520 µM UDP-
diNAcBac and WT PglC containing 1 mM MgCl2 and 560 µM UndP were provided 
for the soluble protein screen. K59R PglC containing 1 mM MgCl2 and 560 µM 
UDP-diNAcBac was provided for the membrane protein screen. A subset of 
crystallization conditions resulting in formation of crystalline material based on 
crystal size, morphology, and crystallization condition components were selected 
for optimization into higher drop volume, 24-well hanging-drop format for each 








Table 4.1. Amino acid sequences of PglC constructs used to attempt to obtain 
liganded structures. Underline denotes N-terminal methionine residue. Red 
indicates position of the point mutations. 
Construct Amino acid sequence 
      
















    
K59R* SGSGMYRNFLKRVIDILGALFLLILTSPIIIATAIFIYFKVSRDVIFTQA     
 RPGLNEKIFRMYKFKTMSDERDANGELLPDDQRLGKFGKLMRSLSLDELP     
 QLFNVLKGDMSFIGPRPLLVEYLPIYNETQKHRHDVRPGITGLAQVNGRN     
 AISWEKKFEYDVYYAKNLSFMLDVKIALQTIEKVLKRSGVSKEGQATTEK     
 FNGKN     
R112Q SGSGMYRNFLKRVIDILGALFLLILTSPIIIATAIFIYFKVSRDVIFTQA     
 RPGLNEKIFKMYKFKTMSDERDANGELLPDDQRLGKFGKLMRSLSLDELP     
 QLFNVLKGDMSFIGPQPLLVEYLPIYNETQKHRHDVRPGITGLAQVNGRN     
 AISWEKKFEYDVYYAKNLSFMLDVKIALQTIEKVLKRSGVSKEGQATTEK     
 FNGKN      
* Constructs provided to HWI for HT screening. 
 
Crystallization of WT and R112Q C. concicus PglC. Crystallization conditions 
identified by the HWI high-throughput screen for WT PglC co-crystallized with 1 







PEG 3350 (w/v) reproduced crystals in 24-well hanging-drop crystallization 
experiment format. Optimization of these crystallization conditions by varying 
concentration of calcium chloride and precipitant (PEG 3350) produced crystals of 
WT and R112Q variant C. concisus PglC which diffracted to sufficiently high 
resolution for data collection (3.0-2.2 Å). The specific crystals used for data 
collection were grown from crystallization experiments set up at 17 °C with 
crystallization reagents purchased from Hampton Research used after 
temperature equilibration. All co-crystallization experiments were performed via 
an 30 minute incubation step on ice and subsequent centrifugation step at 14,000 
rpm for 10 minutes at 4 ° C . WT PglC (280 µM) co-crystallized with 1 mM MgCl2 
and 560 µM UndP (2 equivalents) produced optimized crystals in 0.225 M CaCl2 
pH 5.0 and 21% PEG 3350 and a drop ratio of 2 µL of PglC : 3 µL of well solution. 
Crystals appeared within 3 days and were fully grown in 10 days. R112Q PglC 
(280 µM) co-crystallized with 1mM MgCl2 and 560 µM UndP (2 equivalents) 
produced optimized crystals in similar conditions (0.2 M CaCl2 pH 5.0 and 23% 
PEG 3350) and a drop ratio of 2 µL of PglC : 2 µL of well solution. R112Q variant 
crystals appeared in 2 days and were fully grown in 5 days. All crystals used in 
data collection were flash-cooled in liquid nitrogen for transport to the beamlines 







Phasing and refinement of R112Q and WT C. concisus PglC structures. A WT 
PglC dataset was collected from a crystal diffracting to 2.19 Å at beamline 24-ID-E 
(12665 eV, 100 K ) at the Advanced Photon Source (Chicago, IL). Additionally, a 
dataset from R112Q PglC was collected from a crystal diffracting to 2.33 Å at 
beamline 24-ID-E (12665 eV, 100 K) the Advanced Photon Source (Chicago, IL). 
Indexing of the datasets collected for both WT and R112Q PglC found the space 
group P 32 2 1 and unit cell dimensions of a = b = 71.198 Å, c = 189.64 Å; α=β= 90°, 
γ = 120° for WT, and a = b = 71.136 Å, c = 189.539 Å; α=β= 90°, γ = 120° for R112Q 
PglC. Matthews coefficient analyses for these datasets suggests 2 copies in the 
asymmetric unit (ASU). As the unit-cell dimensions and space group assignments 
identified by indexing were isomorphous to the I57M/Q175M C. concisus PglC 
dataset used to solve the molecular structure presented in Chapter 2 of this 
dissertation, isomorphous replacement was used phase the WT and R112Q 
datasets. The resulting models of R112Q and WT PglC are undergoing continued 
refinement with Phenix.refine (43). Current data collection and refinement 








Table 4.2. Data collection and refinement statistics for WT and R112Q Variant 
PglC. 
    
WT  R112Q variant 
(Dataset ID: C2x5) (Dataset ID: C2x14) 
Data collection   
 Beamline APS 24-ID-E APS 24-ID-E 
 Wavelength (Å) 1.00 0.97918 
 Resolution range (Å) 58.638 - 2.19 (2.26- 2.19) 63.180 - 2.330 (2.41 - 2.33) 
 Space group P 32 2 1 P 32 2 1 
 Unit Cell (Å) a = b = 71.198; c=189.64  a = b = 71.41; c = 189.54  
 Total Reflections  29630 (2235) 24382 (2396) 
 Unique reflections 29277 24451 
 Multiplicity 4.8 (4.3) 4.3 (4.5) 
 Completeness (%) 82.76 (76.47) 98.39 (99.46) 
 Mean I/sigma(I) 13.7 (1.5) 12.3 (1.0) 
 Wilson B-factor 53.09 66.43 
 Rmerge 0.047 (1.77) 0.054 (1.22) 
 Rmeas 0.059 (2.254) 0.07 (1.53) 
 CC1/2 0.99 (0.790) 0.99 (0.397) 
Refinement   
 Refl. used in refinement 25460 (2504) 24382 (2396) 
 Relfections used for Rfree 3754 (340) 3370 (381) 
 Rwork 0.2942 (0.3696) 0.2352 (0.3227) 
 Rfree 0.3340 (0.3872) 0.2905 (0.3494) 
 CCwork 0.845 0.899 
 CCfree 0.808 0.81 
 




 Protein residues 370 370 
 RMS(bonds) 0.005 0.003 











 Rotomer outliers (%) 0.00 1.52 
 Clashscore 13.46 7.47 
 Average B-factor 79.2 92.8 









4.2.5 Structural analyses of sequence conservation presented by Lukose, et al. (2015). 
Sequence conservation across the monotopic PGT superfamily was mapped 
onto the structure of I57M/Q175M C. concisus PglC in UCSF Chimera (75) with the 
Multalign Viewer tool. The multiple sequence alignment reported by Lukose, et al. 
(2015) (17) was loaded into Chimera and the sequence for C. jejuni (Uniprot ID: 
O86156) was associated with the structure for mapping. Sequence conservation 
was rendered on the structure in color ramp on the structure with blue denoting 
high sequence conservation and red denoting low sequence conservation. 
Additional assessment of sequence conservation for the PglC-like subfamily in 
comparison to all three monotopic PGT subfamilies was achieved by rendering 
residues with 70% sequence conservation in blue.  
 
4.2.6 Structural analysis of large unit cell  
A dataset of WT SeMet derivatized PglC was collected to 3.01 Å from a 
crystal grown in 100 mM BisTris pH 6.0, 350 mM MgCl2, and 26% PEG 3350 at 17 
°C with solutions purchased from Hampton Research and temperature 
equilibrated. Crystallization was carried out following the crystallization protocol 
for WT SeMet PglC described in section 2.2.1. The crystal used for data collection 







beamline without any additional cryoprotection. The 3.01 Å WT SeMet dataset 
was collected at Brookhaven National Lab (BNL) beamline 17-ID-1 during 
beamline commissioning experiments at a wavelength of 1.0 Å and a temperature 
of 100 K. The dataset was indexed into P 31 2 1 with unit-cell dimensions of a = b= 
142.82 Å, c = 192.563 Å; α = β= 90°, γ = 120°. Indexing, integration, and scaling were 
performed in HKL2000 (109). Matthews coefficient analyses suggest 8 copies of 
PglC in the ASU. Data collection and refinement statistics are summarized in Table 
4.3. Crystal packing in the large unit cell is highly similar to packing in the small 
unit cell with only subtle rearrangements resulting in the doubling of unit cell axes 









Table 4.3. Data collection and refinement statistics for WT SeMet 
Large-Unit-Cell Dataset 
    
WT SeMet  
(Dataset ID: J2) 
Data collection  
 Beamline BNL NSLS-II 17-ID-1 (AMX) 
 Wavelength (Å) 1.00 
 Resoution range (Å) 47.737 – 3.013 ( 3.121- 3.01) 
 Space group P 31 2 1 
 Unit Cell (Å) a = b = 142.82; c = 192.563  
 Total Reflections 75337 
 Unique reflections 38779 (3544) 
 Multiplicity 1.9 (2.0) 
 Completeness (%) 82.76 (76.47) 
 Mean I/sigma(I) 14.2 (1.0) 
 Wilson B-factor 84.21 
 Rmerge 0.074 (0.656) 
 Rmeas 0.105 (0.928) 
 CC1/2 0.98 (0.553) 
Refinement  
 Reflections used in refinement 38417 (3426) 
 Relfections used for Rfree 3754 (340) 
 Rwork 0.2708 (0.3585) 
 Rfree 0.2833 (0.3651) 
 CCwork 0.811 
 CCfree 0.764 
 
Number of non-hydrogen 
atoms 
12113 
 Protein residues 1480 
 RMS(bonds) 0.002 
 RMS(angles) 0.613 
 Ramachandran favored (%) 95.77 
 Ramachandran outliers (%) 0.34 
 Rotomer outliers (%) 0.34 
 Clashscore 7.92 
 Average b-factor 115.38 









4.3 Results and Discussion 
The structurally-efficient scaffold of PglC imparts membrane-association 
and function through small structural motifs that establish the RMH and directly 
influence active-site geometry through specific arrangement of catalytically-
important residues. The distinct co-facial positioning of the essential catalytic-
dyad residues (Asp93 and Glu94), underpinned by the 310-helix of the AHABh-
motif (Figure 3.15) is further enforced by through the coordination of the Mg2+ co-
factor by Asp93 (figure 4.4). Notably, coordination of Mg2+ by absolutely conserved 
adjacent acidic residues has likewise been predicted biochemically in the 
monotopic PGT superfamily members WecA and WbaP (105, 110). In the crystal 
structure of PglC, the Mg2+ co-factor is further coordinated by the main-chain 









Figure 4.4. Active-site architecture. Depiction of the active-site showing the 
conserved Asp-Glu dyad with Mg2+ and phosphate ligands and sequence logo. 
Phosphate was not added in the protein preparation or crystallization conditions, 
but resulted from hydrolysis of exogenously-added 5-iodo-UDP during 
crystallization. 
 
Surprisingly, catalytically-important interactions are not observed for the 
side chain of Arg88, thus the absolute conservation of this residue across the 
superfamily must arise from a separate mechanism of evolutionary conservation. 







electrostatic environment of the active-site (Figure 4.5). Mapping of the 
electrostatic charge distribution calculated by the Poisson-Boltzmann equation 
(via APBS, see methods in section 3.2.4) (73) onto the molecular structure of PglC 
reveals numerous basic residues forming a positive-electrostatic funnel poised for 
binding and orienting the negatively-charged phosphate-rich UndP and UDP-




Figure 4.5.  Electrostatic surface representations of PglC colored by charge 
from red (-5 kT/e) to blue (+5 kT/e). 
 
4.3.1 PEG andPhosphate binding suggest location of UndP and phosphate-binding 
subsites 
 
As discussed briefly in chapter 2, the structure of I57M/Q175M PglC was 
refined with a PEG molecule occupying an active-site cleft and an inorganic 
phosphate molecule proximal to the catalytic Asp-Glu dyad (Figure 4.6). Presence 
of a molecule of PEG bound within the soluble and membrane-accessible cleft 








putative-binding subsite would allow for the membrane-embedded UndP to 
access the catalytic dyad, and therefore the phospho-sugar intermediate, without 
leaving the membrane. Whereas the PEG molecule is more polar and flexible than 
the isoprenoid moiety of the UndP, the observation within crystal structures of 
PEG molecules bound at hydrophobic-substrate binding-sites localized at the 
membrane interface is not without precedent (111). Additionally, analysis of the 
hydrophobicity of the residues lining the putative UndP-binding cleft illustrates 
an amphipathic directionality to the site. Residues below the predicted membrane 
plane exhibit greater hydrophobicity than those above the membrane plane 
suggesting that the hydrophobic isoprenoid and phosphate moieties of the UndP 









Figure 4.6. Polyethylene glycol (PEG) position in the PglC binding site 
identifies the putative Pren-P binding site.  PEG (pink), Arg112, Glu94, Asp93 
(green), and phosphate (orange) are shown as sticks and Mg2+ is depicted as a grey 
sphere. The hypothetical membrane surface is shown as a transparent grey 
surface. Inset, Fo-Fc simulated annealing omit map contoured to 3σ shown as gray 
wire mesh. PEG molecule 305 (chain A) shown in pink sticks. Phosphate molecule 
302 (chain A) shown in orange sticks. 
 
 
The presence of phosphate within the structure also suggests a putative 
substrate binding-subsite for PglC. Phosphate informs on the putative phosphate-
binding subsite of UDP-diNAcBac or phosphor-sugar intermediate moiety. 







conditions, therefore its observation within the crystal structure resulted from 
hydrolysis of exogenously-added 5-iodo-UDP during crystallization. As UDP is 
not the native substrate for PglC, evaluation of enzymatic phosphate release form 
PglC constructs used in crystallization incubated with UDP were carried 
performed using the Biomol Green assay (Figure 4.7). A measured rate of free 
phosphate liberation from UDP of 1.76 nM s-1 confirms PglC is able to turn over 
UDP only in the presence of the catalytically-required Mg2+ despite the large 
difference in charge between the di-anionic UDP and native UDP-diNAcBac 
substrates. Additionally, enzymatic phosphate release from UDP by variants of 
PglC which are catalytically-inactive against the native substrate 
(I57M/I87M/D93N and I57M/I87M/D93N) suggests the mechanism of phosphate 
release in the enzyme differs from that of the native substrate. Further support for 
a differing mechanism of phosphate-release for non-native substrate is provided 
by measurement of a relatively similar rate of UDP turn over in a competition 
assay with catalytically-active PglC and a significantly less catalytically-active 










Figure 4.7. Time course of phosphate release in the reaction of 20 "M PglC with 
200 "M UDP in the presence and absence of 5 mM MgCl2. Assays were carried 
out in triplicate. Error bars represent mean ± standard deviation. Reaction with 
I57M/I87M PglC at 20 "M with 200 "M UDP and 5 mM MgCl2 gave a rate of 
phosphate release from UDP of 1.76 nM s-1 (brick red, circles).  Reaction 
withI57M/I87M/E94Q PglC at 20 "M with 200 "M UDP and 5 mM MgCl2 gave a 
rate of phosphate release from UDP of 2.44 nM s-1 (black, open circles). Reaction 
with I57M/I87M/D93N PglC at 20 "M with 200 "M UDP and 5 mM MgCl2 gave a 
rate of phosphate release from UDP of 1.72 nM s-1 (green, circles). Reaction with 
I57M/I87M PglC at 20 "M with 200 "M UDP and 80 µM UDP-GlcNAc and 5 mM 
MgCl2 gave a rate of phosphate release from UDP of 1.25 nM s-1 (green, circles) 
(orange, squares). Reaction with WT PglC at 20 "M with 200 "M UDP and 5 mM 
MgCl2 gave a rate of phosphate release from UDP of 1.99 nM s-1 (blue, circles). 
Separate control phosphate analysis experiments using PglC, UDP, buffer, water, 
DDM (0.03%) and MgCl2 (5 mM) individually confirmed that none of these 
reagents contributed to the phosphate measured. 
  






















WT + UDP + Mg2+ (denatured)
I57M/I87M/E94Q + UDP + Mg2+
I57M/I87M/E94Q  + UDP
I57M/I87M/D93N + UDP + Mg2+
I57M/I87M/D93N + UDP
I57M/I87M + UDP + Mg2+ 
I57M/I87M + UDP 
I57M/I87M + UDP + Mg2+ (denatured)
I57M//I87M + UDP + Mg2+ + UDPGlcNAC







4.3.2 Computational docking of UDP-diNAcBac and UndP corroborates predicted 
substrate binding sites for PglC 
 
In the absence of experimentally-determined PglC-substrate complex 
structures, computational docking of the native substrates UDP-diNAcBac and 
UndP into the enzyme active-site performed using AutoDock Vina (108) 
corroborates the positioning of the binding subsites indicated by the phosphate 
and PEG moieties in the crystal structure. The enthalpies of the binding poses 
calculated for UndP were all similar ranging from -6.7 kcal mol-1 to -6.1 kcal mol-1. 
The highest scoring binding pose for UndP (Figure 4.8A) positions the UndP 
isoprenoid moiety into the hydrophobic, putatively-membrane embedded, cleft 
and the UndP phosphate moiety within close proximity to both the catalytic dyad 
and Arg112. Arg112 has been shown to be important in positioning of substrates 
through mutagenesis studies (17). Similarly, the binding pose of UDP-diNAcBac 
chosen as the best pose places the di-phosphate linker between the nucleoside and 
sugar groups in close proximity to both catalytically-important centers of 
functionality. It should be noted that the binding pose with the lowest binding 
enthalpy (-8.0 kcal mol-1) for UDP-diNAcBac did not dock the molecule within 
close proximity to both Arg112 and the Asp-Glu catalytic dyad. Thus, a binding 







the substrate within close proximity to both catalytically-important groups was 
chosen as the best, most-likely binding pose (Figure 4.8B).   
 
 
Figure 4.8. Substrate binding poses computed by AutoDock Vina in proximity 
to the catalytic Asp-Glu dyad and Arg112 (blue sticks). A, Binding pose predicted 
for UndP (rose sticks). B, Binding pose predicted for UDP-diNAcBac (magenta 
sticks). 
 
In the context of the covalent phospho-sugar intermediate mechanism 
described previously for C. concisus PglC (25), which dictates that the UndP and 
UDP-diNAcBac substrates cannot be resident within the enzyme active site at the 
same time, the binding sites for the β-phosphate of the UDP-diNAcBac and the 
UndP are predicted to be coincident. Consistent with this prediction, overlaying 







site clearly illustrates coincidence in the binding sites for the UDP-sugar, β-
phosphate, and UndP phosphoryl moiety (Figure 4.9).  
 
 
Figure 4.9. Overlay of docked poses reveals coincident binding sites for UndP 
and and UDP-diNAcBac. UDP binding subsite indicated with purple dashed 
circle, UndP binding subsite indicated by rose dashed circle, and sugar binding 
subsite indicated by magenta dashed circle. UDP-diNAcBac displayed with uracil 
nucleoside represented by purple sticks, phosphoryl moiety represented by 
orange sticks, and diNAcBac moiety represented by magenta sticks. UndP 
displayed with isoprenoid tail represented by rose sticks and β-phosphate moiety 







The functional residues of PglC identified through conservation and 
mutagenesis by Lukose et al. (2015) (17) map to the structure in coordination with 
the predicted-binding sites. Pro24, a determinant of the kink in the RMH, was 
implicated in interactions with UndP, this follows with the proposed binding-site 
as Pro24 lies within the hydrophobic cleft in which the UndP isoprenoid moiety is 
docked. Arg112, identified to interact with phosphate groups by mutagenesis 
plays a critical function in positioning both the phosphoryl groups from UndP and 
UDP-diNAcBac. Notably, it is possible that guanidinium functional-group of 
Arg112 is important for orienting the uridine ring of UDP-diNAcBac within the 
activesite. However, those interactions were not observed in any of the top 10 
binding-poses identified by AutoDockVina. Subtle ligand-induced binding 
interactions may be missed as docking of substrates is performed with a relatively 
static molecule of PglC. Given the current best docked pose from these docking 
experiments, Asp93 and Glu94 comprising the catalytic dyad are well positioned 









4.3.3 Predicted UndP and UDP-binding subsites are conserved across the monotopic 
PGT superfamily 
 
All monotopic PGTs follow a general reaction scheme where the PGT 
catalyzes the transfer of a C1-phosphsugar to from a UDP-sugar to UndP. Notably, 
the utilization of UDP and UndP is universally conserved across the superfamily; 
however, the identity of the sugar moiety accepted by the individual members 
varies within the subfamilies and superfamily with some PglC-like subfamily 
members (C. concisus, C. jejuni) utilizing diNAcBac as their sugar substrate (20) 
and others utilizing GlcNAc (H. pullorum) (112). Consistent with this, analysis of 
amino-acid conservation across the monotopic PGT subfamilies and superfamily 
as a whole illustrates that the predicted UDP and UndP binding subsites display 
a high degree of conservation in primary structure (Figure 4.10). Similarly, as 
expected, the residues composing the predicted sugar-binding subsite are 









Figure 4.10. Predicted UDP and UndP binding-site is well conserved across the 
three PGT families. A, sequence conservation for the PglC-like family mapped to 
the structure with residues with ≥70% conservation shown as blue sticks. Starred 
residues denote residues of the extended loop with 100% sequence conservation. 
B, Sequence conservation for all three monotopic PGT subfamilies. Residues with 
≥ 70% conservation shown as blue sticks.  
 
 
Unexpectedly, the residues within the extended loop connecting β-strand 2 
with helix C (aa 61- 81) are well conserved in the PglC-like subfamily (Figure 
4.10A, starred). This loop, termed the ANGEL loop based on the sequence forming 
the turn (61-KMTMSDERDANGELLPDDQRLG-81), was predicted by protein 
structure prediction algorithms to fold down over the active site. The 
conformation of this loop was the main difference observed between the predicted 
models and the model determined crystallographically; however, it should be 







protomers proximal to each other (Figure 2.8) which results in the pinning of this 
loop in both protomers into the observed open conformation.  
 
4.3.4 Active site and binding site locations are energetically advantageous 
The location of the active site and proposed substrate-binding sites 
positions all reaction components at the membrane interface. This tactical 
placement of the active site obviates the need for energetically-costly translocation 
of the membrane-embedded substrate and product out of, and back to the 
membrane. In contrast to the molecular logic of PglC, the polyprenol phosphate 
glycosyl transferase, GtrB, responsible for the biosynthesis of a membrane bound 
pholyprenol monophosphosugar, requires a translocation of approximately 15 Å 
of the lipophilic substrate from the membrane to the soluble glycosyltransferase 
domain where catalysis takes place and back again upon product-release (113). 
Additionally, the molecular logic of active sites located far from the membrane 
interface despite membrane-bound substrates and products is re-capitulated in 
many monotopic enzymes (114) (figure 4.11). In these enzymes, hydrophobic 
channels allow for the translocation of membrane-bound substrates out of the 
membrane to the active site (115). As a result, the molecular logic of PglC, as an 







hydrophobic membrane-bound substrates and products while obviating the need 
energetically-costly translocations of hydrophobic substrates through tactical 
placement of the active site at the membrane interface. 
 
	
Figure 4.11. Location of enzyme active sites in relation to the membrane. Left, 
Carnitine palmitoyltransferase shown with its ligand (ID: BUI, green spheres) 
marking the active site position. Middle, GtrB with UDP (pink spheres) marking 
the active site. Right, PglC with cyan circle marking the catalytic-dyad. Protein 
surface colored by normalized consensus hydrophobicity from hydrophobic (red) 
to hydrophilic (white). Membrane represented by gray box. Location of membrane 
plane calculated with PPM server (http://opm.phar.umich.edu/server.php). 
 
 
Overall, the locations of the catalytic dyad, Mg2+ cofactor, and substrate-
binding sites that are defined through structural analysis and computational 
docking afford a mechanistic scheme for PglC catalysis consistent with formation 









Figure 4.12. The structure of PglC provides insight into the molecular basis of 
the chemical mechanism of monotopic PGTs. Mg2+ is shown as gray sphere.  
Figure from Ray, L.C., Das, D., Entova, S., Lukose, V., Lynch, A.J., Imperiali, B., 
and Allen, K.N. Membrane association of monotopic phosphoglycosyl transferase 
underpins function. Nature Chemical Biology (2018). (accepted).  
 
4.3.5 Conformational change could be required for tight substrate binding 
Computational and bioinformatics analysis affords the ability to predict 
and understand the determinants of substrate binding and therefore mechanism 
in PglC; however, experimental structural data is needed to corroborate 
predictions and postulations made from such analyses. Attempts to obtain crystal 
structures of PglC in complex with its substrates with have been largely 
unsuccessful. As result, closure of the ANGEL loop over the active site, as 
discussed previously, has been hypothesized to be required for substrate binding. 
This hypothesis is based on three main observations: the divergence of loop 







crystallographically-determined model (Figure 2.8B), absolute conservation of 
many residues in the ANGEL loop (Figure 4.9A, starred), and lastly, the variable 
loop position correlating to presence or absence of observed positive electron-
density in the active sites of promoters in the large unit-cell dataset ASUs.  
Although the low resolution (3.01 Å) of the large unit-cell dataset, and likely 
low-occupancy binding of substrates, precludes modeling of specific ligands into 
positive Fo-Fc density observed in the active sites of specific promoters, correlations 
between presence or absence of un-modeled density and loop conformation can 
be made. When the eight copies of PglC in the ASU of large-unit cell datasets are 
overlaid, the ANGEL loop is evident as the main region of structural divergence 
between the chains (Figure 4.13A). In chains G and H, comparatively large 
amounts of positive density are present. Chains C, D, E, and F all have minimal 
positive density present. Lastly, chains A and B, have moderate amounts of 
density present (figure 4.13B). Analysis of ANGEL loop conformation in the 
context of active-site occupancy shows chains with more positive density appear 
to be in a more closed conformation than those with little or no density present. 
Chains occupying the same position in the crystal lattice dimer do not do always 
occupy the same ANGEL loop position, thus the difference in loop conformation 







residue B-factors for each overlaid chain to understand the structural basis for this 
divergence reveals that the loops occupy either one of two relatively low-B-factor 
conformations, open or closed, with higher-B-factor loops occupying positions 
between these two conformations (Figure 4.13C).  
 
 
Figure 4.13.  ANGEL loop can move to a more “closed” position upon 
occupancy of binding sites in the activesite. A, Overlay of the 8 chains in the WT 
SeMet large unit-cell dataset (see Table 4.3). Chains colored by rainbow from chain 
A (red) to chain H (violet). B, 2FO-FC (blue, contoured to 1.5 σ) and FO-FC (green 
and red, contoured to 3 σ) electron density observed in the active-site of each chain 
(yellow) show positive density in chains G and H, no density in chains C and D, 
and small areas of positive density in chains E, F, A, and B. C, Low b-factor “open” 







activesite. B-factors for each residue mapped to the ANGEL loop. Final refined 
model for I57M/Q175M PglC shown in black.  
 
4.3.6 High-throughput screening and optimization of novel PglC crystallization 
conditions 
 
All crystals of PglC grown in similar conditions crystallize in the same 
space groups, P 31 2 1 for the large unit cell or P 32 2 1 for the small unit cell, and 
without interpretable ligand-density despite co-crystallization with different 
substrates, substrate-mimics, or additives; it is unlikely given the current 
crystallization conditions will afford a ligand-bound structure of PglC. As a result, 
three PglC constructs were provided for high-throughput crystallization screening 
at HWI to identify crystallization conditions which result in differing crystal forms 
(116). Each construct was co-crystallized with substrate in an attempt to find 
conditions which promoted PglC-substrate complex formation. To avoid turn-
over of substrate during crystallization, UDP-diNAcBac was co-crystallized with 
a catalytically-inactive E94Q and K59R variants. As UndP requires turnover of 
UDP-diNAcBac to be a viable substrate, WT PglC can be co-crystallized with UndP 
without enzymatic turnover. The top crystallization hits resulting in the formation 
of large crystals from HT screening at HWI are summarized in table 4.4. From the 







different from the current crystallization conditions (BisTris pH 6, MgCl2, and PEG 
3350) and produced crystals with different crystal morphology than the regular 









Table 4.4. Initial crystallizaiton conditions selected from HWI HT crystallization screening. Conditions selected 
for optimization denoted by box.  
	
	
Table xxxxx. HWI intial crystal hits. Hits elected for optimization denoted by box.
Construct Co-crystallizaiton HWI Cocktail Salt Buffer Precipitant
+ 560 !M UDP- 17_C0124 5% (w/v) Ethylammonium nitrate (C2H8N2O3) 0.09 M HEPES pH: 6.8 PEG 3350 27% (w/v)
+ 5 mM MgCl2 17_C0437 0.1 M Sodium molybdate dihydrate (Na2MoO4*2H2O) 0.1 M Bis-Tris Propane pH: 7 PEG 8000 20% (w/v)
17_C0453 0.1 M Lithium sulfate monohydrate (Li2SO4*H2O) 0.1 M TAPS pH: 9 PEG 8000 20% (w/v)
17_C0554 0.1 M Ammonium phosphate-monobasic (NH4H2PO4) 0.1 M Bis-Tris Propane pH: 7 PEG 4000 20% (w/v)
17_C0600 0.1 M Sodium molybdate dihydrate (Na2MoO4*2H2O) 0.1 M CAPS pH: 10 PEG 4000 20% (w/v)
17_C0989 0.1 M Sodium citrate tribasic dihydrate pH: 5.5 PEG 3,350 18% w/v
17_C1001 0.1 M Sodium citrate tribasic dihydrate pH: 5.5 PEG 8,000 16% w/v
17_C1007 0.1 M Imidazole pH: 7.0 PEG 20,000 12% w/v
17_C1186 0.2 M Potassium sulfate pH: 6.8 PEG 3350 20%(w/v)
17_C1216 8%(v/v) Tacsimate pH: 7 PEG 3350 20%(w/v)
17_C1218 8%(v/v) Tacsimate pH: 8 PEG 3350 20%(w/v)
17_C1220 0.2 M Succinic acid pH: 7 PEG 3350 20%(w/v)
17_C1430 0.20M Potassium Sodium Tartrate tetrahydrate PEG 3350 20%(w/v)
+ 560 !M UndP   17_C0462 0.1 M Manganese sulfate monohydrate 0.1 M Sodium Acetate pH: 5 PEG 8000 20% (w/v)
+ 5 mM MgCl2 17_C1159 0.2 M Calcium chloride dihydrate pH: 5.1 PEG 3350 20%(w/v)
17_C1220 0.2 M Succinic acid pH: 7 PEG 3350 20%(w/v)
+ 560 !M UDP- M8_C0084 0.4 M Potassium Chloride (KCl) 0.1 M Sodium Citrate pH: 5.6 PEG 400 50% (v/v)
+ 5 mM MgCl2 M8_C0095 0.4 M Sodium Chloride (NaCl) 0.1 M Sodium Citrate pH: 5.6 PEG 400 40% (v/v)
M8_C0242 0.2 M Ammonium Sulfate ((NH4)2SO4) 0.1 M TRIS pH: 8.5 PEG 400 40% (v/v)
M8_C0243 0.2 M Ammonium Sulfate ((NH4)2SO4) 0.1 M TRIS pH: 8.5 PEG 400 50% (v/v)
M8_C0266 0.1 M Potassium Chloride (KCl) 0.1 M TRIS pH: 8.5 PEG 400 30% (v/v)
M8_C0308 0.05 M Sodium Chloride (NaCl) 0.1 M Sodium Citrate pH: 5.6 PEG 4000 20% (w/v)
M8_C0431 0.3 M Magnesium Chloride hexahydrate (MgCl2 * 0.1 M HEPES pH: 7.0 PEG 4000 20% (w/v)
M8_C0469 0.1 M Sodium Chloride (NaCl) 0.1 M HEPES pH: 7.0 PEG 4000 16% (w/v)
M8_C0665 0.4 M Magnesium Chloride hexahydrate (MgCl2 * 0.1 M HEPES pH: 7.0 PEG 2000 30% (w/v)
M8_C1101 0.4 M Magnesium Chloride hexahydrate (MgCl2 * 0.1 M TRIS pH: 8.5 PEG 6000 20% (w/v)
M8_C1259 0.1 M Lithium Sulfate monohydrate (Li2SO4 * H2O) 0.1 M HEPES pH: 7.0 PEG 3350 20% (w/v)
M8_C1369 0.1 M Sodium citrate tribasic dihydrate Jeffamine, pH 7.0 











Figure 4.14. Selected crystal conditions for optimization from HWI HT 
screening.  A, Crystal hits of K59R PglC co-crystallized with 560 µM UDP-
diNAcBac and 5 mM MgCl2. B, Crystal hits of E94Q PglC co-crystallized with 560 
µM UDP-diNAcBac and 5 mM MgCl2. C, Crystal hits of WT PglC co-crystallized 
with 560 µM UndP and 5 mM MgCl2. 
 
The first round of optimization of the selected crystallization conditions in 
24-well hanging-drop format resulted in replication of high-quality crystals only 
from the CaCl2 and PEG 3350 condition for WT co-crystallized with UndP and 
MgCl2 and a new variant, R112Q, co-crystallized with UndP and MgCl2. 
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Unfortunately, this crystallization condition is most similar to the previous 
crystallization conditions. Conversely, only thin crystals of E94Q PglC co-
crystallized with UDP-diNAcBac were obtained from grid-screens around the 
selected tacsimate and PEG 3350 conditions, while other conditions selected for 
optimization did not reproduce crystals. The crystals of WT PglC co-crystallized 
with UndP produced diffraction to 3.0 - 2.19 Å. Similarly, screening of R112Q 
crystals for diffraction revealed crystals grown in 0.2 M CaCl2 and 23% PEG 3350 
produced diffraction to 2.6 - 2.33 Å. Unsurprisingly, the thin crystals grown in 8% 
tacsimate and 22-26% PEG 3350 only produced reflections to 8-10 Å resolution.   
Indexing of the datasets from crystals of WT and R112Q grown in CaCl2 and 
PEG3350 found similar unit cell dimensions and identical space groups found for 
crystals grown in the previously used BisTris pH 6, MgCl2, and PEG 3350 
condition. As a result, the goal of obtaining a new crystal form and therefore novel 
crystal packing was unsuccessful; however, data collection at APS beamline 24-
ID-E from crystals of WT and R112Q PglC resulted in the determination of two 
new higher-resolution structures of PglC. Collection of data from a crystal of WT 
PglC co-crystallized with 560 µM UndP and 5 mM MgCl2 grown in 0.25M CaCl2 
and 21% PEG 3350 allowed the determination of the structure to a resolution of 







Refinement of this model is still ongoing, with a current Rwork/Rfree of 0.2942/0.3340. 
Likewise, collection of a dataset from a crystal of R112Q co-crystallized with 560 
µM UndP and 5 mM MgCl2 grown in a similar condition (0.2 M CaCl2 and 23% 
PEG 3350) allowed the structure of R112Q PglC to be solved to 2.33 Å. Refinement 
of this model is ongoing with a current Rwork/Rfree of 0.2352/0.3494 (Table 4.2). 
Although at higher resolution, clear density for UndP was not observed in either 
dataset, and is therefore not able to be modeled. Notably, in both datasets, density 
similar to that observed for PEG in the I57M/Q175M model of PglC was observed. 
All three molecular structures are highly similar with an RMSD = 0.312 Å for WT 
aligned to I57M/Q175M, and RMSD = 0.250 Å for R112Q aligned to I57M/Q175M. 
 
4.4 Conclusions and Future Directions  
The structural underpinnings of substrate interaction and mechanism 
revealed by structural, biochemical, and computational analyses of the model of 
I57M/Q175M C. concisus PglC support the colvalent phospho-sugar intermediate 
mechanism proposed for PglC, and the monotopic PGT superfamily overall. 
Unfortunately, the current crystallization condition appears non-ideal for 
crystallization of PglC-substrate complexed structures, as the ANGEL loop 







in the crystal lattice produced in this condition. High-throughput screening of 
novel crystallization conditions and constructs with substrate produced crystals 
in many novel conditions. While the crystallization conditions selected for the 
initial round of optimization produced two new higher-resolution molecular 
models of PglC, WT to 2.19 Å and R112Q variant to 2.33 Å, both structures were 
un-liganded and packed in the same crystal lattice observed previously. Notably, 
during this first round of optimization, many of the crystal conditions selected 
from the HT screen produced poor-diffracting crystals or no crystals. Therefore, 
current efforts towards developing crystallization conditions to yield PglC-
substrate-complexed structures are focused on continued optimization of HT 
screening hits in crystallization conditions disparate from the current condition in 
chemical space. In addition, crystallization screening with additives known to 
mediate crystal contacts, 18-crown-6 ether and Anderson-Evans polyoxotungstate, 
is ongoing to promote the formation of differing crystal morphologies in an effort 
to capture the ANGEL loop in a closed conformation (117, 118). In parallel, 
construction of sequence similarity and genome-neighborhood networks for the 
PglC-like subfamily of monotopic PGTs will be undertaken to understand 
sequence determinants of sugar specificity within the subfamily in the absence of 







Overall, further molecular understanding of the structural determinants of 
binding of substrates to PglC garnered through the work provided in this chapter 
and on-going experiments will provide a structural platform from which to 
address development of anti-virulence agents against the entirety of the 



















Biophysical characterization and insight into the structure of PglC, 
primarily via small-angle x-ray Scattering (SAXS) with the use of lipid-bilayer 
nanodiscs (ND), will allow for an understanding of the structure and function of 
PglC within an environment which mimics the physiological membrane in which 
PglC is embedded. Although the highest achievable resolution for many 
biophysical studies makes discerning atomic features impossible, these low-
resolution structural studies are highly complementary to higher resolution 
methods. Despite the comparably low-resolution, SAXS and analytical 
ultracentrifugation (AUC) experiments are advantageous in that they characterize 
proteins in solution in aqueous buffers, and thus, provide an understanding of the 
protein in a more native-like environment, in direct contrast to the non-
physiological highly ordered crystal lattice. The study of membrane proteins via 
biophysical methods is marked by challenges due to inherent insolubility and 
propensity for aggregation (31, 33). This challenge is often abrogated through the 
use of detergents; however, a protein solubilized by detergent is not particularly 
physiologically relevant (119-121). To move towards studying these proteins in the 
most native-like environments feasible, nanodiscs (ND) coupled SAXS present as 







5.1.1 Lipid-bilayer nanodiscs as a tool to solubilize membrane proteins 
Nanodiscs are discrete native-like, discoidal membrane systems with 
defined composition and predictable nano-scale dimensions (8 – 16 nm). 
Structurally, ND are supramolecular self-assembled entities composed of a 
phospholipid bilayer constrained by two copies of a membrane scaffold protein 
(MSP) engineered from an Apolipoprotein A1 scaffold (122, 123). When these 
components solubilized in detergent are mixed in precise ratios, ND of defined 
size and composition will assemble spontaneously upon the removal of the 
detergent (figure 5.1). The unique, well defined structure imparts ideal physical 
properties for the utility of ND as a tool in biophysical studies. Most notably, as 
the hydrophobic environments required by the phospholipid bilayer core is 
satisfied by the amphipathic helices of the MSP scaffold, ND are soluble in 
aqueous buffers and therefore can provide stabilization of integral membrane 









Figure 5.1. Spontaneous assembly (A) and loading (B) of lipid-bilayer 
nanodiscs. 
 
5.1.2 ND enable studies of PglC by SAXS 
With the aid of ND, we can pursue low-resolution structural information 
for PglC in a native-like lipid environment via SAXS. In general, SAXS is a 
contrast-based method which measures small-angle scattering of macromolecules 
that arise from the difference in the average electron density between 
macromolecules and and that of the surrounding solvent. The simultaneous 
observation of randomly oriented of macromolecule in solution in SAXS 







intensities from the macromolecule. In comparison to x-ray crystallography in 
which scattering intensity amplitudes are measured according to the discrete 
three-dimensional function, I(qhkl), corresponding to the reciprocal lattice, the 
spherically-averaged intensity measured in SAXS decays as a function of 
momentum transfer. Ultimately, the distribution of scattering intensity 
amplitudes into reflections afforded by the crystal lattices leads to measurement 
of high-resolution data in crystallography, while the spherically-averaged SAXS 
scattering patterns can only be measured to low resolution. Scattering patterns 
collected during SAXS experiments are rotationally-averaged to give one-
dimensional scattering intensity profile, I(q) as function of the momentum 
transfer, q = 4πsinθ/λ, where λ is the incident wavelength in the experiment, and 
2θ represents the scattering angle (figure 5.2). Ultimately, the shape of the 
scattering curve obtained from SAXS experiments is determined based on the 
fluctuations of scattering-length density in comparison to the solvent. As such, if 
the scattering length density of the solvent, principally H2O in aqueous buffers, is 
equivalent to to that of the sample, the contrast, or excess scattering length density 
described by Δρ = ρsample – ρsolvent, is negligible resulting in no scattering from the 
sample. Contrast presents a unique challenge to the study of membrane proteins 







roughly equivalent to that of water (ρH2O = 334 e nm-3), resulting in no scattering 




Figure 5.2. Schematic representation of a SAXS experiment. 
 
The power of SAXS lies in the subtraction of the solvent scattering signal 
measured from a matched-buffer blank from the scattering signal from the 
macromolecule in solution. Thus, the resultant scattering intensity profile is that 
of the macromolecule alone. Transformations of the macromolecular SAXS 
intensity profile allow interpretation of structural parameters relating to the size 
and overall shape of the macromolecule in solution. One such parameter is radius 
of gyration, Rg, which provides a measure of the average weighted center-of-mass 
distances of the electron density for the particle, thus giving an approximation of 







The Guinier approximation (126), 
! " = 	! 0 &'()*+), 	    (5.1) 
 
allows calculation of Rg and I(0), the intensity of scattering at the zero-angle (2θ 
=0), directly from the scattering function, I(q). However, this approximation is only 
valid at very small scattering agles such that q <1.3/Rg.  Linearization of this 
approximation yields the a format for the standard equation of a line; thus, linear 
fitting to the plot of ln[I(q)] vs q2 gives direct measurement of Rg from the slope of 
the line and I(o) from the y-intercept (127). Measurement of I(0) is critical for 
determination of the molecular mass of the macromolecule in solution via SAXS. 
Similarly, the scattering intensity data can be represented in real-space through 
indirect Fourier transformation resulting in the pairwise distance distribution 
function, P(r), given by,  
! " = 	4. / 0 ∙ 234	(67)67 90:;<=>     (5.2) 
 
where, the scattering intensity I(q) is described by an integral limited to the 








5.1.3 SAXS as a method for determining molecular mass of a sample in solution 
The subtractive nature of SAXS can be leveraged to to determine the 
stoichiometry of resident-protein loaded into ND from the total scattering 
intensity measured during SAXS. However, the current methods of determination 
of MM from SAXS  make assumptions that are only valid for samples with 
homogenous electron density and globular or compact topologies (128-130). The 
physical properties of ND violate these assumptions due to the heterogenous 
electron density and scattering contrast arising from three distinct densities 
(protein, lipid acyl tails, and phospholipid head groups) and their decidedly non-
globular disc shape known to exhibit fluid-like motions (125, 131). 
In general, calculation of the molecular mass (MM) of a protein or particle 
directly from solution SAXS intensity curves is widely used as it allows for 
determination of the oligomeric state of the biomolecule, as well as monitoring of 
aggregation or sample degradation. One method for the determination of MM 
directly from SAXS data is enabled by the power-law relationship between the 
ratio between the term, QR, and particle mass as defined by Rambo and Tainer 
(129),  







where, QR represents the ratio of the I(0) to the total scattering intensity divided 
by Rg, e is Euler’s number (e = 2.718),  and k and c are experimentally determined 
constants specific to a class of macromolecule (e.g. protein, RNA, etc.) calculated 
by analysis of large sets of experimental SAXS data. Unfortunately, the 
dependence upon the empirical constants k  and c, limits MM determination via 
this method to protein only and RNA only particles (129), and therefore is not 
suitable for use in calculating the MM of a nanodiscs or resident-protein-ND 
complex due to a lack of experimental data from which to determine constants k  
and c.  
Though considerably more challenging than the aforementioned method 
due to the need for accurate knowledge of the concentration of the particle within 
the solution and its partial specific volume (v ̅), the more classical method for 
determination of MM by SAXS is more widely applicable (128, 130). By this 
method, in general, MM of particles in solution is calculated by from the absolute 
scattering at the zero-angle, or I(0). Notably, I(0) cannot be directly measured as  
zero-angle scattering cannot be distinguished from the unscattered radiation of 
the direct beam, thus it must be extrapolated by the Guinier approximation (126) 
as delineated above. The extrapolated I(0) values must then been placed on an 







by its relationship to the absolute scattering from water (128). Utilization of water 
as a secondary standard is accomplished by dividing the relative I(0) for the 
particle from the experimental constant scattering of water measured at the time 
of the particle SAXS experiment. Multiplication of this value by the absolute 
scattering of water to yields the absolute I(0) for the particle of interest. With 
knowledge of the absolute I(0) for the particle  it is  possible to determine of the 
MW, assuming accurate knowledge about the concentration particle in solution 
and its partial specific volume (v ̅) (130). Section 5.3.3 of this chapter details the 
development of an application of this method towards the determination of the 
MM of ND and protein-loaded ND ultimately to provide an independent measure 
of the number of target-proteins loaded into a ND.   
 
5.2 Materials and Methods 
5.2.1 ND Constructs used in SAXS and analytical ultracentrifugation (AUC) 
experiments 
All constructs of empty ND, SUMO-tagged C.concisus PglC loaded ND , and 
ND with varying amounts of UndP added to the lipid component prepared and 







Swiecicki (Imperiali Lab, MIT). All constructs used in the experiments presented 
within this chapter are summarized in table 5.1.  
 
Table 5.1. Table of constructs and experimental concentrations for SAXS, AUC, 
and SEC-SAXS experiments. 
ND Construct Experiment Conc., mg/mL 
Empty ND   
 MSP1D1 (10 nm) SAXS 0.40 
 MSP1D1∆H5 (8 nm) SAXS 0.36 
 AUC 0.20 - 0.60 
 SEC-SAXS *0.73 (0.25) 
 MSP1D1E3D1 (12 nm) SAXS 0.40 
    
Protein-loaded ND   
 MSP1D1∆H5 + SUMO-PglC SAXS 0.36 
    
UndP added to ND lipids   
 MSP1D1∆H5 + 1.7% UndP AUC 0.62 
 MSP1D1∆H5 + 3.3% UndP AUC 0.51 
 MSP1D1∆H5 + 5.0% UndP AUC 0.51 
 MSP1D1∆H5 + 6.7% UndP AUC 0.62 
 MSP1D1∆H5 + 8.3% UndP AUC 0.55 
 MSP1D1∆H5 + 10% UndP AUC 0.60 
 SAXS 0.68 
  
SEC-SAXS *0.94 (0.32) 
 
* Numbers in parentheses denote the effective concentration at the beam for SEC-
SAXS samples which experience ~2/3 dilution on the SEC column.  
 
To prevent sample deterioration and aggregation, all SAXS samples were 
kept cold, but never frozen, throughout the entire experimental process by 







°C prior to experimental run, and experimental temperature control at 10 °C, 
unless otherwise noted.  
 
5.2.2 Static Solution SAXS Data Collection and Processing 
Solution SAXS experiments of ND samples were performed at beamline 4-
2 at the Stanford Synchrotron Radiation Lightsource (SSRL) (Menlo Park, CA). ND 
samples were analyzed at the concentrations outlined in table 5.1 and with 
reserved gel-filtration matched buffer for each sample serving as the buffer blank 
for subtraction.  To minimize aggregation-propensity and phase-transition within 
the ND lipids, samples were held at 283.15 K for experiments using a water-chilled 
Autosampler block and capillary holder sample environment at the beamline. For 
each data set, 30 µL of sample was was drawn into the experimental capillary via 
the Autosampler needle and oscillated during data collection to reduce radiation 
damage. Ten images with one second exposure at λ = 1.12 Å were collected on a 
Pilatus 3 x 1M detector positioned 0.45 m from the sample resulting in a resolution 
range of 0.0223 > q = 4πsinθ/λ > 1.69 Å-1, where 2θ is the scattering angle.  
Data images were scaled and radially integrated automatically via 
SAXSPipe implementing the program sastool at the beamline. Scattering profiles 







were removed with SAXSPipe. The buffer contribution to the sample scattering 
was removed by subtraction of the scatting from the matched buffer sample form 
the sample to give the one-dimensional scattering intensity profile for the ND 
samples. Further processing and analysis of the SAXS data was carried out with 
the ATSAS suite of programs (132). Radius of gyration (Rg) for each sample was 
determined from transformation of the scattering intensity profiles in PRIMUS 
(133) via the Guinier approximation (126) (equation 5.1) within a fitting limit of 
qRg ≤ 1.3. The following fitting limits were used for each sample: MSP1D1, qRg = 
0.652 - 1.278 Å-1; MSP1D1ΔH5, qRg = 0.765 - 1.30 Å-1; MSP1D1ΔH5 + PglC, qRg = 
0.49 - 1.29 Å-1; and MSP1D1ΔH5 + 10% UndP, qRg = 0.47 - 1.28 Å-1. The particle 
distiance distribution functions, P(r), for each sample were calculated from the 
scattering intensity curves in PRIMUS using the GNOM and autoGNOM tools to 
determine the longest inter-particle vector, Dmax. For P(r) analyses the following q-
ranges of data were used: empty 8nm ND = 0.0252 ≤ q ≤  0.1796 Å-1; PglC loaded 8 
nm ND = 0.0152 ≤ q ≤ 0.1293 Å-1;  and empty 8nm ND with 10% UndP added = 0. 










5.2.3 Creation of molecular model of SUMO-SGSG-PglC in MSP1D1 (10 nm) ND 
Theoretical molecular models of SUMO-PglC incorporated into ND were 
generated by first creating a predicted model for the SUMO-SGSG-PglC fusion 
construct using the ultra-deep learning structure prediction algorithm, RaptorX 
(49). The predicted model was then overlaid with the experimentally determined 
model for PglC described in Chapter 2 to determine SUMO-tag association with 
the experimentally determined structure for PglC. The SUMO-SGSG-PglC model 
of PglC was docked into a lipid bilayer slab by the PPM server (72) to determine 
the likely membrane interaction for the theoretical fusion construct. The calculated 
membrane plane was manually aligned with the membrane (chain C) of the 
molecular MSP1D1 DOPC nanodisc model (PDB ID: 2MSC, chains A and C) to 
position PglC into the ND model. For the model with 2 SUMO-PglC/ ND, the same 
manual alignment was repeated on the opposite face of the ND lipid bilayer.  The 
relative size of the model of PglC requires that only one SUMO-PglC can be 










5.2.4 Calculation of partial specific volumes for MSP, SUMO-PglC, and DMPC and 
DMPG lipids 
 
SEDNTERP(134) (http://sednterp.unh.edu/) was used to calculate the 
partial specific volumes and molecular masses for the MSP constructs of the ND, 
as well as for SUMO-PglC. The following sequences were input for calculation: 
 







H, 25 °C  
(cm3 g-1) 










22.1 0.7257 0.7193 














35.8 0.7413 0.7349 
    
* Temperature correction for I at the experimental temperature (T = 10 °C) given 
by equation 5.4 (135, 136).  
Temperature correction for partial specific volumes of all components of 
the ND, including loaded protein, at the experimental temperature (T = 10 °C) was 







IJ = 	IKL°N	 + 	4.25×10UV	(W − 25)    (5.4) 
The partial specific volumes of the DMPC and DMPG lipids were 
calculated from the literature values (137) of the specific molecular volumes, V, 
and molar masses, M, for DMPC  (VDMPC = 1.094 x 10-21 ml, MDMPC = 659.0 g mol-1)  
and DMPG (VDMPC = 1.094 x 10-21 ml, MDMPC = 666.9 g mol-1)   by the following 
equation (138):  
YZ[\[] = IZ[\[]×^_`a`bcd     (5.5) 
Following I temperature correction by equation 5.4, I:^eN =0.9861	i?j	kUE and I:^el = 0.9699	i?j	kUE were obtained to allow for 
calculation of the partial specific volume of  nanodiscs outlined in section 5.3.3 
(equations 5.9, 5.10). 
 
5.2.5 Sedimentation Velocity Analytical Ultracentrifugation (SV-AUC) data collection 
and processing 
 
Sample preparation and data collection was performed by Sonya Entova 
and Dr. Jean-Marie Swiecicki (Imperali Lab, MIT). Interference and absorbance 
AUC data were processed via the SEDFIT/SEDPHAT program suite (139). The 
appropriate data range for the sample cell was fit to a Lamm equation model for a 







population size of particles in the sample. Partial specific volumes for the ND 
samples calculated according to equations 5.9 and 5.10 and buffer density of 1.007 
calculated by SEDNTERP for the experimental buffer (134)  and frictional ratio (f/f0 
= 1.3) were adjusted for during model fitting with non-linear regression. Goodness 
of fit was judged by a minimization of RMSD between the model and experimental 
data.  
5.2.6 Size- Exclusion Chromatography-SAXS (SEC-SAXS) 
SEC-SAXS experiments were performed at beamline 4-2 (BL4-2) at SSRL 
(Menlo Park, CA). As temperature control is not available for SEC-SAXS 
measurements at BL4-2, SEC-SAXS experiments were conducted at RT (~ 20 °C). 
The SEC column (GE Superdex 200 3.2/300, 2.4 mL column volume, 0.8 mL void 
volume) used in the experiments was equilibrated with 5 mL of degassed sample 
buffer prior to sample loading. ND samples (table 5.2) were centrifuged at 10.2 
krpm for 30 minutes at 4 °C prior to loading onto the column. Sample injection 
was performed with 90 µL of each through the injection loop onto the SEC column. 
Injection and sample run were conducted at a flow rate of 0.05 mL /minute, 
resulting in a column pressure of 0.75-0.8 mPa. Images with one second exposure 
at λ = 1.12 Å were collected continuously through the run on a Pilatus 3 x 1M 







resolution range of 0.0223 > q = 4πsinθ/λ > 1.69 Å-1, where 2θ is the scattering angle. 
The first 100 images collected were integrated, scaled, and averaged in sastools to 
create a representative matched buffer blank for the sample. Rg and I(0) plots for 
each each image were created by the fplcplots script and every five images over 
the run were averaged by the averagefplc script implemented at the beamline. To 
mitigate radiation-induced aggregation observed in the first sample run, the 
second sample beam shutter was intentionally left closed until the peak 
corresponding to the population of interest was observed on the FPLC (fast protein 
liquid chromatrography) UV (ultraviolet) absorbance trace. For this sample the 
buffer-blank was created from the last 100 frames after the UV absorbance signal 
returned to baseline. Analysis of the Rg and I(0) plots allowed for selection frames 
corresponding to the ND population of interest.  
 
5.3 Results and Discussion 
5.3.1 Nanodiscs are highly-regular native-like lipid eviornments suitable for SAXS 
To confirm the homogeneity of the ND, and therefore their utility for 
biophysical characterization of PglC in a native-like lipid environment via solution 
SAXS, the scattering profiles for empty nanodiscs of two sizes 10 nm (MSP1D1) 







note that solution SAXS is a difference method defined by contrasts in the 
scattering of x-rays between different classes of molecules (e.g., protein vs. 
solvent). Due to the negative scattering length density of the hydrocarbon tails of 
the lipids relative to the aqueous solvent, the scattering from lipids is highly 
similar to the scattering of water, therefore the scattering contribution from the 
lipids is effectively lost during the buffer subtraction (125). This leads to the 
characteristic observation of an initial minimum at q = 0.07 Å-1 feature observed in 
the scattering intensity of nanodiscs (figure 5.3A, arrow).   
 
 
Figure 5.3. Solution SAXS analyses for 8 nm and 10 nm empty ND. A, Scattering 
intensity profiles for 8 nm and 10 nm empty nanodiscs. 8 nm ND scattering 
intensity depicted as blue line. 10 nm ND scattering intensity data depicted as red 
line. Characteristic initial minimum observed in solution SAXS intensity profiles 
denoted with gray arrow. B, Guinier analysis of 8 nm (blue circles) and 10 nm ND 
(red circles).  
 









































5.3.2 PglC incorporation into ND is observable by SAXS 
Analysis of the SAXS data clearly illustrates ideal homogenous nature of 
the ND for use in the study of membrane-proteins in a more native-like lipid 
environment by solution SAXS. As such, similar experiments were repeated with 
8 nm ND loaded with SUMO-SGSG-C. concisus PglC (SUMO-PglC) to confirm the 
observation of loaded protein within discs by SAXS. Gel densitometry analyses 
performed by Sonya Entova and Dr. Jean-Marie Swiecicki (Imperiali Lab, MIT) 
suggests a stoichiometry of 2 SUMO-PglC per 8 nm disc (data not shown).  In the 
8 nm discs (MW= 93 kDa including lipid) (140), SUMO-PglC (35.8 kDa) would 
account for 46% of the total scattering mass of the loaded ND particles. This is well 
above the theoretical limit of  20% detection (141). As a result, it was expected that 
sufficient signal required to resolve resident SUMO-PglC within the ND would be 
achieved. Analysis of the scattering intensity profile for the 8 nm ND with SUMO-
PglC resident within the disc clearly shows a change in the inital minimum at q= 
0.07 A-1 in comparison to the empty discs (figure 5.4A). The removal of this feature 
corresponds to the replacement of the effective negative scattering from the lipids 
within the disc with positive scattering from the SUMO-PglC resident protein.  
Similarly, Guinier analysis of the SUMO-PglC loaded 8 nm ND samples 







The radius of gyration for the SUMO-PglC loaded 8 nm ND (Rg = 57.4 ± 0.23 Å-1) is 
significantly larger than the empty disc; this is expected from the increased 
scattering mass in the discs loaded with 2 SUMO-PGlC/ disc (figure 5.4B). 
Comparison of the pair-wise distance distributions for the empty and loaded ND 
shows a clear increase in in the maximum length the longest inter-particle of the 
vector (Dmax) (figure 5.4C). 
 
 
Figure 5.4. SAXS analysis of 8 nm ND empty and loaded with SUMO-PglC. A, 
scattering intensity profiles with the position of ND characteristic initial minima 
at ≅ 0.07 À-1 indicated by gray arrow.  B, Plot of Guinier region. C, Plot of P(r) 
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Initially, the increased Dmax vector was accounted for by hydrophobic 
protein-protein interactions between the amphipathic helix identified during 
initial structure predictions for PglC (17) and the inner surface of the MSP protein 
belts encompassing the ND lipid bilayer. However, the now experimentally 
determined structure of PglC and the availability of an atomistic model for a 
similar ND (PDB ID: 2MSC) (142) enabled an estimation of the longest inter-
particle vector from the molecular coordinates (figure 5.5). If 2 PglC are resident 
in each ND as suggested by gel densitometry, the longest protein-protein 
interparticle vector estimated from the model coordinates corroborates the 
experimentally determined increase vector length for a loaded ND in comparison 










Figure 5.5. Estimation of Dmax vector from the theoretical model of PglC in ND. 
A, The longest protein-protein inter-particle vector in the empty ND model (PDB 
ID 2MSC, chains A and C) measures to be 97.0 Å. B, The longest protein-protein 
inter-particle vector in the ND model with one PglC per disc measures to be 97.9 
Å. C, The longest protein-protein interparticle vector in the ND model with two 
PglC per disc measures to be 143.9 Å. 
 
 
5.3.3 Quantification of resident-protein to ND stoichiometry from SAXS data 
Thus based on this model, it is critical that the stoichiometry of SUMO-PglC 
within the ND is two SUMO-PglC per ND to explain the increase in the Dmax vector 
observed experimentally. Typically, one common method to determine 
stoichiometry of protein-loading in the ND is thorough utilization of gel 
densitometry by quantitative Coomasie staining (21). However, due to variability 







high precision of protein quantification (143). Therefore, in effort to provide an 
independent measure for resident-protein to disc stoichiometry, the subtractive 
power of SAXS can be leveraged to directly calculate the number loaded proteins 
within the disc from the scattering data. To this end, the following mathematical 
method was developed, where the total scattering mass of protein loaded in the 
ND is calculated and then divided by the MW for the resident protein to obtain 
relative quantitation of the resident protein in the ND.  
To calculate the molecular mass of PglC resident in the MSPΔH5 nanodiscs 
via the total scattering mass the molecular mass of the empty ND was subtracted 
from the molecular mass of the loaded nanodiscs calculated according to the 
equation described by Mylonas and Svergun (130), 
mm = cd n oDpqr)      (5.6) 
	
where, NA is Avogadro’s number (6.023 x 1023 mol-1), I(0)/c is the zero-angle 
scattering intensity normalized by sample concentration, and ΔρM is the scattering 
contrast per mass. ΔρM defined by Mylonas and Svergun (130) accounts for by the 







where, ρM,prot is the number of electrons per mass of dry protein (3.22 x 1023 e g-1), 
ρsolv is the number of electrons per volume of the aqueous solvent (3.34 x 1023 e cm-
3), v̅ is the partial specific volume of the protein, and ro  is the classical scattering 
length of one electron (2.8179 x 10-13 cm).  The heterogeneous composition of 
nanodiscs, both protein-loaded and empty, must be accounted for in the 
calculation of the partial specific volume, v̅. The partial specific volume of empty 
nanodiscs, v̅ND, was calculated as defined by Inagaki, Ghirlando, and Grisshammer 
(144), 
Ic: = K^rz{|}|~Äyrz{|}|~ÄÅÇ^}r{Éy}r{ÉÅÑ^}r{Öy}r{ÖK^rz{|}|~ÄÅÇ^}r{ÉÅÑ^}r{É   (5.8) 
where, M represents the molar masses of the nanodisc components, v̅ represents 
the partial specific volumes of the components. The variables x and y represent the 
relative stiochiometries of the lipids DMPC and DMPG in the nanodiscs, 
respectively. To calculate the partial specific volume for protein-loaded nanodiscs, 
v̅ND,prot, the above equation can be modified by adding mass (MPglC), partial specific 
volume (v̅PglC) , and expected stoichiometry terms (z) for the loaded protein to give  








Thus, to calculate the v̅ND,PglC   and v̅ND for the 8 nm ND used in these experiments, 
the number of lipids loaded in the 8 nm disc was assumed to be 100 with a 3:1 
DMPC:DMPG ratio, therefore,  x = 83 and  y =  27 (145). Using this stoichiometry 
and the Mlipids and v̅lipids calculated with SEDNTERP, v ̅ ND,PglC = 0.7343 cm3  g-1 and v̅ND 
= 0.7339 cm3 g-1. 
Additionally, to accurately compute the MM, the forward scattering of the 
nanodiscs, AbsI(0)P, at zero-angle must be calculated in the absolute scale through 
the use of water as a secondary standard (128) by, 
áàA!(0)e = 	 â(>){,ä=aâ > ã,ä=a	×	 båbç(éo    (5.10) 
where, I(0)P,exp is the experimental forward scattering of the nanodiscs extrapolated 
from the Guinier approximation of the experimental data, I(0)w,exp  is the 
experimental forward scattering of water calculated through subtraction of 
scattering from the empty flow-cell and flow-cell filled with water (130), and 
dΣ/dΩq=0 is the absolute forward scattering intensity of water at the experimental 
temperature as defined by Orthaber, Bergmann, and Glatter (128), 
]è]ê(éo = tKëíWΧJ   (5.11) 
where, ρ is the scattering length density of water (9.388 x 1010 cm-2) , kb is the 







compressibility of water at experimental temperature, 283.15 K, (4.78 x 10-10 Pa-1) 
as extrapolated from the isothermal compressibility of water at 288 K determined 
by Kell (146). 
 Using the aforementioned approach with experimental solution SAXS 
data collected for both empty and loaded 8 nm ND discussed in section 5.3.2 and 
biophysical parameters described in table xxxx resulted in the calculation of a 
stoichiometry of ~ 2 PglC/ND as outlined in table 5.4.  The slight overestimation of 
the stoichiometry (~2.4) can be explained by the uknown mass of the lipids 
displaced by the protein loaded into the disc. Ultimately, this novel method for 
determining the stoichiometry of resident protein in a ND via the total scattering 
mass independently confirms the ~2 SUMO-PglC/ ND as observed by gel 
densitometry. As the collection of a water blank dataset is common practice for all 
SAXS experiments, the mathematical method described above enables the 
independent calculation of resident protein stoichiometry for any high-quality 








Table 5.3. Table of parameters calculated to determine SUMO-PglC - ND 
stoichiometry.  
Parameter Value   
Partial specific volumes (cm3 g-1)   
 DMPC, v ̅ DMPC 0.9699  
 DMPG, v ̅ DMPG 0.9861  
 8 nm ND MSP, v ̅ MSP 0.7193 * 
 PglC, v ̅ PglC 0.7345 * 
 Empty 8 nm ND, v ̅ ND 0.7340  
 SUMO-PglC loaded 8 nm ND, v ̅ ND,PglC 0.7344  
Constants    
 Avogadro’s nubmer, NA (mol-1) 6.02 × 1023  
 No. electrons/ mass dry protein, tMprot (e g-1) 3.22 × 1023 ** 
 No. electrons/ vol. aq. solvent, tMsolv (e cm-3) 3.34 × 1023 ** 
 Scattering length of an electron, ro (cm) 2.82 × 10-13 ** 
    
Scattering from water   
 Experimental constant scattering of H2O, I(0)H2O,exp.  (cm-1) 5.42  × 102  
  
Abs. scattering of H2O at 283.15 K (cm-1) 1.64 × 102 ** 
 
* calculated from aa sequence by SEDNTERP; ** value reported by Orthaber, 










Table 5.4. Experimental and computed parameters for the empty 8 nm ND and SUMO-PglC loaded ND.
Sample 
Conc. I(0) I(0)/c   AbsI(0) 283.15 K AbsI(0)/c 283.15 K   !"M MM283.15 K 
(10-3 g cm-3) (cm-1) (106 cm2 g-1)   ( 10-2 cm-1) (cm2 g-1)   (1010 cm g-1) (kDa) 
Empty ND          
8 nm ND, [h] 0.358 624 1.74  0.19 52.74  0.802 494.0 
8 nm ND, [l] 0.178 288 1.62  0.01 48.96  0.802 458.6 
         MW average = 464.7 
Loaded ND           
8 nm ND +  
SUMO-PglC, 
[h] 
0.18 723 4.02  0.22 121.54  1.12 587.2 
8 nm ND +  
SUMO-PglC, 
[l] 
0.09 334 3.71  0.10 112.29  1.12 542.6 
         MW average = 564.9 
∆MW*          86.42 
SUMO-PglC**          35.8 
        SUMO-PglC/ ND 2.4 
Notation: [h] indicates high concentration samples, [l] indicates low concentration samples; *∆MW = MWavg,empty 







5.3.4 Inclusion of UndP in ND results in sample heterogeneity 
Towards understanding of the effect of PglC membrane association in the 
presence of its native membrane-bound substrate, UndP, empty 8 nm ND were 
prepared with the addition of 10% UndP. Inclusion of 10% UndP into the lipid 
mixture for ND preparation results in incorporation of approximately 3 UndP per 
ND. Notably, scattering intensity profiles curves remain similar for discs with and 
without the addition of UndP as expected; however, calculation of the P(r) 
function revealed an unexpected, drastically increased Dmax for the ND particles 
with 10% UndP incorporation (figure 5.6C). Analysis of the Guinier plot revealed 
linearity in the low-angle region consistent with high-quality non-aggregated 
samples (figure 5.6B); thus, aggregation can be excluded as a cause for the 
unexpected increase in Dmax observed (127) . As a result, despite appearing 
homogeneous by dynamic light scattering (DLS) measurements obtained by Sonya 
Entova and Dr. Jean-Marie Swiecicki (Imperiali Lab, MIT) (data not shown), 
heterogeneity within the sample in the form of multiple distinct populations of 
particles (e.g. ND and lipid micelles) versus non-specific aggregation was 








Figure 5.6. Analysis of scattering data for 8 nm ND ± 10% UndP added to the 
lipid component. A, Scattering intensity profiles with 8 nm ND data shown as 
blue line and 8 nm ND with 10% UndP added shown as purple line. B, Scattering 
data displayed in a Guinier plot for 8 nm ND shown as blue circles and scattering 
data for 8nm ND with 10% UndP added shown in purple triangles. C, P(r) curve 
for 8 nm ND shown as blue line and for 8 nm ND with 10% UndP added shown 
as purple line.  
 
To confirm the heterogeneity suspected within the ND samples with added 
UndP, the samples were analyzed by analytical ultracentrifugation (AUC). AUC, 
in particular sedimentation velocity (SV)-AUC, offers increased resolution of 
hydrodynamic radii over DLS (144), therefore allowing for the deconvolution of 
particle populations outside the resolution limit of standard DLS experiments 




































8 nm ND + 10% UndP
























(147). Fitting of the collected interference SV-AUC data with to a Lamm Equation 
model for continuous C(s) distributions (144) established that the empty nanodiscs 
behave as a single population with a sedimentation coefficient (s) of ~2.5 
representing 82% of the mass in the sample (figure 5.7A,B). Oppositely, fitting of 
the data collected from ND samples with 10% UndP added revealed clear 
heterogeneity in the sample with the largest population (s ≅ 2.5) only accounting 
for 45-47% of the total mass (Figure 5.7B).  The increased heterogeneity appears to 
be dependent upon the amount of UndP added with discs with < 5% UndP 
appeared to behave similar to the empty discs with no added UndP (figure 5.7C).  
At concentrations of UndP <5% incorporation of UndP into the discs is sub-
stoichiometric, therefore the major population sedimenting at s ~2.5 is 








Figure 5.7. C(s) distributions modeled from interference SV-AUC data for ND 
samples with varying amounts of UndP added to the lipid component. A, 
Multiple populations are seen with the addition of 10% UndP in a concentration 
independent manner. B, Percent concentration of the total mass within the sample 
of each C(s) peak from panel A. C, Effect of added UndP concentration illustrated 
by plots percent concentration of the total mass within the sample of each C(s) 
peak for samples with 0.0% to 10% UndP added.  All plots created in GraphPad 
Prism.  
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5.3.5 SEC-SAXS as a method for characterizing a single ND population 
The SV AUC experiments illustrate the need for an additional purification 
step to isolate a single population for biophysical experiments involving the 
physiologically-relevant concentration of 10% UndP added per disc. Specifically, 
for SAXS experiments, the development of in-line size-exclusion chromatography 
(SEC) apparatuses enables collection of SAXS data from isolated populations 
directly as they come off the column. Preliminary SEC-SAXS experiments with the 
8nm ND and 8 nm ND with 10% UndP allowed for sufficient separation of single 
populations (figure 5.8A). Continuous data acquisition during SEC-SAXS 
experiments allows for selection of frames in which only a single population is 
present based on the chromatogram for further data analysis. Notably, during 
these experiments a climbing I(qmin) trace (figure 5.8 B, blue circles) for the empty 
ND sample was observed. This behavior is indicative of radiation-induced 
aggregation coating the experimental capillary in the beam path.  Therefore, the 
Rg measured for the empty 8nm ND by SEC-SAXS was significantly larger (Rg = 
~53 Å)  in comparison to that measured by static SAXS (Rg = ~45 Å) is likely 
resultant of over estimation of the Rg due to the aggregation observed (127) . To 
mitigate these effects in further experiments, the shutter was intentionally left 







by UV absorbance at λ = 280 nm (figure 5.8A, arrow). As a result, the I(qmin) trace 
is not visible for the 10% UndP added sample. As a result, the preliminary SEC-
SAXS data collected for the ND sample with 10% UndP added was of significantly 
higher quality.  Guinier anlyais shows the Rg reported for this sample (Rg = ~ 56 Å) 
was highly similar to that measured statically, Rg = ~57 Å (figure 5.6B). Thus, 
sample heterogeneity cannot be the only cause for the apparent unexpectedly large 
Dmax and Rg for the 8nm samples with approximately three UndP incorporated per 
ND. One such possibility is that the inclusion of UndP into the lipid-bilayer causes 
slight distortion and disassembly for the nanodiscs as was previously observed for 








Figure 5.8. Preliminary SEC-SAXS experiments show separation between 
multiple ND populations. A, Absorbance ( λ = 280 nm) FPLC trace from 
experimental runs of  8 nm ND with 10% UndP added to the lipid component of 
the discs (green trace) and empty 8 nm ND with no added UndP (blue trace). 
Arrow indicates peak of major population of interest. B, Rg and I(0) script for every 
image collected during SEC-SAXS run for ND with no UndP added. Plot created 
with beamline fplcplots. Red open circles indicate calculated Rg, green open circles 
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smallest angles, I(qmin), and gray box indicates zoom region illustrated in panel 
C. C, Rg and I(0) for every frame within zoom region indicated in B. Black line 
indicates average Rg of the peak corresponding to the ND population of interest. 
D, Rg and I(0) script for every image collected during SEC-SAXS run for ND with 
10% UndP added. Plot created with beamline fplcplots. Red open circles indicate 
calculated Rg, green open circles indicate extrapolated I(0), and gray box indicates 
zoom region illustrated in panel C. E, Rg and I(0) for every frame within zoom 
region indicated in B. Black line indicates average Rg of the peak corresponding to 
the ND population of interest. 
 
5.4 Conclusions and Future Directions 
From the data presented in this chapter, it is evident we are able to produce 
and characterize high-quality lipid ND for biophysical and structural studies of 
PglC in a native-like phospholipid environment. SAXS data for SUMO-PglC 
loaded into the disc clearly illustrates resolution of the 35.8 kDa particle within an 
8 nm ND from the changes in the scattering intensity profile. Notably, 
incorporation of PglC into nanodiscs yielded an in initially unexpected increased 
Dmax of the particles. However, upon modelling the expected SUMO-PglC loaded 
ND with 2 PglC/ND, the increased length was corroborated. With the atomic 
structure of PglC now known, it would be worthwhile, in the future, to attempt 
model-based shape reconstruction of SUMO-PglC in the ND via a similar hybrid 
model-based ab initio shape reconstruction method used to elucidate the structure 







Additionally, the mathematical method outlined in section 5.3.3 allows for the 
calculation of resident-protein loading into a ND from directly from high-quality 
SAXS data, thus, providing an independent corroboration of the loading of 2 PglC-
SUMO per 8 nm ND as suggested by gel densitometry experiments. Notably, this 
mathematical method has only been tested with the SUMO-PglC loaded discs 
present in this chapter; thus, it would be worthwhile to confirm utility of the 
calculation on different ND samples like MSPE3D1 ND which preferentially have 
a 1:1 PglC:ND stoichiometry (21).  However, preliminary SAXS experiments with 
these discs show high aggregation propensity, and therefore, optimization of 
experimental conditions will be required. Recent studies of terbium-mediated 
luminescence of PglC performed by Dr. Debasis Das (Imperiali Lab, MIT) (data 
not shown), suggests an additional independent quantification of PglC loaded into 
the ND could be achieved through quantification of luminescence upon saturating 
conditions of lanthanide as was observed for lanthanide-binding-tag (LBT)-
Ubiquitin (150). 
 Lastly, towards understanding effects of substrate, Und, incorporation into 
ND with PglC, preliminary SAXS studies with empty discs with UndP added were 
performed. Though heterogeneity, confirmed by AUC, within the sample was 







for ND with 10% UndP added, preliminary SEC-SAXS experiments to isolate a 
single population of ND determined highly similar Rgs for the heterogeneous 
sample measured by static SAXS.  Thus, the observed heterogeneity in the ND 
samples with 10% UndP added is not directly causitive of the increased molecular 
dimensions measured by SAXS. Toward understanding the increase particle 
dimensions of UndP addition, SEC-SAXS experiments on ND with varying 
concentrations of UndP added will be required to understand the effect of UndP 
addition into the ND. Notably, a similar phenomenon was observed for ND with 
incorporation of cholate where P(r) anlalyes from ND with increasing cholate 
concentration coupled with course-grained molecular dynamics simulations 
elucidated specific ND structural disruptions upon cholate incorporation into the 











In prokaryotes, protein glycosylation can be a determinant of pathogenicity 
as it plays a role in host adherence, invasion, and colonization (2, 3). Impairment 
of glycosylation in pathogenic bacteria leads to decreased virulence; thus, opening 
new avenues for the development of inhibitory agents (6). Notably, the first 
membrane-committed step of en bloc glycosylation pathways, marked by catalysis 
of the transfer of a phosphor-sugar from a soluble nucleotide-diphosphate sugar 
to a membrane-bound PrenP by a PGT enzyme, is a shared feature in the 
biosynthesis of many complex glycoconjugates (4).  
PGTs are classified into two isofuncitonal, yet structurally- and 
mechanistically-diverse superfamilies. The polytopic PGT superfamily, typified 
by the structurally-characterized enzyme MraY, proceed through a ternary 
complex enzymatic mechanism and are known to be inhibited by the bi-substrate 
analog inhibitor tunicamycin (24). Conversely, the monotopic PGT superfamily is 
not inhibited by Tunicamycin although it catalyzes the same general reaction as 
the polytopic superfamily (20).  Recently, Das et al. demonstrated PglC, an 







intermediate enzymatic mechanism (25). Prior to the work presented in this 
dissertation, the structure, and therefore the basis for lack of inhibition by 
tunicamycin, of the putative transmembrane protein monotopic superfamily was 
experimentally unknown. PglC, from the well-characterized N-linked 
glycosylation pathway in  C. jejuni, shares significant homology to the PGTs, WbaP 
and PglB (N.g.) which catalyze the same membrane-committed steop in the O-
antigen and O-linked glycoprotein biosynthetic pathways. The small size of PglC 
(201 aa) compared to homologous PGTs suggests it may represent the minimal 
catalytic unit for the monotopic PGT superfamily, thus positioning PglC as an 
optimal target for molecular structure elucidation (17). Notably, structure 
determination of PglC, poised to provide much-need structural information for an 
entire superfamily of PGT enzymes, will also add another example of the structure 
monotopic membrane protein to the vastly underrepresented class in the PDB.  
Herein, the structure of C. concisus PglC including its putative TM domain 
has been solved to 2.74 Å resolution to reveal a novel protein fold with a unique 
α-helix-associated β-hairpin (AHABh) motif and largely solvent-exposed 
structure. Analysis of the structure reveals that both membrane-association and 
active site geometry are underpinned within the minimal structure of PglC by 







bonds, and extensive hydrogen-bond networks.  
The RMH, confirmed through biochemical and bioinformatics studies, is a 
structurally defining feature of PglC and the monotopic PGT superfamily in that 
the hydrophobic helix is re-entrant on the cytoplasmic face of the membrane rather 
than membrane spanning as originally predicted. Comparison of the structural 
determinants membrane association evident for PglC with other monotopic 
membrane proteins suggests PglC represents a first-in-class structure of a novel 
membrane-interaction mode. The AHABh-motif represents a second structurally-
defining feature of PglC.  This motif is structurally and functionally conserved as 
it establishes the co-facial positioning of the catalytic Asp-Glu dyad. Molecular 
docking of PglC substrates, undecaprenyl phosphate (UndP) and UDP-N,N-
diacetylbacillosamine (UDP-diNAcBac), within the active-site reveals co-incident 
binding sites, consistent with the proposed covalent phospho-sugar intermediate 
mechanism.  
Lastly, loading of PglC into membrane-bilayer nanodiscs (ND) allows for 
the investigation of PglC structure and function within a more native-like 
membrane environment by small-angle x-ray scattering (SAXS). Detection of PglC 
laded in ND via SAXS confirms the application of the method for studying small, 







independently corroborate biochemical estimations of the stoichiometry of PglC 
incorporation within ND, a mathematical approach by which resident-protein-to-
ND stoichiometry can be deduced from measured scattering intensity was 
developed.  
 Overall, the understanding of the molecular structure and mode of 
membrane association of PglC presented in this dissertation and summarized in 
figure 6.1, provides critical understanding of the structure-function relationship 










Figure 6.1. Structural basis for membrane-association and mechanism in the 
monotopic PGT superfamily, as exemplified by C. jejuni PglC. Green brackets 
denote the enzymatic mechanism for PglC supported by structural analyses. Red 








Understanding the feasibility of anomalous SAXS experiments 
 
A1.1 Introduction  
SAXS is a complementary technique in structural studies in that it provides 
unique structural information about a sample in solution, thus, it can offer lower-
resolution context to a high-resolution structure of a protein constrained in the 
crystal lattice. SAXS structural studies on proteins with genetically-encoded 
lanthanide-binding tags (LBTs) (150-152) enables the measurement of anomalous 
small-angle x-ray scattering (ASAXS) intensity data by exploiting the high 
anomalous scattering of the lanthanides. ASAXS allows for the positions of the 
anomalous scatterer bound to the LBTs, often terbium (Tb) (150), to be located in 
relation to the protein, thus, providing distance information that would be highly 
sensitive to changes in conformation or relative orientations. For PglC, ASAXS 
experiments with PglC in nanodiscs could enable an understanding of the 
interactions between PglC and the next-downstream member in the N-linked 
glycosylation pathway, PglA, as well as a validation and further understanding of 







In solution, anomalous scattering has two components cross-terms and 
anomalous terms.   Cross-terms depend on the on the relative location of the 
anomalous centers in relation to the center of mass for the protein, while the 
anomalous terms depend on the the distances between the anomalous centers (153, 
154). Using the iron anomalous signal from hemoglobin  the cross-terms were 
observable to give iron to center-of-mass (CoM) of protein distance of ~8.6 Å, 
which is whin ~1 Å  of the distance observed in a crystal structure (155). Notably, 
the second component terms, the anomalous terms, are at least two-orders of 
magnitude smaller than the cross-terms, consequently making their measurement 
likely beyond the the current experimental sensitivities.  
An ASAXS experiment is highly similar to a SAXS experiment, but utilizes 
several wavelengths near the absorption edge of the anomalously scattering atoms 
instead of a fixed wavelength as in a standard experiment. The anomalous 
scattering is observable as scattering intensity differences at the various 
wavelengths. Precedent for ASAXS experiments have demonstrated  successful 
measurement of  the cross-terms between the heme iron and mygoblin  from an 
anomalous scattering intensity difference of 1% of native myogoblin signal (155). 
Similarly, Tb cross-terms were measured in parvalbumin from anomalous 







anomalous scattering power of lanthanides (~ 20 scattering electrons) bound to 
genetically-encoded LBT tags should enable increased magnitudes of anomalous 
scattering intensity differences.  
The work presented in this appendix details preliminary ASAXS 
experiments with a structurally well-characterized construct of ubiquitin with two 
genetically-encoded LBTs (156), and subsequent computational simulations of 
LBT-enabled ASAXS experiments to understand the feasibility of measurement of 
anomalous scattering intensity differences for both simple proteins and more 
complex systems.  
 
A1.2 Materials and Methods 
A1.2.1 Protein expression, purification, and TbCl3-loading 
Expression and purification of dLBT-Ubiquitin was performed following 
previously published protocols (152, 156). One liter Luria Broth (LB) media was 
inoculated with BL21(DE3) E. coli cells and allowed to grow at 37 until an optical 
density of  OD600 = 0.6-0.8. Protein expression was induced with 500 mg isopropyl-
β-D-1-galacotpyranoside (IPTG) per liter of cultured cells. Induction was carried 
out at 16 and cells were allowed to continue to grow until OD600 = 1.2-1.4. Cells 







resuspension in Buffer 1 (50 mM Tris pH 8, 300 mM NaCl, 10 mM imidazole) at a 
volume of 5 mL/g of cell pellet. Cells were lysed using a microfluidizer. Cell debris 
was separated from the soluble fraction via ultracentrifugation at 38,000 rpm. 
dLBT-Ubiquitin was purified from the soluble fraction via immobilized nickel 
affinity column with elution via buffer 2 (100 mM NaCl, 20 mM HEPES pH 7, and 
150 mM imidazole). Pure dLBT-Ubiquitin was dialyzed overnight at 4 against 
4L of dialysis buffer (20 mM HEPES pH 7.5, 100 mM NaCl). Any aggregation was 
pelleted via ultra-centrifugation at 38,000 rpm and the resulting pure, soluble 
protein was diluted to 1 mg/mL in dialysis buffer. Purified dLBT-ubiquitin was 
separated into two aliquots. One aliquot was loaded with Tb3+ at a ratio of 1:1.1 
(protein: TbCl3) molar equivalents with two-minute incubations between each 
addition of TbCl3. The reserved aliquot was loaded with Ca2+ via incubation with 
1:1 protein to CaCl2 for 1 hour on ice.  
 
A1.2.2 Preparation of SAXS samples 
Resulting pure protein was concentrated using an Amicon centrifugal 
concentrator with a molecular weight cut-off of 3,500 Da to a final concentration 
of 15.5 mg/mL. To ensure accurate buffer subtraction, concentrated dLBT-







of the resulting dialysis buffer was reserved for background SAXS measurements. 
Following dialysis, the dLBT-ubiquitin protein was flash frozen in liquid nitrogen 
for transport to the beamline. Protein was thawed on ice at the beamline and serial 
dilutions of Tb3- loaded dLBT-ubiquitin were performed from 10 mg/mL to 0.88 
mg/mL. ASAXS data collection was carried out with a dLBT-ubiquitin 
concentration of 5 mg/mL. 
  
A1.2.3 ASAXS data collection and processing 
Anomalous SAXS data collection was performed at Brookhaven National 
Lab (BNL), National Synchrotron Light Source-II (NSLS-II), beamline 16-ID-B 
(LiX), Upton, NY. 1 mM TbCl3 in 25 mM ammonium acetate was used as a Tb 
standard to perform an x-ray absorption spectrum for Tb. the anomalous 
scattering factors for the absorption spectra were determined by CHOOCH (157).  
For anomalous SAXS measurements, data was collected at five different energies 
(7521 eV, 7517 eV, 7510 eV, 7500 eV, and 7482 eV) spanning five different Bragg 
angles, respectively (15.0885 ° , 15.0965 ° , 15.111 ° , 15.132 ° , and 15.169 ° ). The 
SAXS scans at each energy were averaged and buffer subtracted at the beamline 
with PyXS (https://www.bnl.gov/ps/x9/software/pyXS.asp). Resulting buffer-







A1.2.4  Prediction of theoretical anomalous differences 
ASAXS experiments were simulated with CRYSOL v. 2.8.3 (158) from the 
atomic coordinates in PDB format for Tb3+ at 7517 eV, 7500 eV, and 7521 eV. Plots 
of solution scattering patterns covering a range from 0 ≤ q ≤ 2.0 Å-1 calculated to 
ensure observation of any weak larger q range scattering intensity differences. To 
account for the difference in scattering intensities for Tb3+ at the different x-ray 
energies, elements corresponding to the appropriate number of electrons 
scattering were substituted for Tb in the 2OJR coordinate set (table A1.1).  
Theoretical models of dLBT-OmpA, LBT-KRas, and dLBT-KRas were generated 
from splicing the LBT from 2OJR into loops in the OmpA (1BXW) and KRas-
nanodisc (2MSC) coordinate sets.  
A1.3 Results and Discussion 
A1.3.1 Preliminary ASAXS measurements for Tb3+ loaded dLBT-ubiquitin  
Towards the goal of ASAXS measurements from proteins embedded in 
nanodiscs, preliminary experiments were initially performed with a structurally 
well-characterized construct of ubiquitin with two engineered LBTs (dLBT-Ubq) 
(156). The expected SAXS and WAXS patterns for dLBT-Ubq were calculated with 
with CRYSOL (158) from the atomic coordinates for dLBT-Ubq (2OJR) with Tb3+ at 







and 7521 eV). To account for the difference in scattering intensities for Tb3+ at the 
different x-ray energies, elements corresponding to the appropriate number of 
electrons scattered were substituted for Tb3+ in the 2OJR coordinate set (table A1.1).  
Table A1.1. Scattering factors f″ and f′ for each x-ray energies remote and near 
to the Tb LIII absorption edge. Elements corresponding to the adjustment required 
to make number of anomalously scattering electrons correct for each energy tested 
for CRYSOL simulations. 
Energy 
(eV) 




7521 1.6485 11.65 -23.77 41.23 Nb (41) 
7517 1.6494 6.02 -18.62 46.38 Pd (46) 
7500 1.6431 4.16 -12.49 52.51 Te (52) 
 
In solution, anomalous scattering is observable as differences between the 
scattering intensities observed in data collected at different energies. Simulated 
ASAXS experiments for dLBT-ubiquitin reveals differences in the scattering 
curves observed for intensities in the low- to mid-q region (~ 0.25 – 1.25 Å-1) for the 
expected 7517 eV calculated data (figure A1.1A). The differences between the 
calculated intensities at remote, edge, and native intensity is at greatest 3.3% in 
this region of the scattering curve and less than 1% at q < 0.2 Å-1 and q > 1.2 Å-1 
(figure A1.1B). Anomalous differences on this order of magnitude have been 
demonstrated to be experimentally measurable via ASAXS using iron anomalous 







approximately 1% (155). Thus, theoretically, anomalous signal should be 
measurable for dLBT-ubiquitin.  
 
Figure A1.1. Expected results from dLBT-Ubiquitin ASAXS experiments. A, 
Scattering patterns calculated at the different energies used experimentally. 
Curves corresponding to 7521 eV, 7500 eV, and Tb native energies overlay. B, 
percent difference between the scattering curves at the different energies as a 
function of scattering angle.   
 
 Preliminary experimental ASAXS measurements of Tb3+-loaded dLBT-Ubq 
were collected during commissioning at NSLS-II beamline 16-ID (LiX) at energies 
near (7521 eV and 7517 eV), and remote (7500 eV) to the absorption edge (LIII = 
7514 eV) of the scattering atom (Tb3+).  Additionally, as a control, ASAXS data from 
the same dLBT-Ubq sample loaded with Ca2+ in place of Tb3+ was collected at the 
same energies (7521 eV and 7517 eV). Ca2+, which binds tightly to the LBT (151), 
does not display significant scattering at these energies with f′ = 0.336 e- at 7521 eV 
and f′ = 0.334 e- at 7517 eV  (159).  Upon normalization of the data with the 








































scattering intensity peak from water, no observable differences were measured for 
Tb3+ anomalous scattering at the different energies tested (figure A1.2).  
 
 
Figure A1.2. Double logarithmic plot of scattering intensity profiles for 
Tb3+loaded dLBT-Ubq. Data collected at 7521 eV (black), 7517 eV (red), and 7500 
eV (green) and Ca2+ loaded dLBT-Ubq collected at 7521 eV (blue), 7517 eV 
(orange).   
 
 The lack of anomalous difference measurability in the preliminary 
experiments could could be due to a number of different factors, including 
variation between the theoretical absorption edge and the experimentally 
determined absorption edge. Ideally, x-ray absorption spectra (XAS) of the 
element of interest would be acquired prior to ASAXS experiments to allow for 
appropriate beamline energy choice. However, during commissioning 







experiments. Thus, the theoretical absorption edge for Tb3+ was used as an 
approximation of the peak anomalous absorption (figure A1.3).  It is evident from 
the XAS determined at the beamline (blue lines) that data collection for the above 
experiments was not performed at the true anomalous edge for Tb at the LiX 
beamline. Comparison of the scattering factor f′ minimum for all lanthanides 
revealed there are only slight differences in the the number of anomalously 
scattering electrons across the lanthanides (f′ ≅ 20 e-) with the exception of La and 
Ce, which scatter to a less (f′ ≅  14 e-). Thus, changing the lanthanide used in ASAXS 
experiments is not likely to have a significant effect on measurability of the signal. 
The greatest improvement in measurability is likely to come from optimized 
selection of experimental energies after performing an x-ray absorption scan at the 
beamline. Additionally, further optimization of sample quality, data collection 
parameters, and experimental geometry could lead to success in measurement of 









Figure A1.3. Theoretical (red) and experimentally-determined (blue) x-ray 
absorption spectra (XAS) plots in the region of the Tb LIII edge. Vertical dashed 
lines represent the energies at which ASAXS data was collected (7500 eV, 7517 eV, 
and 7521 eV). Experimental XAS plot created with CHOOCH(157). Theoretical f’ 
and f″ values based on the approximation by Cromer and Liberman (159) 
(accessed via http://skuld.bmsc.washington.edu/scatter/AS_periodic.html.)  
 
 
A1.3.2 Effect of protein size on ASAXS difference intensity theoretical 
measurement with LBTs 
 
 Both proteins which have shown measured (155) or theoretically 
measurable ASAXS intensity differences, myoglobin and dLBT-ubiquitin, are 
relatively small proteins with molecular weights of 16.7 and 12.4 kDa, respectively.  
Tb3+-loaded dLBT-Ubiquitin (111 aa) yields a 3% anomalous intensity difference 
compared to native with approximately 1 Tb3+ for every 50 amino acids 





















the intrinsic iron co-factor has been measured for myoglobin (154 aa) (155).  
Comparatively, the anomalous scattering from Tb stems from ~ 20 electrons versus 
~ 7 electrons from iron; thus, the ratios of aa to anomalously scattering electrons to 
are 2o.9 e- for myoglobin and 2.76 e- for dLBT-ubiquitin. Therefore, it is conceivable 
that the increase anomalous signal from that arises from the additional 
anomalously scattering electrons in lanthanides (e.g. Tb) bound to LBTs 
engineered into proteins could provide sufficiently measurable signal from larger 
proteins and potentially more complex systems.  
 Simulation of ASAXS data via CRYSOL (158) allowed investigation of the 
effect of relative protein size on the measurability of ASAXS difference signal for 
two proteins larger than dLBT-ubiquitin and myogolbin: LBT-IL1β and dLBT-
OmpA. Data simulated from the atomic coordinates for IL1-β with a single 
engineered LBT (PDB ID: 3LTQ) with Tb3+-bound at 7517 eV, 7500 eV, and 7521 eV 
resulted in scattering curves which showed increased scattering intensity for data 
simulated at the Tb absorption edge (7517 eV) between q ≅ 0.25 Å-1 and q= 0.6 Å-1 
(figure A1.4A).  Dividing the scattering intensity profiles at remote and edge 
energies by the native data calculated the observable anomalous difference to be 
at most 1.4% of native in this region of the scattering curve and largely negligible 







that with an approximately 3-fold increase in aa-to-scattering electron ratio 
observed for LBT-IL1β (8.37 e-) in comparison to that of dLBT-ubiquitin, 
anomalous differences remain theoretically measurable. 
 
Figure A1.4. Predicted expected anomalous differences from Tb3+ -loaded LBT-
IL1β. A, ASAXS intensity profiles calculated near and remote to the Tb absorption 
edge. Curves corresponding to 7521 eV (black), 7500 eV(green), and native (gray) 
energies overlaid. B, percent difference between the scattering curves at the 
different energies as a function of scattering angle.  Curves corresponding to 7500 
eV and native (gray) energies overlaid.  
 
 Furthermore, ASAXS data was simulated for a theoretical model of dLBT-
OmpA (198 aa). The model of was created through insertion of single LBT tags at 
the N-terminus (periplasmic) and loop EL3 (extracellular) into a structure of 
OmpA from the PDB (PDB ID 1BWX). Single LBT tag structures were spliced from 
the experimentally-determined crystal structure of LBT-IL1β (PDB ID 3LTQ). 
Simulated ASAXS intensity profiles from q = 0 – 2 Å-1 from theoretical atomic 
coordinates for dLBT-OmpA with Tb3+-bound at 7521 eV, 7517 eV, and 7521 eV 








































(figure A1.5A). Minimal differences were observed between the scattering curves 
with the exception of slight increase in intensity corresponding to the data 
collected at 7517 eV b for the range ~0.25 < q < -0.5 Å-1. Calculated anomalous 
differences between between the intensities at remote, edge, and native intensity 
is no greater than 0.5% of the native scattering intensity at any angle (figure A1.5B). 
Although the anomalous difference is minimal, the profile of the difference plot 
with a clear peak at ~0.25 < q < -0.5 followed by an oscillation about zero suggests 
the anomalous differences would be theoretically measurable within the at least 
within that q-range at the Tb Edge. However, a 0.5% difference may be 
exceedingly challenging to measure experimentally, and may be below the 
sensitivity of the practical ASAXS experiment on a whole. Additionally, it is worth 
noting that the aa-to-anomalous scattering electrons ratio is lower for dLBT-OmpA 
(4.86 e-) than for LBT-IL1B (8.37 e-); however, the apparent inverse-relationship 
between the ratio aa-to-anomalous scattering electrons and percent anomalous 









Figure A1.5. Predicted expected anomalous differences from Tb3+ -loaded dLBT-
OmpA. A, ASAXS intensity profiles calculated near and remote to the Tb 
absorption edge. Curves corresponding to 7521 eV (black), 7500 eV (green), and 
native (gray) energies overlaid. B, percent difference between the scattering curves 
at the different energies as a function of scattering angle.  Curves corresponding 
to 7500 eV and native (gray) energies overlaid.  
	
	
A1.3.3 Predicted ASAXS signal from a protein tethered to a nanodisc 
From the relatively simple test simulations of ASAXS data for dLBT-
ubiquitin, LBT-IL1β, and dLBT-OmpA, Tb3+- bound LBTs inserted into protein 
termini or loops enable sufficiently measurable signal, theoretically. Thus, to 
understand the feasibility of measurement of anomalous differences for 
significantly more complex systems, data from LBT and dLBT models of a protein 
resident on a MSP1D1 DOPC : DOPS nanodisc (ND) were simulated. The LBT- 
and dLBT-KRas · ND constructs were created by splicing the LBT (from 3LTQ) or 
dLBT (from 2OJR) into a loop on the KRas molecule distal from the ND in the KRas 
nanodisc model (PDB ID 2MSC) (figure A1.6A, D). Unsurprisingly, the simulated 






































ASAXS intensity profiles do not show any apparent significant difference between 
data simulated at different energies near or remote from the Tb absorption edge 
(figure A1.6B, C). The Tb3+ anomalous signal within the model is unable to be 
resolved from the total scattering of the resident KRas protein and MSP belts of 
the ND. Together the protein components of the ND contribute 601 aa; thus, the 
ratio aa-to-scattering electrons for this test system is 29.41 e-. Adding an additional 
Tb3+ atom via dLBT-KRas does provide a significant improvement in the ratio of 
aa to scattering electrons for the ND constructs with 29.4 e- for the single LBT and 
14.9 e- for the dLBT. However, the improvement is not reflected in percent 
difference for the anomalous scattering compared to native scattering, where the 
anomalous difference is only at most 0.3% of the native scattering at any given 
scattering angle (figures A1.6E and A1.6F). Ultimately, the anomalous difference 
signals form the anomalously scattering atoms in highly complex scattering 
systems, such as a resident-protein loaded into a ND, are likely too low for 











Figure A1.6. Simulated ASAXS data from Tb3+ -loaded LBTs on a protein 
tethered to a nanodiscs. A, Atomistic model of KRas with theoretical Tb3+ -loaded 
LBT spliced into a loop region tethered to MSP1D1 (80 : 20 DOPC:DOPS) 
nanodiscs, based on 2MSC. Tb3+ shown as green sphere. B, ASAXS intensity 
profiles calculated near and remote to the Tb absorption edge. Curves 
corresponding to 7521 eV (black), 7521 eV (red), 7500 eV(green), and native (gray) 
energies overlaid. C, percent difference between the scattering curves at the 
different energies as a function of scattering angle.  Curves corresponding to 7521 
eV (black), 7500 eV (green), and native (gray) energies overlaid.  D, Atomistic 
model of KRas with theoretical Tb3+ -loaded dLBT spliced into a loop region 
tethered to MSP1D1 (80 : 20 DOPC:DOPS) nanodiscs. Tb3+ shown as green spheres. 
E, ASAXS intensity profiles calculated near and remote to the Tb absorption edge. 
Curves corresponding to 7521 eV (black), 7521 eV (red), 7500 eV(green), and native 
(gray) energies overlaid. F, percent difference between the scattering curves at the 
different energies as a function of scattering angle.  Curves corresponding to 7521 







A1.4 Conclusion and Future Directions 
Overall, the work presented in this appendix found that measuring 
anomalous scattering intensity differences from preliminary ASAXS experiments 
with a structurally well-characterized construct of ubiquitin with two genetically-
encoded LBTs will require further optimization of experimental design, geometry, 
and sample-preparation in order to measure the ~3% anomalous difference 
predicted for simulated ASAXS experiments by CRYSOL. Computational 
simulations of LBT-enabled ASAXS experiments to understand the feasibility of 
measurement of anomalous scattering intensity differences for both simple 
proteins and more complex systems revealed that the theoretically achievable 
ASAXS intensity differences proceeded were maximized in small globular 
proteins with a low aa-to-scattering electron ratio (table A1.2). However, the 
measurement of the theoretical differences (0.5%) predicted for a slightly larger 
protein system, OmpA, are likely outside of the current sensitivity of the practical 
experiment.  Similarly, simulated data for a complex system of a single or double 
LBT-tag inserted into a protein tethered to a nanodiscs revealed negligible 








Table A1.2. Theoretical ASAXS anomalous difference possible. 







Myoglobin 154 Fe (1) 20.9 1* 
dLBT-Ubiquitin 111 Tb (2) 2.72 3.3 
LBT-IL1β 171 Tb (1) 8.37 1.5 
dLBT-OmpA 198 Tb (2) 4.86 0.5 
LBT-KRas · ND 601 Tb (1) 29.41 0.15 
dLBT-Kras · ND 612 Tb (2) 14.9 0.3 
* Measured experimentally (155). Note: f′Fe= -7.36, f′Tb= -20.43. 
 
 Thus, as scientific questions are often asking increasingly complex 
questions of increasingly complex systems, it is unlikely that ASAXS will be able 
to provide sufficient anomalous to answer those questions. Ultimately, ASAXS, 
though still incredibly challenging, is better suited to relatively small proteins like 
myoglobin and ubiquitin. However, it would be interesting, in the future, to try to 
understand the relationship between the ratio of the number of amino acids in a 
protein to the number of scattering electrons and the theoretically achievable 
anomalous difference signal. From the very small test set presented in this 
appendix, a predictable inverse-relationship emerged.  However, the model of 
dLBT-ubiquitin appeared to be an outlier where greater signal would be 











Towards an understanding of the structural determinants of lipin1 cellular 
localization and function 
 
A2.1. Introduction 
Disturbances in processes contributing to lipid homeostasis have long been 
linked to the development of pathologic metabolic dysregulations, such as type-2 
diabetes, metabolic syndrome, and obesity related dyslipidemia. Not only are 
these health concerns widely prevalent in today’s population, their incidence and 
severity is continuing to increase at an alarming rate.  Notably, loss-of-function 
mutations in the protein lipin-1 have been found to promote abnormal adipocyte 
differentiation, peripheral neuropathy, impaired glucose tolerance, circulating 
hyperlipidemia, and neonatal liver steatosis (160), all of which are hallmarks of 
dysregulated lipid homeostasis. Additionally, lipin1 has been shown to be directly 
phosphorylated in response to insulin signaling in humans, further corroborating 
the ties between type-2 diabetes and dysfunction of lipin-1 (161, 162). Expression 
of the lipin1 gene is highly regulated via hormonal signaling with lipin1 
transcription being induced by fasting, high-fat diets, diabetes, chronic alcohol 







Lipin-1, a member of the lipin family of proteins, is the predominant lipin 
isoform present in organs and tissues with high rates of lipid flux, including the 
liver, which plays a critical role in lipid metabolism and homeostasis in humans 
(164). Recently, lipin-1 has already been identified as a therapeutic target for 
disorders involving dysregulation of lipid homeostasis, dyslipidemia, and 
nonalcoholic fatty acid liver diseases and alcoholic liver disease (165). In addition 
to lipin-1 expression in the most impactful tissues for lipid homeostasis, it is poised 
as a unique target to attempt to quell dysregulation of lipid homeostasis as it plays 
a role in two functionally different pathways of lipid metabolism and homeostasis. 
Unlike most proteins, which play only a single role within the cell, lipin-1 displays 
a unique bi-functionality as a phosphatase and a transcriptional co-activator 








Figure A2.1. Schematic of the dual roles of lipin1 in the different cellular 
compartments cytoplasm (green), membrane, and nuclear (yellow). Figure 
courtesy of Dr. Jeremiah Farelli.  
	
Functionally, lipin-1 plays a central role in triacylglycerol biosynthesis via 
its phosphatidic acid (PA) phosphatase activity through its catalysis of the 
conversion of membrane PA to diacylglycerol (DAG) (166). Additionally, lipin-1 
acts as a transcriptional co-activator to increase the transcription of lipid oxidative 
metabolism and membrane biogenesis (165). Not only are the dual functions of 
lipin-1 mechanistically independent, they have been shown to be highly correlated 







membrane, lipin-1 carries out its PA phosphatase activity, and when localized to 
the nucleus lipin1 acts as a transcription co-activator via interactions with the 
transcription factors PPARα and PGC-1 (165). This localization of lipin1 is highly 
regulated by many different processes including covalent post-translational 
modifications, as well as non-covalent modulations by interactions with its 
binding partners.  
Structurally, lipin-1 is a large complex molecule (890 aa) made up of 
multiple domains, known recognition motifs, and post-translational modification 
sites. The primary structure of lipin is compartmentalized by its different domains 
with a short amphipathic helix (aa 1-20) and a highly conserved NLIP (N-terminal 
domain of lipin) domain at the N-terminus (aa 21-106) of the protein and a 
haloalkanoic acid dehalogenase (HAD) phosphatase domain (aa 654-890) at the C-
terminus (Figure A2.2).  The domains at the termini are well conserved 
evolutionarily and have been predicted to assume well-characterized folds. The 
NLIP domain has been predicted via homology modeling to take on an 
immunoglobulin-like beta-sandwich fold, while the HAD domain takes on the 
characteristic HAD-domain rossmanoid core fold (167). Structural similarity is 
high, even when sequence similarity is low, among all HADSF family members, 







the domains at the termini are well conserved and therefore predicted to be well 
ordered, the sequence bridging the gap between the two termini is a 540 aa stretch 
of largely non-phylogenetically conserved, likely disordered sequence referred to 
as the intervening sequence. While the intervening sequence is thought to be 
largely disordered, it does contain important sequence elements including many 
of the sites for post-translational modification (phosphorylation and sumoylation), 
as well as recognition motifs for 14-3-3 proteins. In order to define the mechanism 
of lipin-1 function in the cell, information is needed about the basic structure-
function relationship of lipin1 domains and sequence motifs (168, 169).  
 
Figure A2.2. Domain structure of human lipin-1α. Boxed domains indicated 
predicted well-ordered domains. 
 
While there are predictions for the structure of the well-ordered domains, 
there have been no experimental structure determinations for lipin-1. Any 







fundamental understanding of the structural basis of the specific molecular 
interactions between lipin1 and its substrate, the membrane, and its binding 
partners, 14-3-3 and transcription co-activators, PPARα and PGC-1α. Ultimately 
this will help to define the poorly understood regulation of a key protein central 
to two pathways maintaining lipid homeostasis. Because of difficulties 
encountered previously in the Allen Lab with expression and purification of lipin-
1 constructs, focus has shifted to expressing and purifying a homolog of lipin1 
from E. coli, Nir2, and ortholog of lipin-1 from S. cerviseae, Smp2.  
 Nir2 shares 14% sequence identity (21% highly similar) with lipin-1. The 
construct of Nir2 used in the studies presented in this chapter is 345 amino acids 
comprising amino acids 911-1244 of the native Nir2 sequence. Functionally, Nir2 
is a phosphatidylinositol-transfer and phosphatidic-acid binding protein (170). 
The construct employed in this chapter represents the two lipin-like domains and 
excluded the phosphatidylinositol transferase domain (figure A2.3A and B).  
Notably, Nir2 shares the DXDGT/V motif and Rossmanoid-core fold known in 
HAD superfamily members to be capable of phosphoryl-transfer (95). However, 
the catalytic Asp residue in Nir2 is mutated to serine giving rise to phosphatidic 
acid binding function over phosphatidic-acid phosphatase function as seen in 







plasma membrane in response to external signaling.  Similarly, Smp2 shares high 
sequence similarity and domain structure to human lipin-1 (171, 172). Specifically, 
the construct employed in the studies presented in this appendix was a truncated 
construct which fused the NLIP and HAD-domains together (figure A2.3 C and 
B). Ultimately, by fusing the two well-ordered domains of Smp2 together, while 
omitting the intrinsically disordered intervening domain should allow for 










Figure A2.3. Comparison of Nir2, Smp2, and Lipin-1 domain structure. NLIP 
domains represented in blue, HAD domains represented in green, and highly-
conserved Nir C-terminal domain represented in red. A, Domain structure of 
lipin-1 human homolog Nir2. B, Domain structure of Lipin-1β. C, Domain 
structure of lipin-1 yeast ortholog Smp2. Cartoon representations of the molecular 








Leveraging biophysical and structural biology tools, a quantitative and 
molecular view of the key mechanisms for lipin1 functional regulation can be 
obtained to corroborate insights gained from previous macro-level studies of the 
protein. Using a multi-faceted approach that combines genetic engineering of 
lipin1 constructs, in vitro thermodynamic and structural analyses, and biophysical 
techniques, accurate lipin1 models can be generated, which define the structure-
function relationship for lipin1 domains and its molecular interactions with its 
substrate, the membrane, and its protein partners.  
 
A2.2. Materials and Methods 
Work on the expression, purification, and crystallization of the truncated Smp2 









A2.2.1. Constructs of Nir2, lipin, and Smp2 
Table A2.1. Constructs of Nir2, Smp2, and lipin-1β used in this appendix. 
 
** human lipin-1β was purified from HeLa cells by James Eaton (Harris Lab, 
University of Virginia). 
 
A2.2.2. Purification of Nir2 (911-1244) 
One mL of overnight culture was inoculated into 1 L of Luria Broth media 
treated with 1x carbenicillin and 1x chloramphenicol. For each prep of Nir2, 4-6 L 
of media were inoculated. Cells were allowed to grow at 37 °C with shaking until 
an OD600 = 0.6-0.8 was reached. Once the appropriate OD was reached, cells were 
allowed to temperature equilibrate to 16 ° C prior to induction of Nir2 protein 
expression for at least 1 hour. Following temperature equilibration 0.5 mM IPTG 
was used to induce protein expression and cells were allowed to continue to grow 
with shaking overnight. The resulting cell suspensions were pelleted by 
centrifugation at 6,000 rpm. Cell pellets resuspended and homogenized in lysis 
buffer (25 mm HEPES pH 7.5, 500 mM NaCl, 10 mM Imidazole, 5 mM MgCl2, 2% 
Construct Native Protein AA Vector Tag? Antibiotic MW (Da) Experiment
Nir2 (911-1244) 911-1244 pET-24a 6His (non-cleav.) Carb./ Cam. 37376.5 Crystallography
SAXS
Truncated Smp2 21-100, 346-590 p15 (TEV) 6His Carb./ Cam. 41961.5 Crystallography 









glycerol) with the addition of protease inhibitors and DNAse. Following 
homogenization cells were lysed with a microfluidizer and the lysate was pelleted 
in the ultracentrifuge at 38,000 krpm for 30 minutes at 4 °C. Purification of protein 
was achieved through Ni2+-NTA affinity chromatography using a peristaltic 
pump and commercially procured pre-packed HisTrap-HP column (GE 
Healthcare). Elution of Nir2 from the affinity column was accomplished with a 
step-gradient of 10%, 20%, 25%, 35%, 50%, 75% and 100% elution buffer (25 mM 
HEPES pH 7.5, 150 mM NaCl, 500 mM imidazole, 5 mM MgCl2, 2% glycerol) over 
20 column volumes.  Nir2 Purification from 6 L of inoculated culture generally 
yields 30 mL of 0.5 mg/mL pure Nir2 protein. Pure protein was dialyzed overnight 
against 4 L of protein buffer (50 mM HEPES pH 7.5, 100 mM NaCl, 5% glycerol) to 
remove excess imidazole. Following dialysis any remaining precipitation was 
removed by centrifugation at 38,000 rpm for 30 minutes at 4 °C. Homogeneity of 
the resulting pure protein was characterized by dynamic light scattering (DLS) at 
4 °C.  
 
A2.2.3. Differential scanning fluorimetry (Thermofluor)  
To screen for optimized buffer conditions via the Thermofluor Solubility 







of Sypro Orange Dye (500X, from Invitrogen) was prepared by dilution to the with 
water. To each well of a 96 well white-walled PCR tray (Eppendorf), 10 µL of 
protein solution plus 10 µL of well solution were added for a final reaction volume 
of 20 µL.  Clear sealing fil was applied to the top of the plate to mitigate 
evaporation of sample during the the thermal melt assay. The fully prepared assay 
plate was placed onto the heat-block of a RealPlex ep Mastercycler thermocyler 
(Eppendorf) and the lid was closed. The protein samples were subjected to a 
termal melt program that starts at a constant 4 ° C step for 15. Following 
temperature equilibration at 4 °C, the temperature is increase at 1°C per minute 
until the temperature reaches 95°C. After the temperature ramp is completed, the 
temperature is again held constant at the high temperature (95 °C). During the 
assay, fluorescence at 520 nm is monitored.  
 
A2.2.4. Purification of truncated yeast SMP2 
Truncated yeast Smp2 was overexpressed in E. coli (DE3) with overnight 
cultures diluted 1:1000 in YT medium containing 100 µg/ml carbenicillin and 
35 µg/ml chloramphenicol. Cultures were agitated continuously at 225 rpm at 37° 
C to an OD600 of 0.6 at which point expression of Smp2 was induced by addition of 







with agitation at 16° C. Cells were then pelleted at 6,000 RPM for 15 and frozen at 
-80°C. Cells were suspended in lysis buffer (50 mM BisTris Propane (pH 6.2), 
500 mM NaCl, and 20 mM imidazole) and lysed by microfluidization at 18,000 psi. 
The lysate was centrifuged at 38,000 RPM for 30 min. Clarified lysate was loaded 
onto an ÄKTAxpress FPLC (GE Healthcare). Lysate was passed through a 5 mL 
HisTrap FF column (GE Healthcare), washed with 10 column volumes of lysis 
buffer, and eluted in buffer containing 50 mM BisTris Propane (pH 6.2), 100 mM 
NaCl, and 500 mM imidazole. Peak fractions were collected and protein was 
analyzed by SDS/PAGE, and run through an additional round of column 
chromatography. 
 
A2.2.5. Expression testing of truncated Smp2 
To test for optimal induction conditions of the truncated construct of Smp2, 
twelve colonies of BL21 cells were used to inoculate three groups of LB media, 
each of which was grown to an OD of 0.4 then two groups were induced by 
addition of IPTG to a final concentration of 1 mM.  One group was grown at 37° C 
for 3 h post-induction, one group was grown at 16° C overnight, and one group 
was grown in minimal media at 37°C for 12 hours to test for auto-induction. The 







To test for optimized expression across differing cell-lines, a pUC vector 
containing the gene for Smp2 was used to transform BL21-CodonPlus (DE3) 
Competent Cells, Arctic Express (DE3) Competent Cells, BL21-Gold(DE3)pLysS 
Competent Cells, and SoluBL21 (DE3) Competent Cells from Agilent. All 
competent cells were thawed on ice for 10 minutes. XL10-Gold β-mercaptoethanol 
mix was diluted 1:10 in de-ionized water and 2 µL were added to the CodonPlus 
and Arctic Express cells during incubation on ice for 10 minutes with slight 
agitation every 2 minutes. Each cell line was transformed with 5 µL containing 1-
50 ng of plasmid DNA and incubated on ice for 30 minutes. The cell lines were 
then heat shocked at 42° C for 20 seconds and incubated on ice for 2 minutes. Then 
0.9 mL of preheated (42 °C) SOC medium was added to each transformation 
reaction and the reactions were incubated at 37 °C for 1 hour with shaking at 225–
250 rpm. Finally, the reactions were plated on plates containing 1x 
chloramphenicol and grown overnight at 37°C. The next day, three colonies were 
selected from each cell line and used to prepare and overnight culture. The 
overnights were each grown at 37° C to an OD600 of 0.4 and IPTG was added to a 
final concentration of 1mM. The cells were allowed to continue growing at 37° C 
for 3 h post-induction. Pre- and Post-induction samples were collected and 







To compare the effects of final concentration of IPTG on expression, three 
colonies of CodonPlus cells were used to inoculate overnight cultures of LB. The 
overnights were each grown at 37° C to an OD600 of 0.4 and IPTG was added to 
final concentrations of 0.05 mM, 0.2 mM, 0.5 mM and 1.5 mM IPTG. The cells were 
allowed to continue growing at 37° C for 3 h post-induction. Pre and Post-
induction samples were collected and compared via gel electrophoresis. Finally, 
the addition of a Rosetta (pRare) plasmid was tested both through co-
transformation with the Smp2 plasmid and with a 2 step transformation in which 
competency was reintroduced after transformation with the Rosetta plasmid. The 
transformation was performed as above with DNA containing the Rosetta 
plasmid, the following day, a single colony of transformed cells was used to 
inoculate 10 mL of LB containing 1x antibiotic and was grown overnight at 37° C 
shaking at 225–250 rpm. The next day, 2 mL of this culture was added to 100 mL 
fresh LB and grown to an OD600 of 0.6. The cells were then poured into 50 mL 
conical tubes and incubated on ice for 10 minutes.  Next the cells were centrifuged 
at 6000 RPM for 15 min, the media was removed and each tube was re-suspended 
10 mL 0.1 M CaCl2. The two tubes were combined then pelleted again and the 
CaCl2 was poured off.  The final cell pellet was re-suspended in 4 mL 0.1 M CaCl2 







A sample of 50 µL of the resulting suspension was aliquoted into 1.5 mL 
centrifuge tubes were frozen in liquid nitrogen and stored at -80 °C. One aliquot, 
however, was used in a second transformed with Smp2 plasmid DNA as described 
above. A single colony of transformants were used to inoculate 10 mL of LB 
containing 100 µg/ml carbenicillin and 35 µg/ml chloramphenicol and was grown 
overnight at 37° C shaking at 225–250 rpm. This starter culture was used to 
inoculate fresh LB the following day which was grown to an OD600 of 0.4 and IPTG 
was added to final concentrations of 1 mM IPTG. The cells were allowed to 
continue growing at 37° C for 3 hours post-induction. Pre -and Post-induction 
samples were collected and compared via gel electrophoresis. 
 
A2.2.6. Crystallization of Nir2 and truncated yeast Smp2 
Crystallization condition screening of purified Nir2 protein was carried out 
via commercially-available high-throughput (HT) sparse-matrix screens (96 well) 
from Hampton Research and Microlytic. Concentration of protein (7 - 23 mg/mL), 
temperature (4 °C, 17 °C, 25 °C, and 37 °C), and crystallization experiment 
geometry (hanging-drop, sitting-drop, and under-oil) was varied for high-
throughput screening. Conditions producing crystal hits, confirmed by IZIT dye 







through grid screening focused on variation sin protein concentration, pH, 
precipitant concentration, protein: well solution ratio, or slowed equilibrium in a 
24-well hanging-drop crystallization geometry. 
HT sparse-matrix crystallization condition screens were prepared with 
purified Smp2 protein concentrated to 15 mg/ml in 96-well sitting-drop geometry. 
Individual crystallization drops were prepared with 1 µl of protein and 1 µl of 
screening condition. Following set up at room temperature (~25 ° C), 
crystallization plates were incubated at 17 °C for crystal growth.  Crystal hits 
identified through HT screens were optimized via similar grid-screening 
optimization strategies employed for Nir2.  
 
A2.2.7. SAXS data collection and data processing for Nir2 and human lipin-1β 
Solution SAXS experiments of Lipin-1β and Nir2 were performed at X9 at 
Brookhaven National Lab (BNL) National Synchrotron Lightsource (NSLS-I) 
(Upton, NY). Nir2 and lipin-1β samples, prepared as described above, were 
transported to the beamline on wet ice. Prior to experiments, all samples were 
centrifuged for at least 30 minutes at 18,000 rpm (rotations per minute) on a table 
top microcentrifuge followed by filtration to remove any aggregates within the 







2.75, and 3.98 mg/mL and with reserved sample dialysis for each sample serving 
as the buffer blank for subtraction.  Lipin-1β samples were run at two 
concentrations 1 mg/mL and 0.5 mg/mL. For each data set, 20 µL of sample was 
was drawn into the experimental capillary. Images were collected with a 30 second 
exposure at λ = 0.98 Å were collected on a MarcCCD detector positioned 3.4 m 
from the sample resulting in a resolution range of 0.0064 < q = 4πsinθ/λ > 2.0 Å-1, 
where 2θ is the scattering angle. 
Data images were scaled and radially integrated via pyXS scripts 
implemented at the beamline. Scattering profiles computed for each image 
collected for the sample (n = 3) were subsequently averaged. The buffer 
contribution to the sample scattering was removed by subtraction of the scatting 
from the matched buffer sample form the sample to give the one-dimensional 
scattering intensity profile for the protein samples. Further processing and 
analysis of the SAXS data was carried out with the ATSAS suite of programs (132). 
Radius of gyration (Rg) for each sample was determined from transformation of 
the scattering intensity profiles in PRIMUS (133) via the Guinier approximation 
(126) within a fitting limit of qRg ≤ 1.3. The particle distiance distribution functions, 
P(r), for each sample were calculated from the scattering intensity curves in 







particle vector, Dmax.  The molecular envelopes of lipin and Nir2 were generated 
by calculation of 4 ab inito shape reconstructions in DAMMIN that were then 
averaged by DAMAVER to select the most populated volume for all 
reconstructions.  
 
A2.2.8. AUC data collection and data processing for human lipin-1β  
Human Lipin-1β with a C-terminal FLAG-tag purified from HeLa cells was 
provided for sedimentation equilibrium (SE) and sedimentation velocity (SV) 
AUC experiments by James Eaton (Harris Lab, University of Virginia). 
Absorbance optics SV-and SE-AUC) experiments using a Beckman XL-A/I 
ultracentrifuge, equipped with a Ti50An rotor using a 12mm six channel 
centerpieces for SE and 12mm two channel centerpiece for SV with quartz 
windows and detection by UV at 280 nm. AUC experiments out at 4 °C in a buffer 
of 20mM HEPES pH 7.2, 150mM NaCl, and 10% glycerol.  For SE, protein at 
concentrations of 0.7, 0.5, and 0.2mg/mL Samples were subjected to spins at 6400 
rpm for 21 hours to achieve equilibrium before five replicates of two scans were 
recorded. Rotor speed was to 8000 rpm for 21 hours to achieve a new equilibrium 
before two scans were recorded. Rotor speed was increased to a final speed of 







final 2 scans were recorded.  For SV experiments, lipin-1β at a concentration of 
0.6mg/mL was subjected to centrifugation at 42,000 rpm for 19 h allowing for 
collection of a total of 867 scans. 
 SV data was fit to a Lamm equation model of rapid-self-association 
equilibrium between monomer and dimer or monomer, dimer, and tetramer with 
the following parameters: v ̅sample = 0.729 cm3 g-1, ρbuffer= 1.035 g ml-1, ηbuffer = 0.015 P 
in SEDFIT (139, 174). Both models fit the data with rmsd = 0.008 – 0.004 between 
the model and experimental data. Notably, to achieve good fits to the data for both 
models, a term accounting for a small (s ≅ 0.1), rapidly sedimenting particle. SE 
data was initially processed in SEDFIT, and analyzed globally in SEDPHAT (139). 
Global reduced chi-squares (gcrs) indicating goodness of fit were between ~ 3-7 
for the monomer-dimer-tetramer model for fitting.  
 
A2.2.9. Microscale thermophoresis (MST)  
Preliminary microscale thermophoresis experiments were performed using 
a Nanotemper Monotlith NT.115 insturment. Lipin-1β was fluorescently labeled 
on solvent exposed lysine residues with a 2x excess of fluorescent dye NT-495 dye 
(Nanotemper) resulting in labelling of an estimated 5 lysines/ lipin molecule. 







against increasing amounts of purified PPARα (100 µM, 26 µM) provided by Dr. 
Jeremiah Farelli (Allen Lab, BU) from 0.9 nM – 59 nM in 100 mM Tris buffer at pH 
8.0. Thermophoretic movement of the lipin molecules was observed as a change 
in fluorescence signal. Fitting the fluorescence data to the Hill equation (175) 
allowed calculation of the equilibrium dissociation constant Kd = 16 ± 7 nM.  
Additionally, MST was used to probe for binding between full-length lipin-
1β and phospholipid membrane bilayers (nanodiscs) in vitro. Fill length lipin-1β 
was labeled at lysine residues with a 5x excess of NT-495 dye. This fluorescent 
lipin-1β (100 uL, 1.8 µM) was then titrated with increasing amounts of membrane 
8 nm nanodiscs (MSPΔH5 construct, DMPC/DMPG 3:1) with a concentration 
range of 0.08 nM- 11µM in 100 mM Tris buffer pH 8.0.  Fluorescence data was fit 
to the Hill equation (175) to give an estimation of Kd = 21 nM.  
 
A2.3. Results and Discussion 
A2.3.1. Optimization of Nir2 and truncated Smp2 protein for structural studies 
Previous work in the Allen lab towards an understanding of the unique 
structural underpinnings of cellular localization and function in lipin1 
encountered difficulty with expression and purification of lipin-1 constructs 







aggregation propensities during purification. As a result, high-resolution 
structural studies by x-ray crystallography focused on a human homolog, Nir2, 
and yeast ortholog, Smp2, of lipin which allowed for more reliable expression and 
purification of the high-quality protein needed for crystallography.  
Although it was possible to obtain pure protein protein of Nir2, the protein 
was largely unstable with high degrees of aggregation and precipitation seen in 
preparations of Nir2. As a result, low yields of protein of sufficient quality for 
structural studies was obtained from a 6 L prep. In attempt to mitigate Nir2 
instability, differing purification and protein handling strategies were tested. 
Notably, adding a gel filtration step and low-pH elution strategies to the 
purification protocol had no effect in ameliorating aggregation during Nir2 
preparation. To address the possibility that the aggregation propensity was 
coupled to temperature, dynamic light scattering (DLS) at different temperatures 
was performed. DLS experiments revealed Nir2 was extremely stable and 
monodisperse at 4°C and 17°C, but at 23°C, the entire sample displayed 
aggregation (figure A2.4A), thus, indicating that between 17°C and 23°C, the 
protein crosses a stability threshold and aggregates. Additionally, differential 
scanning fluorimetry (176) allowed for selection of optimal buffer conditions (50 







increase in melting temperature (Tm, optimized = 48.0 ° C) for for Nir2 in comparison 
to the original buffer (25 mm HEPES pH 7.5, 500 mM NaCl, 10 mM Imidazole, 5 
mM MgCl2, 2% glycerol, Tm, original = 45.3 ° C) (figure A2.4B). Notably, the 
components of the original and optimal buffers for Nir2 are highly similar with 
the exception of the exclusion of imidazole. Unsurprisingly, imidazole has been 
shown in other his-tagged protein systems to lead to instability and insolubility 
(177). As a result of changing the buffer and maintaining sample temperature at 
17 °C or below throughout protein purification, pure, stable Nir2 in sufficient 










Figure A2.4. Optimization of Nir2 Purification. A, DLS traces of Nir2 at 4 °C (red 
trace), 17 °C (blue trace), and 23 °C (green trace). B,  Thermal melting curves for 
Nir2 in the original purification elution buffer (25 mm HEPES pH 7.5, 500 mM 
NaCl, 10 mM Imidazole, 5 mM MgCl2, 2% glycerol; Tm, original = 45.3 ° C; red trace) 
and optimized buffer (50 mM HEPES pH 7.5, 100 mM NaCl, and 5% glycerol; Tm, 
optimized = 48.0 ° C; blue trace). C, SDS-PAGE gel of purified Nir2 for x-ray 







In addition to purification of Nir2, purification and optimization of a 
truncated construct of Smp2, a homolog of lipin-1 from yeast was attempted for 
crystallographic studies in collaboration with undergraduate research assistant 
Merissa Brousseau.  The truncated construct of Smp2 was reliably purified with 
high purity; however, low-levels of protein expression lead to overall yields of 
purified truncated Smp2 that were often too low to perform structural studies. As 
such, protein expression strategies, namely varying post-induction growth time 
and temperature, cell-line, and IPTG induction concentration, were assayed to 
determine an optimal expression system for truncated Smp2. Comparison of 
protein-expression levels following varied growth times and temperatures post-
IPTG induction revealed no significant differences between cells allowed to grow 
at 37 °C for 3 h and cells allowed to grow for 16-18 h at 16 °C (Figure A2.5A). 
Transformation of truncated Smp2 into BL21-CodonPlus(DE3) competent cells, 
ArcticExpress(DE3) competent cells, BL21-Gold(DE3)-pLysS competent cells, and 
SoluBL21(DE3) competent cells from Agilent allowed for testing of the effect of 
cell-line on the protein expression levels of Smp2.  BL21-CodonPlus(DE3) and 
ArticExpress(DE3) competent cells offered increased expression levels in 
comparison to the original soluBL21(DE3) cell line used (figure A2.5B). Both BL21-







engineered to aid in heterologous expression of non-bacterial proteins in E. coli.  
Specifically, BL21-CodonPlus(DE3) (Agilent) cells are specifically engineered with 
additional copies of tRNA genes to aid in heterologous expression in E. coli (178) 
and ArcticExpresss(DE3) (Agilent) cells aid in increasing protein folding through 
concurrent over-expression of specific chaperone proteins (179). As expression 
levels between the CodonPlus and ArcticExpress cell lines were equivalent, 
CodonPlus cells were selected for further expression of the truncated Smp2 due to 
the relative simplicity of growth protocol. Similarly, to the expression time and 
temperature, variation of IPTG had negligible effect on protein expression levels 
(figure A2.5D). Overall, increased levels of Smp2 protein expression were 









Figure A2.5. Results of expression testing for truncated Smp2 (indicated by *). 
A, Varied growth time and temperature. B, Varied cell lines. C, Varied induction 
concentration of IPTG. D, Final purification yield of truncated Smp2 after the first 
and second His-Trap purification steps. Gray horizontal bars identify the bands 
corresponding to Smp2.  Experiments performed by undergraduate research 
assistant Merissa Brousseau.  
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A2.3.2. Crystallization of Nir2 and truncated Smp2 constructs 
Optimization of purification and expression protocols for Nir2 and 
truncated Smp2 allowed for production of sufficient quantities of pure, 
monodisperse protein for structural studies by x-ray crystallography.  High-
throughput crystallization screening of Nir2 yielded twelve initial crystal hits 
(Table A2.2), which were then further screened for diffraction. Of these twelve 
initial hits, only two crystals did not diffract as salt; however, they did not diffract 
past 20 Å (figure A2.6). Optimization through grid screening around these 
condition was attempted, but in addition to no production of crystals of improved 
diffraction quality, the initial hit was not reproduced. Additionally, the level of 
precipitation observed in the high-throughput crystal screens (approximately 
50%) was below ideal (80-90%), indicating the protein concentration used to set up 
crystals should be increased (173). Subsequently, increasing the protein 
concentration from 10 mg/mL, used in the initial screen, to 20 mg/mL for the 
second iteration of the screen, did not yield any positive crystal hits or 













Well Condition [Nir2] mg/mL
 Drop ratio 
(prot.: well) Izit Dye Diffraction?
MCSG1 D11 0.2M Sodium Iodide 10.12 1:1 + protein, >20 Å
20% w/v PEG 3350
MCSG2 F01 0.2M NaCl 10.12 1:1 - SALT
0.1M Imidazole pH 8.0
0.1M Ammonium Phosphate Dibasic
MCSG2 C07 0.1M Tris:HCl pH 8.5 10.12 1:1 - SALT
1.5M Ammonium Phosphate Dibasic
MCSG2 E06 0.1M Sodium Acetate pH 4.5 10.12 1:1 - SALT
1M Ammonium Phosphate Dibasic
MCSG2 G06 0.2M NaCl 10.12 1:1 - SALT
0.1M Sodium Citrate pH 5.5
1.0M Ammonium Phosphate Dibasic
MCSG3 A04 1M Imidazole pH 8.0 9.86 1:1 - SALT
1M Ammonium Phosphate Dibasic
MCSG3 E01 0.2M NaCl 9.86 1:1 - SALT
0.1 M NaH2PO4/K2HPO4pH 6.2
 50% (v/v) PEG 200
MCSG4 C10 1 M NaH2PO4/K2HPO4 pH 8.2 9.86 1:1 - SALT
MCSG2, A05 0.2M Lithium Sulfate 20.3
0.1 CAPS pH 10.5
1.2M NaH2PO4/K2HPO4
MCSG4, A12 0.1M Bis-Tris Propane pH 7.0 20.3 1:1 - SALT
4M Sodium Nitrate
PegRx HT 4 M Potassium Formate 14.5 1:1 + protein, >20 Å
0.1 M BisTris propane pH 9.0
2% w/v PEG monomethyl ether 2000
MCSG3, A4 0.1M Imidazole, pH8.0 9.86 1:1 - SALT








Figure A2.6. Initial crystal hits of Nir2 diffracting to > 20 Å. A, Crystal hit from 
10.12 mg/mL Nir 2 in 0.2 M Sodium Iodide, 20% w/v PEG 3350. B, Zoom of circled 
region in A to show crystal detail. Dimensions given in mM.   C, Crystal hit from 
14.5 mg/mL Nir 2 in 4.0 M Potassium Formate, 0.1 M BisTris Propane pH 9.0, and 
2% PEG monomethyl ether 2000. D, Zoom of circled region in C to show crystal 
detail. Dimensions given in mm. 
 
Following the failure of continued grid-screening and HT-screening, in situ 
proteolysis via the Proti-ace screen (Hampton Research) was used to 
proteolytically cleave any flexible loops or domains that may be hindering 







wells of the in situ proteolysis crystallization experiments, but no additional crystal 
hits or reproductions were observed. The use of additives can often help coax 
recalcitrant proteins into forming crystals (173). Using detergent (β-octyl 
gluocoside), the native substrate (PA) intrinsic co-factor (Mg2+) of Nir2, and a 
crown ether observed to mediate protein crystal contacts (118) as additives to the 
Index HT screen (Hampton Research) did not produce any additional crystal hits. 
In continuing with crystallization screening for Nir2, it would be worthwhile to 
explore robotic based high-throughput crystallization at the Hauptman-
Woodward Institute to allow screening of many more conditions with the limited 
quantities of crystallography-quality protein obtained (116). Additionally, using a 
crystal-former device to allow for the formation of concentration gradients and 
therefore increase the effective number of crystallization conditions screened (181).   
High-throughput crystallization screening of Smp2 yielded four initial 
crystal hits (table A2.3).  The crystals produced in the high-throughput 96-well 
trays were too small in size to be looped and screened for diffraction. However, 
dying with izit dye which penetrates into the solvent channels of protein crystals, 
but is excluded from inorganic salt crystals, revealed all hits with the exception of 
those from the MgCls and PEG 3350 were likely protein crystals (figure A2.7). 







diffraction-quality crystals through grid-screening were largely unsuccessful. 
Varying protein concentration, precipitant, salt, and buffer concentration, and 
temperature resulted in formation of heavy precipitate in each well. As a result, 
future efforts towards the crystallization of truncated Smp2 should be directed at 
additives aimed at increasing protein solubility to allow for formation of crystals 
over non-native protein aggregates (182).  
 
Table A2.3.  Initial truncated Smp2 crystal hits from high-throughput 
crystallization screens.  
 
  
Well Condition [Smp2] mg/mL
 Drop ratio 
(prot.: well) Crystal Description
Index HT 0.2 M Calcium chloride dihydrate 15 1:1 microcrystals
0.1 M BIS-TRIS pH 6.5 
45% w/v (+/-)-2-Methyl-2,4-pentanediol
PegRX 0.05 M Calcium chloride dihydrate 15 1:1 microcrystals
0.1 M MES  monohydrate pH 6.0
45% w/v Polyethylene Glycol 200
MCSG-1 0.16 M Magnesium Chloride 15 1:1 small crystal
0.08 M Tris: HCl, pH 8.5 
24% (w/v) PEG 4000
20% (v/v) glycerol 
Peg/Ion 0.2 M Magnesium Chloride Hexahydrate 15 1:1 small crystal








Figure A2. 7.  Representative crystal hits of truncated Smp2 from initial HT 
crystallization condition screening. A, Microcrystals (MC) obtained from 0.2 M 
CaCl2·2H2O, 0.1 M BisTris pH 6.5, 45% w/v (+/-)-2-Methyl-2,4-pentanediol. B, MC 
obtained from 0.05 M CaCl2·2H2O, 0.1 M MES monohydrate  pH 6.0, 45% w/v PEG 
200. C, Small 3D crystal (circled) obtained from 0.16 M MgCl2, 0.08 M Tris-HCl pH 










A2.3.3. Low-resolution molecular envelopes for Nir2 and Lipin-1β   
In parallel to crystallization condition screening for Nir2, small-angle x-ray 
scattering (SAXS) studies of Nir2 were performed to obtain a low-resolution 
molecular envelope of Nir2 in solution. Guinier analysis of Nir2 scattering 
intensity profiles indicated high-quality data and sufficient linearity at small-
angles allowing for determination of the Rg (Rg =  31.3 ± 0.669 Å) and cross-sectional 
Rg (Rc = 13.8 ± 0.378 Å) for the particle in solution (figure A2.8B). Fourier 
transformation of the scattering intensity profiles allowed calculation of the 
distance distribution function for Nir2 at 1.9 mg/mL gave a maximum inter-
particle dimension, Dmax, of 103.49 Å (figure A2.8C). Cylindrical approximations 
(equation 5.6), the Rg and cross-sectional Rg (Rc) suggest dimensions of radius of 
19.65 Å and height of 100.23Å for the Nir2 particle. Notably, the consistency of the 
maximum dimensions calculated through Guinier analysis and P(r) analyses (~100 
Å) provides independent confirmation of data quality and particle dimensions. 
Guinier and P(r) analyses indicated Nir2 SAXS intensity profiles were of 
sufficiently high quality for shape-reconstruction. Ab initio bead modeling 
algorithms were applied to the data via DAMMIN (183) to produce an averaged 
low-resolution molecular envelope for Nir2 (figure A2.8D). Analysis of the 







dimensions similar, but not identical, to those calculated from the reciprocal-space 
Rg and cylindrical approximation calculations. Notably, the molecular envelope of 
Nir2 appears to have 2-fold symmetry indicating the possible formation of a Nir2 
dimer in solution. 
	
Figure A2.8. SAXS experiments allow calculation of the molecular envelope of 
Nir2. A, SAXS intensity profiles for Nir2 at 1.3 mg/mL (blue), 1.9 mg/mL (green), 
and 2.75 mg/mL (orange). B, Guinier analyses of Nir2 data at the three 
concentrations. Data at 2.75 mg/mL (orange) and 1.9 mg/mL (green) are linear 
within the Guinier region. Aggregation is apparent in the 1.3 mg/mL sample (blue) 
as the sharp increase in intensity at very small angles.  C, P(r) function for the 1.9 
mg/ mL SAXS dataset indicating a Dmax of ~103 Å.  D, Ab inito shape-reconstruction 





















































In addition, SAXS was used to investigate the oligomeric state, volume, and 
shape of the lipin-1β particle prepared from HeLa cells by James Eaton (Harris 
Lab, University of Virginia). Guinier analysis (126) allowed determination of the 
Rg to be equal to 64.8 ± 1 Å from the linear region at small-angles (Figure A2.9B). 
Fourier transformation of the scattering intensity profile resulted in the calculation 
of the the P(r) function. The x-intercept of the P(r) function corresponds to the 
maximum diameter for the particle in solution (Dmax = ~230 Å) (figure A2.9 C). Ab 
initio shape-reconstruction (183) of the lipin-1β particle shows a ring-like structure 
with an estimated volume of 4.3 x 107 Å3 (Figure A2.9D). Notably, the ring 
structure has a diameter of approximately 60 Å which is similar to the dimension 
estimated for the center diameter of ring-like particles observed negative-stain EM 
images collected by the Harris Lab (data not shown, unpublished results).  From 









Figure A2.9. SAXS experiments allow calculation of the molecular envelope of 
human lipin-1β. A, SAXS intensity profile for lipin-1β. B, Guinier analyses of 
lipin-1β data showing linearity within the Guinier region allowing for the 
calculation of Rg = 64.8 ± 1 Å. C, P(r) function shows ring-like topology with 
maxima at 25 Å and 60 Å and Dmax of ~230 Å is observed.  D, Ab inito shape-
reconstruction of the molecular envelop of Lipin-1β from the P(r) transformed data 
in panel C shows ring-like topology with an ~60 Å opening at the center. Data 
shown in this figure processed by Dr. Stefan Jehle (Allen Lab, BU). 
 
A2.3.4. AUC experiments with lipin-1β  
In order to validate molecular envelope for lipin-1β determined by SAXS 
via an orthogonal biophysical method, analytical ultracentrifugation (AUC) 
sedimentation velocity (SV) and equilibrium (SE) experiments were performed. 







best when using a Monomer-dimer-tetramer model with molecular weights for 
the species of 72.8 kDa, 217 kDa, and 402 kDa, respectively (figure A2.10 A, B). 
These molecular weights are lower than expected with the molecular weight of the 
monomer is calculated to be 102 kDa. The under-estimation of molecular weight 
suggests the presence of lipids moving with the protein, resulting in an effective 
lowering of the buoyant molecular mass in solution (184). Overall, the non-
standard sedimentation behavior observed for both SV and SE-AUC experiments 









Figure A2.10. SV-AUC experiments with lipin-1β. A, Representative 
experimental data for lipin-1β in SV-AUC. B, Resulting C(s) distribution from 
fitting the data to a Lamm equation model of self-interacting monomer-dimer-























To further investigate the presence of lipids tightly bound or covalently-
linked to lipin mass spectrometry (MS) experiments were performed in 
collaboration with the Costello group at Boston University Medical Center. 
Specifically, liquid chromatography-MS (LC-MS) was attempted to look for lipid 
modifications to Lipin1. Tryptic digestion of the protein, using sequencing grade 
trypsin (Promega), was performed on 100 micrograms of sample in 100 mM 
ammonium bicarbonate in the presence of 1 mM dithiothreitol (DTT), 5 uM 
iodoacetamide, and 7.5% trifluoroethanol. Trypsin was added in a 1:20 ratio with 
lipin-1β and digested overnight. Sample was stored at -80 prior to running LC-MS. 
From this initial experiment, 66% sequence coverage of the peptides identified 
from the mass spectrum was obtained. However, none of the hypothesized lipid 
modifications were observed. In the future forward, repletion of the LC-MS 
experiments with an increased protein amount as well as a more hydrophobic 
column (C4) could allow for enrichment for possible non-covalently bound lipids. 
Additionally, analysis of the lipin-1β sequence in collaboration with Dr. Cathy 
Costello (BUMC) further with the aid of Dr. Cathy Costello, revealed a number of 
canonical N-linked glycosylation sites (S-X-P) throughout the protein, namely 
concentrated in the 540aa intervening domain of lipin-1β (185, 186). It is possible 







observed (187). It would be worthwhile to investigate the presence of 
glycopeptides through MS analysis of lipin treated with n-glycosidase and 
subsequently run through matrix assisted laser desorption and ionization- mass 
spectrometry (MALDI-MS).  
  
A2.3.5. Microscale thermophoresis investigation of lipin binding interactions 
Mircoscale thermophoresis (MST) provides a unique avenue for studying 
high-affinitity binding interactions of lipin-1 with its binding-partners and the 
membrane, overall (188). In the preliminary MST experiments, lipin-1β was 
fluorescently labeled at lysine residues (approximately 5 lysines/ lipin). When the 
labeled lipin (held at a constant 1.8 µM) was titrated with increasing amounts of 
unlabeled purified PPARα (0.3 nM-5800 nM) in 100 mM Tris buffer, pH 8.0 the 
thermophoretic movement markedly changed as indicated by an increase in 
fluorescence. This change in thermophoretic movement results in a sigmoidal 
protein-protein binding curve (figure A2.11A). From fitting the resultant data to 
the Hill equation, the calculation of the equilibrium dissociation constant revealed 
a Kd of 16±7 nM. This dissociation constant is within the physiological range 
observed for transcriptional co-regulators binding to PPARα (between 10-7-10-10 M) 







possesses N-terminal amphipathic helix hypothesized to bind to the membrane, 
and nanodisc phospholipid membrane bilayers in vitro. To this end, full length 
lipin1β was labeled at lysine residues with a 5x excess of NT-495 dye. This 
fluorescent lipin-1β was then titrated with increasing amounts of membrane lipid 
bilayer nanodiscs with a diameter of 8 nm (MSPΔH5, DMPC/DMPG 3:1) 
(concentration range 0.08 nM- 11 µM) in 100 mM Tris buffer pH 8.0.  The resulting 
sigmoidal binding curve suggests binding between lipin1 and the membrane 
nanodiscs with a Kd of 21 nM. While this binding constant is dependent upon the 
number of available binding sites per nanodiscs, there is however, a clear 
difference between the bound and unbound state of lipin-1β with the nanodiscs 
(figure A2.11B). 
 
Figure A2.11. MST reveal tight-binding interactions between lipin-1β and 
PPARα and membrane-bilayer nanodiscs. A, Labeled lipin-1β (held at a constant 
1.8 µM) titrated with increasing amounts of unlabeled purified PPARα (0.3 nM-
5800 nM) in 100 mM Tris buffer, pH 8.0. Fitting data to the hill equation gave Kd = 







membrane lipid bilayer nanodiscs (0.08 nM- 11µM) in 100 mM Tris buffer pH 8.0. 
Fitting data to the hill equation gave Kd ≅ 21 nM.  
 
A2.4. Conclusions and Future Directions 
Overall, optimization of the purification protocols for Nir2 and truncated 
Smp2 yielded expression and purification of high-quality protein for 
crystallographic studies of the structural determinants of lipin-1 cellular 
localization and function. However, recent purifications of Smp2 had increasingly 
poor yields. Because the truncated Spm2 construct is co-transformed with the 
pRare plasmid, it will be worthwhile to have the gene synthesized independently 
to allow for optimal expression in the future. Nir2 expression remains promising, 
however no crystallization condition screens yielded viable crystals for high-
resolution diffraction. Nir2 would be a good candidate for high-throughput 
crystallization condition screening at the Hauptman-Woodward Institute to 
explore vast areas of chemical space with minimal amounts of Nir2 protein.  
SAXS experiments of Nir2 afforded a molecular envelope which displayed 
2-fold symmetry and molecular dimensions that could be consistent with 
formation of a Nir2 dimer in solution. Similarly, SAXS experiments with human-
cell-derived lipin-1β afforded a molecular envelope, which corroborated negative-







the SAXS envelope, AUC data experiments were performed. However, the 
sedimentation behavior of lipin in these experiments was highly non-ideal, 
suggesting the presence of tightly-bound or covalently-bound lipids resulting in 
lower effective-molecular weights. LC-MS experiments aimed at determining the 
identity of any bound lipids to lipin were unsuccessful, however analysis of the 
lipin-1β sequences suggested high prevalence of canonical glycosylation sites in 
the lipin intervening domain, and across the sequence as a whole.  
 Preliminary experiments investigating the binding interactions with lipin-
1β with its predicted binding-partner PPARα and the lipid-bilayer membrane via 
experiments with nanodiscs were performed via MST. These initial experiments 
allowed for determination of preliminary binding constants for these associations. 
MST presents a unique opportunity to study native interactions of lipin with its 
binding partners in that it does not require tagged proteins and will allow for easy 
titration of a complex with a third member of a ternary complex. Therefore, the 
predicted associations between lipin-1, PPARα, and PGC-1α can be investigated. 
Utilization of truncation constructs of lipin and PPARα will allow determination 
of the specific binding sites between the two partners by assessing the impact of 
removing binding-site motifs by deletion or mutagenesis on the Kd. Similar 







mode of membrane association for lipin-1β with the lipid-bilayer nanodiscs. 
Overall, the experiments detailed in this chapter and proposed for the future will 
allow for a molecular understanding of the structural determinants of lipin-1 
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